





















The	 epithelial	 sodium	 channel	 (ENaC)	 is	 a	 heterotrimeric,	 amiloride-sensitive	 Na+	
channel	 located	at	 the	plasma	membrane	of	various	 tissues,	 including	kidneys	and	the	
vasculature.	 ENaC	 abundance	 and	 activity	 at	 the	 plasma	membrane	 is	 pivotal	 for	 the	
maintenance	 of	 total	 body	 Na+,	 blood	 pressure	 and	 blood	 volume	 and	 is	 crucially	
controlled	by	 the	 trafficking	of	ENaC	to	and	 from	the	plasma	membrane.	Recently,	 the	
COMMD	(Copper	Metabolism	Murr1	Domain	containing)	family	have	been	linked	to	the	
regulation	of	 the	trafficking	(transport	 to	and	from	the	plasma	membrane)	of	multiple	





COMMD10.	 Therefore,	 this	 study	 aimed	 to	 investigate	 whether	 COMMD10	 is	 a	 novel	
regulator	 of	 protein	 trafficking	 and	 whether,	 specifically,	 COMMD10,	 similar	 to	 other	
COMMD	members,	is	able	to	regulate	ENaC.		
	
Through	 immunocytochemistry	 experiments,	 with	 various	 trafficking-associated	
proteins	 it	 was	 identified	 that	 COMMD10	 co-localises	 with	 Arf1	 (a	 small	 GTPase	
localised	 to	 the	endoplasmic	reticulum	(ER),	Golgi	and	endosomal	compartments),	but	
not	 with	 other	 ER	 and	 Golgi	 associated	 proteins,	 suggesting	 an	 endosomal	 role	 for	
COMMD10.	 In	 support	 of	 this	 COMMD10	 co-localised	 with	 the	 endosomal	 marker	
transferrin-546	(Tf-546)	and,	when	knocked-down,	COMMD10	reduced	protein	levels	of	
the	recycling,	and	thus	endosome,	associated	proteins	COMMD1	and	Vps35	suggesting	a	
role	 for	 COMMD10	 in	 trafficking	 between	 endosomal	 compartments	 and	 the	 plasma	
membrane.	In	U2OS	cells	with	a	stable	COMMD10	knockdown	there	was	an	increase	in	
endocytosis	of	Tf-546	as	well	as	impaired	Tf-546	recycling	providing	further	evidence	of	




A	 stable	 COMMD10	 knockdown	 (C10	 KD)	 of	 COMMD10	was	 developed	 in	 Fischer	 rat	
thyroid	 (FRT)	 cells	 using	 shRNA.	 FRT	 COMMD10	 knockdown	 cells	 transfected	 with	
plasmids	 encoding	 αβγENaC	 exhibited	 a	 reduction	 in	 amiloride-sensitive	 short-circuit	
current	(Isc-amil)	suggesting	a	reduction	of	ENaC	at	the	plasma	membrane.	Treatment	of	
epithelia	 with	 Brefeldin-A	 highlighted	 that	 COMMD10	 did	 not	 affect	 ENaC	 trafficking	
through	the	synthetic	(i.e.	ER	to	Golgi	to	plasma	membrane)	pathway.	Results	indicated	
that	C10	KD	increases	the	ubiquitination,	and	thus	the	endocytosis,	of	ENaC.	In	support	
of	 this	 FRT	 COMMD10	 KD	 cells	 increased	 the	 endocytosis	 of	 Tf-546	 from	 the	 plasma	
membrane	 providing	 further	 evidence	 that	 COMMD10	 is	 a	 novel	 regulator	 of	 ENaC	
endocytosis.	 Preventing	 endocytosis	 in	 C10	 KD	 epithelia,	 using	 Nedd4-2	 siRNA	 or	 a	
Liddle’s	mutation,	however,	only	partially	rescued	Isc-amil.	Studies	with	transferrin-546	
suggested	 that	 C10	 KD	 delays	 recycling	 of	 the	 transferrin	 receptor	 to	 the	 plasma	




but	 not	 COMMD1,	 protein	 levels	 in	 mouse	 cortical	 collecting	 duct	 cells	 (M1CCD)	
suggesting	COMMD10	regulates	ENaC.	
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Ion	 channels	 are	pore-forming	membrane	proteins	 selective	 for	 the	passage	of	 one	or	
more	 ions	 across	 the	 plasma	 membrane,	 thus	 contributing	 to	 many	 cell	 functions,	
including	 establishing	 the	 cell’s	 resting	membrane	potential,	 regulation	 of	 cell	 volume	
and	 control	 of	 the	 flow	 of	 ions	 across	 secretory	 and	 epithelial	 cells	 (cells	 with	 apical	
(lumen-facing)	and	basolateral	(blood-facing)	membranes).	There	are	over	300	types	of	
ion	channel	 identified	so	 far	(Gabashvili	et	al.,	2007)	and	they	are	 found	in	the	plasma	
membrane	of	 almost	 all	 cell	 types.	 Ions	 are	 able	 to	pass	 through	 channels	down	 their	
electrochemical	 gradient	 without	 the	 input	 of	 ATP.	 The	 archetypal	 ion	 channel	 is	
permeable	to	just	one	species	of	ion,	for	example	the	potassium	channel	KCa3.1	(which	
permits	the	passage	of	K+	only)	(Joiner	et	al.,	1997),	but	some	channels	are	permeable	to	
more	 than	 one	 species	 and	 are	 selective	 for	 another	 parameter	 (e.g.	 only	 positive	





low	water	 potential),	 between	 body	 compartments.	 Epithelia	 form	polarised	 layers	 of	
cells	that	are	connected	through	tight-junctions,	which	prevent	the	“leakage”	of	material	
between	 the	 cells	 (reviewed	 in	 (Dejana,	 2004).	 This	 results,	 therefore,	 in	 two	 distinct	
membrane	compartments,	the	apical	(lumen-facing)	and	basolateral	membranes	(blood-
facing).	Epithelial	Na+	channels	mediate	sodium	reabsorption	from	the	lumen	across	the	














As	 ion	 channels	play	 crucial	 roles	 in	numerous	 cellular	 functions,	 channel	dysfunction	
and	deregulation	has	been	described	in	an	ever-growing	number	of	human	diseases.	For	
example	Cystic	 Fibrosis	 results	 from	mutations	 in	 the	Cystic	 Fibrosis	Transmembrane	
conductance	 Regulator	 (CFTR)	 gene	 causing	 a	 dysfunctional	 CFTR	 chloride	 channel	
(Riordan	et	al.,	 1989);	 one	 form	of	 epilepsy	 is	 caused	 through	mutations	 to	 the	 genes	
encoding	 the	 sodium	 channel,	 Nav	 1.1	 (Escayg	 et	 al.,	 2000);	 and	 Liddle’s	 syndrome,	
characterised	by	hypertension,	is	caused	by	mutations	to	the	genes	encoding	either	the	β	
or	γ	subunits	of	the	epithelial	sodium	channel	(ENaC)	(Hansson	et	al.,	1995).	Due	to	the	
fact	 that	 ion	channel	dysfunction	can	result	 in	a	variety	of	human	diseases,	 identifying	
how	 ion	 channels	 are	 regulated	 and	potential	 regulators	of	 channels	 is	 crucial.	 In	 this	
introduction	 one	 particular	 ion	 channel,	 ENaC,	 will	 be	 described.	 	 The	 regulation	 of	
ENaC,	 particularly	 through	 protein	 trafficking	 pathways,	 will	 be	 described,	 as	 will	 a	
novel	 family	 of	 proteins	 linked	 to	 ENaC	 regulation,	 the	 COMMD	 family.	 The	 results	
described	 later	 in	 this	 thesis	 focus	on	one	COMMD	family	member,	COMMD10,	and	 its	

























It	 was	 initially	 described	 that	 epithelial	 tissues	 are	 able	 to	 transport	 Na+	 across	 the	
apical	 membrane	 (i.e.	 luminal	 face)	 (Koefoed-Johnsen	 &	 Ussing,	 1958;	 Benos,	 1982)	
down	an	electrochemical	gradient	through	an	amiloride-blockable	Na+	channel	(Benos,	
1982)	(for	an	example	of	Na+	reabsorption	across	a	typical	epithelial	cell,	see	figure	1.2-	
based	on	original	 proposed	model	 from	 (Koefoed-Johnsen	&	Ussing,	 1958)).	Hamilton	
and	 Eaton,	 using	 an	 amphibian	 epithelial	 cell	 line,	 and	 Palmer	 and	 Frindt,	 using	 rat	
cortical	collecting	tubule,	subsequently	used	the	patch-clamp	technique	to	characterise	
this	channel	(Hamilton	&	Eaton,	1985;	Palmer	&	Frindt,	1986).	 It	was	determined	that	
amiloride	 reduced	 the	 mean	 opening	 time	 of	 these	 channels	 and,	 when	 open,	 the	
channel	 had	 a	mean	 conductance	 of	 between	 5	 and	 8	 pS	 (picoSiemens)	 (Hamilton	 &	
Eaton,	1985).	Canessa	et	al.	 first	 cloned	αENaC,	 in	1993,	 from	rat	distal	 colon	after	an	
amiloride	 sensitive	 current	 was	 observed	 in	 epithelia	 of	 the	 colon	 (Will	 et	 al.,	 1981;	
Schultz,	 1984;	 Canessa	 et	 al.,	 1993;	 Lingueglia	 et	 al.,	 1993).	 The	 αENaC	 mRNA	 was	
isolated	 by	 expression	 cloning	 in	 Xenopus	 laevis	 oocytes	 but	 the	 amiloride	 sensitive	
current	 generated	 was	 significantly	 lower	 than	 that	 observed	 in	 vivo	 suggesting	 that	
more	ENaC	subunits	or	additional	protein	interactions	were	required	for	maximal	ENaC	
activity.	 The	 β	 and	 γ	 rat	 ENaC	 subunits	 were	 subsequently	 identified,	 by	 expression	
cloning	 in	 Xenopus	 oocytes,	 and	 together	 with	 the	 α	 subunit	 generated	 a	 100-fold	
increase	 in	 amiloride	 sensitive	 current,	 in	Xenopus	 laevis	oocytes,	 suggesting	 all	 three	
subunits	 are	 required	 to	 form	a	 fully	 functional	ENaC	 channel	 (Canessa	et	al.,	 1994b).	
Human	orthologues	have	also	been	cloned	and	show	similar	properties	to	the	rat	ENaC	











































































LIEFHRSYRELFEFFCNNTTIHGAIRLVCSQHNRMKTAFWAVLWLCT                  
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A	 -	 Structure	 of	 the	 Epithelial	 Sodium	 Channel	 (ENaC).	 The	 fully	 functional	 ENaC	 channel	 is	
formed	of	 three	homologous	 subunits,	 αβγ,	 each	with	 two	membrane-spanning	domains,	 one	
extracellular	 loop	 and	 intracellular	 N	 and	 C-termini.	 B	 -	 Common	 features	 and	 membrane	
topology	 of	 ENaC.	 Each	 ENaC	 subunit	 has	 two	 membrane	 spanning	 domains	 (M1-M2),	 one	
extracellular	loop	with	two	glycosylated	cysteine	rich	domains	(CRD)	and	intracellular	N	and	C-
termini.	 Each	C-terminal	 domain	 contains	 a	PY	motif	 C	 -	Human	αENaC	amino	 acid	 sequence	
highlighting	 common	 features	 of	 the	 ENaC	 subunits.	 Membrane	 spanning	 domains	 are	



































Although	 functional	 experiments	 have	 suggested	 that	 one	 α,	 one	 β	 and	 one	 γ	 subunit	
form	a	functional	ENaC	channel	the	exact	stoichiometry	of	a	functional	αβγENaC	is	still	




however,	 two	 further	 models	 that	 have	 also	 been	 proposed	 (2α:1β:1γ	 and	 3α:3β:3γ)	
after	 experiments	 with	 coexpression	 of	 inhibitor-sensitive	 or	 insensitive	 mutants	 in	
Xenopus	oocytes	(Ling	et	al.,	1991;	Firsov	et	al.,	1998;	Kosari	et	al.,	1998).	The	tetrameric	





1999;	 Dijkink	 et	 al.,	 2002;	 Staruschenko	 et	 al.,	 2004a).	 This	 differing	 evidence	 on	 the	
structure	of	ENaC,	though,	could	be	due	to	a	number	of	different	cell	 lines,	models	and	
relating	ENaC	structure	to	ASIC	channels	being	used.	Due	to	this,	although	there	is	some	
evidence	 to	 suggest	 that	 the	 ENaC	 channel	 is	 not	 formed	 in	 a	 1α:1β:1γ	 arrangement	




functional	 ENaC	 channel	 with	 the	 β	 and	 γ	 subunits	 (Waldmann	 et	 al.,	 1995).	 The	










ENaC	 mediates	 sodium	 reabsorption	 in	 many	 epithelial	 tissues	 throughout	 the	 body,	




vasculature	 smooth	muscle	 cells	 (Drummond	 et	 al.,	 2008)	 and	 in	 taste	 receptor	 cells	
(Chandrashekar	 et	 al.,	 2010).	 Through	 its	 role	 in	 sodium	 reabsorption,	 ENaC	 is	
important	in	the	control	of	salt	and	water	homeostasis	as	well	as	the	regulation	of	blood	
pressure	 and	 total	 blood	 volume	 (Rossier	 et	 al.,	 2002).	 Consequently,	 dysfunction	 of	








is	 responsible	 for	 fine-tuning	 Na+	 reabsorption	 in	 the	 distal	 kidney	 (the	 distal	
convoluted	 tubule	 (DCT),	 the	 connecting	 tubule	 (CT)	 and	 the	 cortical	 collecting	 duct	
(CCD))	(approximately	2%	of	reabsorbed	Na+	in	the	kidney	is	through	ENaC)	(Lifton	et	
al.,	2001;	Loffing	et	al.,	2001b;	Mironova	et	al.,	2017)	(see	table	1.1	 for	an	overview	of	
sodium	reabsorption	 in	 the	kidney).	This	 fine-tuning	of	 sodium	reabsorption	 is	highly	
regulated	and,	when	defective	 is,	 in	 general,	more	disruptive	 to	Na+	homeostasis	 than	
malabsorption	in	other	parts	of	the	kidney	(Palmer	&	Schnermann,	2015).	 	The	critical	
role	of	ENaC	 in	 this	 fine-tuning	of	 sodium	reabsorption	 in	 the	kidney	was	highlighted	
when	 a	 knockout	 for	 the	 mineralocorticoid	 receptor	 (receptor	 for	 the	 hormone	
aldosterone	that	targets	ENaC	(causes	an	increase	in	ENaC	expression	–	to	be	described	
later)	 (Hummler	et	al.,	 1997))	 led	 to	 the	development	of	PHA1	 (characterised	by	 salt-
wasting	 and	 low	 blood	 pressure).	 Heterozygous	 mouse	 models	 (αENaC	 +/-)	 showed	






mutations	 in	 the	 PY	 motif,	 prevention	 of	 ubiquitination	 through	 Nedd4-2	 (to	 be	
described	later),	of	either	the	β	or	γ	ENaC	subunits	lead	to	an	accumulation	of	ENaC	at	
the	cell	surface	leading	to	increased	sodium	reabsorption	in	the	kidney	and	thus	results	
in	 increased	 blood	 volume	 and	 blood	 pressure	 (Shimkets	 et	 al.,	 1994;	 Hansson	 et	 al.,	
1995;	Ma	et	al.,	2008;	Rotin	&	Staub,	2011).	This	clinical	manifestation	is	termed	Liddle’s	





































clearance	and	 regulating	 luminal	 fluid	 (Enuka	et	al.,	 2012;	Althaus,	2013;	Hobbs	et	al.,	







CFTR	and	ENaC	critically	 regulate	airway	 surface	 liquid	by	driving	 fluid	 secretion	and	
absorption,	respectively.	It	has	been	shown	that	overexpression	of	ENaC	causes	similar	
symptoms	to	those	seen	in	cystic	fibrosis	(Mall	et	al.,	2004;	Hobbs	et	al.,	2013)	and	it	has	










cells	 (Golestaneh	 et	 al.,	 2001;	 Jernigan	 &	 Drummond,	 2005)	 and	 taste	 receptor	 cells	
(Chandrashekar	 et	 al.,	 2010).	 There	 is	 evidence	 to	 suggest	 that	 endothelial	 ENaC	
(EnNaC)	is	regulated	similarly	to	ENaC	expressed	in	epithelial	cells.	 It	has	been	shown	
that	aldosterone	(an	ENaC	activator)	increases	αENaC	mRNA,	total	EnNaC	protein	level	
and	 the	 membrane	 insertion	 of	 EnNaC	 and	 that	 these	 effects	 can	 be	 prevented	 by	
blocking	mineralocorticoid	receptors	(MR)	in	the	endothelial	cells	(Kusche-Vihrog	et	al.,	











ENaC	 is	 crucial	 in	 maintaining	 total	 body	 water	 and	 sodium	 homeostasis	 that	
consequently	highlighting	ENaC’s	vital	role	in	the	regulation	of	blood	volume	and	blood	

















ubiquitinated	 through	 the	 ubiquitination	 ligase	 Nedd4-2	 and	 endocytosed	 to	 the	 early	
endosome.	At	 the	early	endosome	a	decision	 is	made	and	ENaC	can	either	be	 trafficked	 to	 the	







The	 main	 hormone	 that	 controls	 ENaC	 activity	 is	 the	 mineralocorticoid	 aldosterone,	
although	the	effects	of	aldosterone	vary	and	appear	to	be	tissue-specific	(Escoubet	et	al.,	
1997;	Hager	et	al.,	2001;	Loffing	et	al.,	2001b;	Greig	et	al.,	2002).	Aldosterone	is	secreted,	
from	 the	 zona	 glomerulosa	 in	 the	 adrenal	 cortex,	 in	 low-sodium/low	 blood	 pressure	
conditions	 to	 promote	 sodium	 reabsorption	 in	 the	 amiloride	 sensitive	 distal	 nephron	
(ASDN),	 in	 the	 kidney,	 comprising	 the	 distal	 convoluted	 tubule,	 the	 connecting	 tubule	
	 12	
and	 the	 collecting	 duct.	 Aldosterone	 acts	 as	 a	 ligand	 for	 both	 glucocorticoid	 and	
mineralocorticoid	 receptors	 (GR/MR)	 located	 in	 the	 cytoplasm.	 The	 ASDN	 is	 only	
sensitive	to	aldosterone	due	to	the	presence	of	the	enzyme	11-βHSD2.	11-βHSD2	is	able	
to	 prevent	 circulating	 glucocorticoids	 binding	 to	MR/GR,	meaning	 therefore	 that	 only	
aldosterone	 can	 bind	 to	 MR/GR	 in	 the	 ASDN	 (Funder	 et	 al.,	 1988;	 Bostanjoglo	 et	 al.,	
1998;	 Subramanya	 &	 Ellison,	 2014).	 Once	 ligand-bound,	 the	 receptor-aldosterone-
dynein	complex	translocates	along	microtubules	to	the	nucleus	through	a	nuclear	pore	
(figure	1.4).	Concurrently	as	aldosterone	binds	to	MR,	Hsp90	(heat-shock	protein	90)	is	
released	 from	 the	 MR	 complex	 and	 plays	 a	 crucial	 role	 in	 non-genomic	 action	 of	
aldosterone	 (McEneaney	 et	 al.,	 2007;	 Thomas	 et	 al.,	 2007).	 Once	 in	 the	 nucleus	 the	
ligand-aldosterone	 complex	 binds	 to	 a	 hormone	 response	 element	 in	 the	 promoter	
region	 of	 the	 ENaC	 genes	 (encoding	α,	 β	 or	 γ	 subunits)	 promoting	 their	 transcription	
(Sayegh	et	al.,	1999;	Epple	et	al.,	2000).	Aldosterone	promotes	the	synthesis	of	α,	β	and	
γENaC	 in	 a	 tissue-specific	 manner.	 It	 has	 been	 shown	 that	 αENaC	 transcription	 is	
induced	in	the	kidney	whereas	in	the	colon	the	transcription	of	β	and	γ	ENaC	is	induced	
(Stokes	&	Sigmund,	1998;	Masilamani	et	al.,	1999)	although	it	has	been	shown	that	an	
increase	of	all	 the	ENaC	subunits	 is	required	to	 increase	overall	ENaC	activity	(Volk	et	
al.,	 2005).	 This	 raises	 the	 question	 of	 how,	 in	 the	 kidney	 for	 example,	 aldosterone	
increases	ENaC	activity	when	the	 transcription	of	only	αENaC	 is	 induced.	Loffing	et	al.	
(2001)	and	Masilamani	et	al.	(1999)	have	shown	that	β	and	γ	subunits	are	translocated	
from	 an	 intracellular	 pool	 to	 the	 apical	 membrane	 after	 aldosterone	 stimulation	
(Masilamani	et	al.,	1999;	Loffing	et	al.,	2001b)	suggesting	that	β	and	γ	subunits	present	






Aldosterone	 binds	 to	 Mineralocorticoid/Glucocorticoid	 receptors	 (MR/GR)	 located	 in	 the	
cytoplasm	 and	 is	 translocated	 to	 the	 nucleus	 along	microtubules	 and	 through	 a	 nuclear	 pore.	







mRNA	translation	and	subsequent	protein	 translocation	 into	 the	ER	 is	 the	 first	step	 in	











thus	 suggesting	 that	 the	 assembly	 and	 trafficking	 of	 ENaC	 out	 of	 the	 ER	 is	 a	 very	
inefficient	process	(Cheng	et	al.,	1998;	Prince	&	Welsh,	1998;	Hughey	et	al.,	2004a).	The	
mechanism	that	prevents	efficient	 trafficking	has	not	yet	been	 identified	although	 it	 is	
hypothesised	 that	 all	 three	 subunits	 are	 required	 for	 correct	 protein	 folding	 and	 to	
prevent	 degradation	 of	 subunits	 through	 ER-associated	 degradation	 (ERAD)	 and	 the	
proteasome	(Valentijn	et	al.,	1998;	Buck	et	al.,	2010).	For	example	in	the	kidney,	β	and	γ	
ENaC	 subunits	 are	 expressed	 at	 a	 higher	 level	 than	 the	α-subunit	 (Staub	et	al.,	 1997).	
Due	to	the	lack	of	the	α-subunit	both	β	and	γ-subunits	are	degraded	by	the	proteasome.	
Once	 aldosterone	 induces	 the	 expression	 of	 the	 α-subunit	 the	 β	 and	 γ-subunits	 are	
stabilised	and	functional	ENaC	channels	are	assembled	(Asher	et	al.,	1996;	Masilamani	
et	al.,	1999),	and	it	has	been	shown	that	when	the	αβγ	complex	is	formed	the	half-lives	




(Prince	 &	 Welsh,	 1998;	 Ergonul	 et	 al.,	 2006).	 Glycosylated	 ENaC	 is	 necessary	 for	
interactions	with	ER	 folding	proteins,	 like	 calnexin	 and,	 on	mature	proteins,	 stabilises	




ENaC	 that	exits	 the	ER	 is	either	 transported	 to	 the	Golgi	or	directly	 to	 the	cell	 surface	
(Hughey	et	al.,	2004a;	Hughey	et	al.,	2004b).	The	exit	of	ENaC	from	the	ER	appears	to	be	
regulated	by	the	α-subunit,	which	contains	a	consensus	sequence	for	an	interaction	with	
COPII	 machinery	 (Mueller	 et	 al.,	 2007).	 	 In	 brief,	 trafficking	 of	 newly	 synthesised	
proteins	 from	 the	 ER	 to	 the	 Golgi	 is	 mediated	 by	 COPII	 complexes	 (Bednarek	 et	 al.,	
1995).	These	complexes	accumulate	at	the	ER	forming	a	bud.	As	the	membrane	buds	off	
from	 the	 membrane	 several	 proteins	 are	 incorporated	 into	 the	 maturing	 vesicles	
(Matsuoka	et	al.,	1998).	How	the	vesicles	finally	bud	off	from	the	membrane	is	unknown,	
but	once	the	scission	process	has	occurred	the	vesicles	are	carried	along	microtubules	to	




in	 the	 folding	 of	 transmembrane	 or	 secretory	 proteins,	 are	 initially	 trafficked	 to	 the	
Golgi	 to	 undergo	 Golgi	 specific	 modifications	 (see	 1.2.2.3	 for	 further	 details)	 and,	
therefore	need	to	be	returned	to	the	ER.	Proteins	that	are	destined	for	the	ER	contain	a	
KDEL	 (Lysine-Aspartic	Acid-Glutamic	Acid-Leucine)	 retention	motif	 (Munro	&	Pelham,	
1987).	Golgi	to	ER	transport;	through	COPI	vesicles,	returns	ER-resident	proteins	from	








Proteins	exported	 from	the	ER	 to	 the	Golgi	are	extensively	sorted,	post-translationally	
modified	 and	 then	 packaged	 to	 be	 either	 secreted	 from	 the	 cells,	 or	 transported	 to	
various	 organelles	 throughout	 the	 cell,	 such	 as	 the	 lysosome.	 The	 Golgi	 consists	 of	 a	
series	of	flattened	cisternal	membranes	stacked	on	top	of	each	other,	with	an	ER-facing	
cis-face,	 termed	 the	 cis-Golgi,	 and	 a	 plasma	 membrane-facing	 trans-face,	 termed	 the	
trans-Golgi.	Each	Golgi	cisterna	contains	different	protein	modification	enzymes	which	
catalyse	 appropriate	 post-translational	 modifications	 to	 the	 cargo	 proteins,	 such	 as	





Beyond	 the	 trans-Golgi	 is	 the	 trans-Golgi	 network	 (TGN),	 a	 compartment	 viewed	 as	 a	
cargo	 sorting	 station,	 where	 proteins	 are	 sorted	 into	 transport	 carriers	 that	 are	
trafficked	to	various	destinations,	including	both	the	apical	and	basolateral	membranes	
(in	 epithelia),	 endosomal	 compartments	 (encompassing	 both	 the	 early	 endosome	 and	
recycling	endosome)	and	the	lysosome	(reviewed	in	(Bard	&	Malhotra,	2006)).	The	TGN	
recruits	 cytosolic	 cargo	 adaptors	 to	 bind	 cargo	molecules	 prompting	 the	 formation	 of	






For	 ENaC	 in	 particular,	 as	 ENaC	 transits	 the	 Golgi	 it	 undergoes	 maturation	 through	
proteolytic	 cleavage	 and	 glycan	 processing	 (Rotin	 et	 al.,	 2001;	 Ergonul	 et	 al.,	 2006).	
There	are	two	different	types	of	αβγENaC	complex	that	have	been	described	at	the	cell	
surface.	Firstly	an	active/mature	form	with	complex	N-glycans	that	have	been	processed	
and	 cleaved	by	 serine	proteases	 in	 the	Golgi.	 Secondly,	 inactive/immature	 forms	with	
high	mannose	type	N-glycans	that	are	believed	to	bypass	the	Golgi	(Hughey	et	al.,	2004b;	
Frindt	 et	 al.,	 2016b),	 a	 phenomenon	 that	 has	 previously	 been	 described	 for	 other	
proteins	(Baldwin	&	Ostergaard,	2002;	Yoo	et	al.,	2002;	Deryugina	et	al.,	2004).	
	
There	 are	 a	 number	 of	 serine	 proteases	 that	 have	 been	 reported	 to	 cleave/activate	
αβγENaC	 including	 furin	 (Hughey	 et	 al.,	 2004a;	 Hughey	 et	 al.,	 2004b;	 Kleyman	 et	 al.,	
2009),	 channel-activating	 protease	 (Vallet	 et	 al.,	 1997;	 Vallet	 et	 al.,	 1998),	 prostasin	






activate	 ENaC	 in	 oocytes,	 Chinese	 Hamster	 Ovary	 and	 MDCK	 (Madin-Darby	 canine	
epithelial	 cells)	 cells	 and	 increases	 channel	 open	 probability	 (Chraibi	 et	 al.,	 1998;	
Caldwell	 et	 al.,	 2004;	 Hughey	 et	 al.,	 2004a;	 Sheng	 et	 al.,	 2006).	 αENaC	 has	 two	 furin	
















shown	 by	 a	 reduction	 in	 Na+	 current	 (Carattino	 et	 al.,	 2006).	 Channels	 that	 lack	
proteolytic	 cleavage	 sites	 for	 furin	 exhibit	 a	much-reduced	 activity	 and	 increased	Na+	
self-inhibition	(Sheng	et	al.,	2006).		
	
The	other	proteases	 that	 are	known	 to	activate	ENaC	are	not	 located	within	 the	Golgi	
and	 can	 be	 found	 either	 at	 the	 apical	 membrane	 or	 extracellularly.	 For	 example,	




2002),	which,	 considering	 that	serine-protease	cleavage	 is	known	to	 increase	 the	Po	of	
ENaC,	 suggests	 that	 aldosterone	 is	 able	 to	 augment	 ENaC	 activity	 both	 by	 increasing	
ENaC	 subunit	 synthesis	 and	 by	 increasing	 the	 Po	of	 the	 channel.	 Activation	 of	 urinary	
prostasin,	through	aldosterone,	has	been	linked	to	hypertension	(Zhu	et	al.,	2008;	Koda	






The	TGN	 is	 crucial	 for	 the	maintenance	of	 cell	polarity	and	regulates	 the	 trafficking	of	
proteins	 to	 their	 appropriate	 cellular	 destination,	 such	 as	 the	 apical	 and	 basolateral	





Mellman	&	Nelson,	 2008).	 Once	 proteins	 have	 trafficked	 away	 from	 the	 TGN	 towards	
their	appropriate	membrane	exocytosis	of	the	cargo	protein	is	initiated	by	a	Ca2+	influx	












In	brief,	 target	SNAREs	 (t-SNAREs)	and	vesicle	SNAREs	 (v-SNAREs)	 induce	membrane	





et	 al.,	 2003;	 Condliffe	 et	 al.,	 2004)	 although	 it	 has	 been	 hypothesised	 that	 different	




channels	 and	 transporters	 (Tobi	 et	 al.,	 1998).	 Similarly	 to	 syntaxin	 1A,	 SNAP-23	was	
shown	 to	 inhibit	αβγ-ENaC	current	when	co-expressed	 together	 (Saxena	et	al.,	 2006a)	
but	 at	 low	 concentrations	 stimulated	 amiloride-sensitive	 ENaC	 current	 (Saxena	 et	 al.,	





that	RhoA	augmented	plasma	membrane	 levels	of	ENaC	 through	 its	 stimulation	of	 the	
membrane	phospholipid	PI(4)P5K	(Staruschenko	et	al.,	2004b).	PI(4)P5K	is	an	enzyme	
that	 catalyses	 the	 formation	of	 PI(4,5)P2,	which	has	 been	 shown	 to	have	 a	 role	 in	 the	





by	 enhancing	 exocytosis	 from	 an	 intracellular	 pool	 (Snyder,	 2000;	 Butterworth	 et	 al.,	
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2005b;	 Yang	 et	 al.,	 2006)	 upon	 stimulation	 by	 vasopressin	 (a	 key	 regulator	 of	 water	
retention	in	the	kidney)	(Reif	et	al.,	1986;	Robert-Nicoud	et	al.,	2001).	When	water	loss	
exceeds	 intake,	 vasopressin	 is	 secreted	 from	 the	 hypothalamus	 to	 promote	 water	
reabsorption	 in	 the	distal	nephron.	Vasopressin	binds	 to	vasopressin	receptors	on	 the	
basolateral	 membrane	 of	 distal	 nephron	 cells	 prompting	 an	 increase	 in	 intracellular	
cAMP	 levels,	 thereby	 causing	 a	 rapid	 insertion	 of	 ENaC	 and	 AQP2	 into	 the	 apical	





Following	 their	 completion	 of	 their	 roles	 within	 the	 membrane,	 membrane	 proteins,	
lipids	and	ligands	can	be	retrieved	from	the	plasma	membrane	by	endocytosis	through	
either	 clathrin-mediated	 (CME)	 or	 clathrin-independent	 (CIE)	 pathways.	 It	 is	 believed	
that	adaptor	protein-2	(AP-2)	mediates	CME	endocytosis	through	tyrosine	or	di-leucine	
based	motifs	 (Marmor	&	Yarden,	 2004)	with	 common	 cargoes	 such	 as	 the	 transferrin	
receptor	 (Motley	et	al.,	 2003)	 and	 the	 epidermal	 growth	 factor	 receptor	 (Huang	et	al.,	
2004).	 Clathrin-mediated	 endocytosis	 occurs	 in	 three	 distinct	 stages;	 1	 –	 assembly	 of	
clathrin	and	formation	of	coated	pits,	2	–	invagination	of	coated	pits	and	3	–	budding	of	
the	coated	vesicles	(Mousavi	et	al.,	2004).	The	plasma	membrane’s	curvature,	to	form	a	
vesicle,	 is	 induced	by	 the	binding	of	 epsin	 to	PIP2	(phosphatidylinositol	 bisphosphate)	




Numerous	 cargoes	 have	 been	 shown	 to	 be	 endocytosed	 independently	 from	 clathrin,	
named	 clathrin-independent	 pathways	 (CIE)	 (reviewed	 in	 detail	 by	 (Mayor	&	Pagano,	
2007)).	 Caveolae-mediated	 endocytosis	 is	 the	 best	 described	 CIE	 (Parton,	 2003).	
Caveolae-mediated	 endocytosis	 occurs	 similarly	 to	 CME	with	 the	 formation	 of	 coated	
pits	and	subsequent	budding	of	coated	vesicles,	although	these	vesicles	are	coated	with	
sphingolipids	 and	 cholesterol	 (Simons	&	 Ikonen,	 1997).	 A	 number	 of	 other	 CIEs	 have	






suggested	 that	 internalisation	can	occur	 through	 lipid	rafts	(Hill	et	al.,	2002;	Hill	et	al.,	
2007).		
	
αβγENaC	 has	 been	 shown	 to	 directly	 interact	 with	 epsin	 and	 has	 been	 shown	 to	 be	
located	 in	 the	 same	 cellular	 fraction	 as	 clathrin-coated	 vesicles	 (Wang	 et	 al.,	 2006;	







Ubiquitination	 of	 membrane	 proteins,	 by	 E3	 ubiquitin	 ligase	 enzymes,	 initiates	 their	
endocytosis	 and	 subsequent	 journey	 towards	 the	 early	 endosome	 (EE)	 (reviewed	 in	
(Piper	et	al.,	2014)).	Sorting	events	at	the	EE	determine	the	fate	of	endocytosed	proteins;	
directing	 them	 for	 either	 recycling	 back	 to	 the	 plasma	 membrane	 (see	 1.2.3.6)	 or	
degradation	 to	 the	 lysosome,	 through	 the	 late	 endosome	 (LE)/multivesicular	 bodies	
(MVB).	 Recognition	 of	 ubiquitinated	 cargo	 is	 carried	 out	 by	 Hrs	 (Hepatocyte	 growth	
factor-regulated	 tyrosine	 kinase)	 (Raiborg	 et	 al.,	 2002),	 which	 in	 turn	 prompts	 the	






2001;	Wiemuth	 et	al.,	 2007;	 Eaton	 et	al.,	 2010;	 L	 et	al.,	 2013).	 Ubiquitination	 of	 ENaC	
occurs	 through	 the	 E3	 ubiquitin	 ligase	 Nedd4-2	 (neural	 precursor	 cell	 expressed	
developmentally	 down-regulated	 gene	 4-2).	 Nedd4-2’s	 importance	 to	 ENaC	
ubiquitination	 is	 highlighted	 in	 Liddle’s	 syndrome	 (see	 1.2.2.1)	whereby	mutations	 in	
the	PY	motif	of	the	C-terminal	domains	of	the	ENaC	subunits	prevent	ubiquitination	and	
results	 in	 hypertension	 and	 hypokalaemia.	 The	 PY	 motif	 located	 in	 the	 C-terminal	





al.,	 2006).	 Ubiquitinated	 ENaC	 is	 recruited	 to	 the	 early	 endosomes	 through	 UIM	
(ubiquitin-interacting	motif)	components,	and	epsin	specifically	(Wang	et	al.,	2006),	of	
the	endosomal	complex	(Clague	&	Urbe,	2006)	before	being	trafficked	to	the	 lysosome	
for	 degradation.	 It	 has	 recently	 been	 described	 that	 the	 interaction	 between	 Hrs	 and	
ENaC	is	crucial	for	the	targeting	of	ENaC	for	degradation	(Zhou	et	al.,	2010).		
	
The	aldosterone	 induced	serum	and	glucocorticoid	 regulated	kinase	1	 (SGK1)	 is	a	key	
regulator	 in	 preventing	 ENaC	 ubiquitination	 through	 its	 inhibition	 of	 Nedd4-2	
(Debonneville	et	al.,	2001).	It	was	identified	that	SGK1	increases	the	amiloride-sensitive	
ENaC	current	both	in	Xenopus	oocytes	(Bohmer	et	al.,	2000;	Rauh	et	al.,	2006)	as	well	as	
numerous	cell	 lines	(Snyder	et	al.,	2002;	Watt	et	al.,	2012;	 Ismail	et	al.,	2014;	 Jacobs	et	
al.,	2016).	SGK1	does	this	 through	phosphorylation	of	 the	ubiquitin	 ligase	Nedd4-2	(at	
Ser-221,	Thr-246	and	Ser-327)	(Debonneville	et	al.,	2001;	Snyder	et	al.,	2002),	resulting	
in	the	recruitment	of	the	14-3-3	protein	(Bhalla	et	al.,	2005;	Nagaki	et	al.,	2006)	which	in	
turn	 prevents	 the	 interaction	 between	 Nedd4-2	 and	 ENaC,	 thus	 inhibiting	 ENaC	
ubiquitination.	 A	 mouse	 knockout	 of	 SGK1	 resulted	 in	 reduced	 amiloride-sensitive	





ubiquitination	 (Ke	 et	 al.,	 2010;	 Chang	 et	 al.,	 2011).	 This	 occurs	 through	 interactions	
between	COMMD1	and	SGK1	(Ke	et	al.,	2010)	suggesting	possibly	that	COMMD1	is	able	










Recycling	 of	 endocytosed	 cargo	 is	 crucial	 for	 allowing	 the	 rapid	 replenishment	 of	
membrane	 proteins,	 if	 required.	 As	 described	 above,	 EE	 sorting	 of	 endocytosed	 cargo	
determines	 their	 fate:	 either	 recycling	 of	 the	 cargo	 back	 to	 the	 plasma	membrane	 of	
degradation	 in	 the	 lysosome	 (see	 1.2.3.5).	 Deubiquitination	 of	 endocytosed	 cargo,	 by	
deubiquitinating	 enzymes	 (DUBs),	 allows	 cargo	 to	 be	 recycled	 back	 to	 the	 plasma	
membrane.	In	epithelial	cells,	this	recycling,	at	the	apical	membrane,	can	occur	through	
either	 a	 “fast”	 or	 “slow”	 route	 (Sheff	 et	 al.,	 1999;	 Sonnichsen	 et	 al.,	 2000):	 “fast”	 is	

















2012),	 have	 been	 shown	 to	 be	 recycled	 back	 to	 the	 plasma	membrane,	 although	 the	
exact	 mechanisms	 for	 ENaC’s	 recycling	 have	 yet	 to	 be	 described.	 Butterworth	 et	 al.	
(2007)	 described	 the	 deubiquitinating	 enzyme	 (DUB)	 UCH-L3	 as	 being	 important	 in	









One,	 relatively	newly,	described	protein	 complex	 implicated	 in	endosomal	 sorting	and	
recycling	 is	 the	 Retromer	 complex	 (figure	 1.7).	 This	 Retromer	 complex	 consists	 of	 a	
WASH	 (Wiskott-Aldrich	 syndrome	 protein	 and	 SCAR	 Homologue	 complex)	 complex	
(comprising	Strumpellin,	SWIP,	CCDC53,	WASH1	and	Fam21),	a	CCC	complex	(consisting	
COMMD1,	 CCDC22,	 CCDC93	 and	C16orf62)	 and	 the	Retromer	 itself	 (comprising	 a	 Snx	
complex	and	a	Vps	complex).	Retromer	has	been	implicated	in	facilitating	the	recycling	
of	numerous	membrane	proteins	including	the	mannose	6-phosphate	receptor	(Arighi	et	
al.,	 2004),	 Crumbs	 (Crb)	 (Pocha	 et	 al.,	 2011),	 SorL1	 (Nielsen	 et	 al.,	 2007),	 GLUT1	
(Temkin	 et	 al.,	 2011)	 and	 the	 β2-adrenergic	 receptor	 (β2AR)	 (Temkin	 et	 al.,	 2011;	
Steinberg	et	al.,	2013).	Since	ENaC	is	known	to	be	regulated	by	COMMD	family	members	




of	 disorders,	 including	 Alzheimer’s	 and	 Parkinson’s	 diseases.	 Through	 microarray	
studies	 Retromer	was	 first	 linked	 to	 Alzheimer’s	 disease	 in	 2005	 (Small	 et	al.,	 2005).	
Further	work,	both	in	vivo	(Lane	et	al.,	2010;	Wen	et	al.,	2011)	and	in	vitro	(Vieira	et	al.,	
2010;	 Mecozzi	 et	 al.,	 2014)	 provided	 further	 evidence	 of	 this,	 most	 likely	 through	
disruptions	 to	 Vps35	 (part	 of	 the	 Vps	 complex)	 causing	 increased	 pathological	
processing	of	 the	 amyloid	precursor	protein,	 through	 increasing	 the	 time	 the	 amyloid	
precursor	protein	 resides	 in	 endosomal	 compartments	 (Lane	et	al.,	 2010;	Vieira	et	al.,	
2010;	 Wen	 et	 al.,	 2011;	 Mecozzi	 et	 al.,	 2014).	 Similarly,	 Vps35	 mutations	 have	 been	
linked	 to	 late-onset	 Parkinson’s	 disease	 (Vilarino-Guell	 et	 al.,	 2011;	 Zimprich	 et	 al.,	
2011)	which	prevents	Vps35	interacting	with	the	WASH	complex	(McGough	et	al.,	2014;	
Zavodszky	et	al.,	2014).	Disruption	to	Retromer	has	also	been	linked	to	Down	Syndrome	
(through	 deficiency	 of	 Snx27)	 (Wang	 et	 al.,	 2013)	 and	 hereditary	 spastic	 paraplegia	
(most	 likely	 through	 Strumpellin)	 (Valdmanis	 et	al.,	 2007).	 This	 highlights	 the	 crucial	
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A	 proposed	 model	 to	 represent	 the	 Retromer,	










COMMD1,	 previously	Murr1,	was	 first	 described	 due	 to	 its	 proximity	 to	 the	 imprinted	
U2af1-rs1	gene	 in	mice	 (Nabetani	et	al.,	 1997).	Through	positional	 cloning,	 a	mutation	
was	identified	in	the	Murr1	gene	as	a	cause	for	copper	toxicosis	in	the	Bedlington	terrier	
canine	strain	 (van	De	Sluis	et	al.,	2002).	Murr1	 is	highly	conserved	 in	mammals	and	 is	
ubiquitously	expressed	with	the	highest	expression	in	the	testes,	heart	and	liver	(van	De	
Sluis	 et	 al.,	 2002).	 Using	 bioinformatic	 and	 biochemical	 approaches	 Burstein	 et	 al.	
identified	a	family	of	nine	other	proteins	structurally	and	functionally	related	to	Murr1	
(Burstein	 et	 al.,	 2005).	 This	 family	 represents	 a	 recently	 identified	 family	 of	
evolutionarily	conserved	proteins,	named	COMMD1-10	to	recognise	the	initial	described	
COMMD	 role	 in	 copper	 metabolism.	 All	 COMMD	 family	 proteins	 contain	 a	 highly	
conserved	(between	both	family	members	and	across	species)	C-terminal	COMM	domain	
(figure	 1.8	 A-B).	 This	 COMM	 domain	 is	 a	 previously	 unrecognised,	 leucine-rich	 motif	
approximately	 70	 amino	 acids	 in	 length.	 With	 the	 exception	 of	 COMMD6,	 which	 is	
comprised,	 mostly,	 of	 the	 COMM	 domain,	 each	 COMMD	 protein	 possesses	 N-terminal	
structures	that	are	not	conserved,	at	the	amino	acid	level,	amongst	family	members	but	
are	 conserved	 through	 species.	 All	 COMMD	 proteins	 are	 widely	 expressed	 in	 human	














the	mRNA	 level,	 COMMD3	 is	 expressed	 highest	 in	 the	 thymus,	 COMMD5	 is	 expressed	
highest	 in	 the	heart	and	COMMD10	 is	expressed	highest	 in	 the	 thyroid	(Burstein	et	al.,	
2005).	 At	 the	 protein	 level,	 COMMD3	 is	 expressed	 highest	 in	 the	 lung,	 bladder	 and	







The	 COMM	 domain	 of	 all	 ten	 family	 members	 is	 partially	 conserved	 (A).	 Analysis	 of	 the	







been,	 by	 far,	 the	 most	 thoroughly	 studied	 COMMD	 family	 member.	 COMMD1	 is	














in	 the	 liver	 (the	 vital	 organ	 for	maintaining	 copper	 homeostasis)	 of	 the	 affected	 dogs	
(Klomp	 et	 al.,	 2003).	 The	 human	 form	 of	 copper	 toxicosis	 is	 termed	 Wilson	 disease,	
which	 is	 caused	 by	 mutations	 in	 the	 gene	 encoding	 the	 copper-transporting	 ATPase	
(ATP7B)	(Tanzi	et	al.,	1993;	Yamaguchi	et	al.,	1993),	preventing	copper	transport	out	of	
the	 cell	 and	 resulting	 in	 intracellular	 copper	 accumulation.	 Although	 no	 COMMD1	
mutations	have	been	identified	in	Wilson	disease	(Lovicu	et	al.,	2006;	Wu	et	al.,	2006)	it	
has	 been	 described	 that	 COMMD1	 directly	 interacts	 with	 ATP7B	 (Tao	 et	 al.,	 2003;	





2006).	 This	 was	 further	 supported	 by	 work	 from	Muller	 et	 al.,	 who	 described	 that	 a	
number	 of	 COMMD	 proteins	 were	 significantly	 down-regulated	 in	 hepatic	 cells	 with	
copper	 overload	 (Muller	 et	 al.,	 2007).	 	 Interestingly,	 some	 ATP7B	 mutations	 seen	 in	
Wilson	 disease	 increased	 the	 interaction	 of	 COMMD1	 and	 ATP7B	 causing	 increased	
degradation	 of	 the	 copper	 transporter	 (de	 Bie	 et	 al.,	 2007).	 It	 was	 subsequently	








NF-κB	 (Nuclear	 Factor	 kappa	 B)	 proteins	 are	 a	 group	 of	 transcription	 factors	 that	
regulate	the	expression	of	a	large	number	of	genes	involved	in	immune	responses,	viral	
replication,	 apoptosis,	 inflammation,	 cell	 cycle	 control	 and	 oncogenesis	 (reviewed	 in	
(Hayden	&	Ghosh,	2012).	NF-κB	proteins	consist	of	 five	members;	Rel,	RelA,	RelB,	NF-
κB1	and	NF-κB2	(Yu	et	al.,	2009).	Through	 interactions	with	 IκB	(NF-κB	 inhibitor)	 the	
activity	of	NF-κB	 is	 tightly	regulated.	Phosphorylation	of	 IκB	targets	 it	 for	degradation	






the	 degradation	 of	 IκB,	 thus	 down-regulating	 NF-κB	 (Mao	 et	 al.,	 2011).	 More	 recent	
evidence	suggests	that	COMMD1	interacts	with	RelA	(Burstein	et	al.,	2005;	de	Bie	et	al.,	
2006)	and	prompts	its	degradation	through	an	E3	ubiquitin	ligase	(Thoms	et	al.,	2010;	
O'Hara	 et	 al.,	 2014).	 It	 has	 also	 been	 shown	 that	 COMMD1	 is	 able	 to	 bind	 NF-κB	








A	previous	study	 in	our	 laboratory	 identified	that	COMMD1	was	able	 to	bind	to	 the	C-
terminal	domain	of	the	δ-ENaC	subunit	as	well	as	to	the	α-,	β-	and	γ-ENaC	subunits	and	
co-expression	of	COMMD1	with	either	δβγ	or,	to	a	lesser	extent,	αβγENaC	resulted	in	a	
reduction	 in	sodium	current,	 suggesting	a	reduction	 in	ENaC	 in	 the	plasma	membrane	
and	a	possible	increase	in	ENaC	degradation	(Biasio	et	al.,	2004;	Ke	et	al.,	2010).	It	was	
identified	 that	 the	 C-terminal	 domain	 of	 δ-ENaC	 was	 crucial	 for	 mediating	 COMMD1	
function,	 and	 removal	 of	 this	 C-terminal	 domain	 rescued	 sodium	 current.	 Subsequent	
studies	have	 shown	 that	COMMD1	decreases	ENaC	numbers	at	 the	plasma	membrane	
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and	increases	the	level	of	ENaC	ubiquitination	(Ke	et	al.,	2010;	Chang	et	al.,	2011).	This	
happens	 through	 interactions	between	COMMD1	and	SGK1,	but	not	 through	COMMD1	
and	 Nedd4-2	 (Ke	 et	 al.,	 2010),	 promoting	 an	 increase	 in	 localisation	 of	 ENaC	 in	 the	
recycling	 endosome	 (Chang	 et	 al.,	 2011).	 Subsequently	 it	 has	 been	 described	 that	 all	
COMMD	family	members	are	able	to	coimmunoprecipitate	with	ENaC	and	that	COMMD3	
and	 COMMD9	 are	 also	 able,	 similarly	 to	 COMMD1,	 to	 down-regulate	 ENaC	 (Liu	 et	 al.,	






Recently,	 there	 have	 been	 a	 number	 of	 studies	 investigating	 the	multiple	 functions	 of	
COMMD1.	 Numerous	 functions	 for	 COMMD1	 have	 been	 described,	 including	 the	
regulation	of	copper	homeostasis,	regulation	of	ENaC	and	regulation	of	NF-κB	signalling.	
More	 functions	 for	 COMMD1	 have	 started	 to	 be	 described,	 including	 roles	 in	 the	
regulation	of	other	ion	channels,	such	as	NKCC1	(Smith	et	al.,	2013)	and	CFTR	(Drevillon	
et	 al.,	 2011;	 de	 Becdelievre	 et	 al.,	 2013).	 Most	 recently	 COMMD1	 has	 also	 been	
implicated	 in	 the	 CCC	 (ccdc22/ccdc93/COMMD1)	 complex,	 a	 recycling-associated	
complex,	suggesting	a	role	 for	COMMD1	in	trafficking	of	cargo	to	and	from	the	plasma	
membrane	 (Phillips-Krawczak	 et	 al.,	 2015;	 Bartuzi	 et	 al.,	 2016)	 (described	 in	 further	
detail	in	1.3.4).	COMMD1	has	also	been	implicated	in	various	cancer	types	and	cell	lines	
(van	 de	 Sluis	 et	 al.,	 2010;	 Zoubeidi	 et	 al.,	 2010;	 Fernandez	 Masso	 et	 al.,	 2013;	 Li	 &	
Burstein,	2014;	Li	et	al.,	2014;	Taskinen	et	al.,	2014;	Fedoseienko	et	al.,	2016;	Yeh	et	al.,	
2016)	 and	 exploring	 this	 further	 would	 be	 an	 interesting	 avenue	 for	 further	






COMMD10,	 although	 having	 no	 described	 function,	 has	 been	 shown	 to	 result	 in	
embryonic	lethality	at	day	8.5-post	coitum	in	homozygous	knockout	mice	suggesting	it	
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plays	a	 crucial	 cellular	 role	 (unpublished	data,	Burstein	and	McDonald)	 (figure	1.9	A).	
Early	studies	have	shown	that	COMMD10	interacts	with	Arf1	(ADP-ribosylation	factor	1)	
(figure	 1.9	 B),	 a	 COPI-associated	 protein	 with	 several	 functions	 including	 the	
recruitment	 of	 vesicle	 coat	 proteins	 at	 the	 Golgi.	 	 TAP	 (Tandem	 Affinity	 Purification)	
screen	 results	 have	 revealed	 that	 COMMD10	 interacts	 with	 many	 other	 trafficking-
associated	proteins,	including	COPB1	(required	for	budding	from	Golgi	after	recruitment	
by	 Arf1),	 Rab1a	 (recruits	 proteins	 for	 vesicle	 formation,	 movement,	 tethering	 and	
fusion)	 (figure	 1.9	 C)	 and	 ccdc93	 (Wan	 et	 al.,	 2015;	 Burstein	 &	 Starokadomskyy,	
unpublished	work)	suggesting	a	possible	role	for	COMMD10	in	the	regulation	of	protein	





adaptors	 in	 the	Golgi	 to	 localise	 to	COPI	vesicles	 to	 form	carriers	 that	are	 transported	
from	 the	 cis-Golgi	 to	 the	 rough	 endoplasmic	 reticulum	 (Sohn	 et	 al.,	 1996).	 The	MxxE	
motif	is	found	in	all	Arf	proteins	that	are	known	to	associate	with	the	Golgi.		This	motif	is	
used	by	Arf1	to	bind	membrin	(SNARE	protein)	to	localise	to	the	cis-Golgi.	Based	on	this	
evidence	 it	was	hypothesised	 that	COMMD10	acts	as	a	regulator	of	protein	 trafficking,	
possibly	between	the	Golgi	and	the	ER.		
	
Analysis	 of	 the	 mRNA	 expression	 pattern	 of	 COMMD10	 suggests	 that	 it	 is	 widely	
expressed	throughout	the	body	(Burstein	et	al.,	2005).	At	the	mRNA	level,	COMMD10	is	
expressed	highest	in	the	thyroid,	kidney,	pancreas	and	uterus	(Burstein	et	al.,	2005).	At	
the	 protein	 level	 COMMD10	 is	 expressed	 highest	 in	 the	 pancreas	 shown	 through	





No	 study	 has	 been	 conducted	 to	 investigate	 the	 cellular	 function	 of	 COMMD10,	 but	
genome-wide	 studies	 have	 identified	 COMMD10	 as	 being	 a	 common	 gene	 underlying	
asthma	 (Smolonska	 et	 al.,	 2014)	 (believed	 to	 be	 through	 NF-κB),	 colorectal	 cancer	










































protein	 trafficking.	 COMMD1	 has	 been	 described	 as	 being	 crucial	 for	 the	 retrograde	
transport	of	the	copper	transporter,	ATP7B,	from	endosomal	vesicles	to	the	trans-Golgi	
(Miyayama	et	al.,	2010)	although	the	mechanism	wasn’t	described.	A	 further	study,	by	
Phillips-Krawczak	 et	 al.	 (2015),	 described	 COMMD1	 as	 being	 part	 of	 the	 CCC	
(COMMD1/CCDC22/CCDC93)	 complex	 and	 thus,	 the	 Retromer	 (through	 interactions	
between	ccdc22,	 ccdc93	and	Retromer	proteins)	 (Harbour	et	al.,	 2012;	Freeman	et	al.,	








complex,	 similarly	 to	 COMMD1,	 and,	 when	 depleted,	 resulted	 in	 reduced	 Notch	
expression	at	the	cell	surface,	suggesting	COMMD9	plays	a	critical	role	in	the	endosomal	
sorting	 of	 Notch.	 This	 study	 also	 identified,	 through	 tandem	 affinity	 purification,	 that	
COMMD9	interacts	with	3	endosomal-associated	Rab	proteins,	Rab	5,	Rab7	and	Rab11,	
providing	 further	 evidence	 for	 a	 role	 for	 COMMD9	 in	 endosomal	 trafficking	 (Li	 et	 al.,	






for	 endosomal	 sorting	 of	 the	 low-density	 lipoprotein	 receptor	 (LDL-R),	 therefore	
increasing	 plasma	 low-density	 lipoprotein	 (LDL)	 levels	 (Bartuzi	 et	 al.,	 2016).	 It	 had	
previously	 been	 described	 that	 CCDC22	 or	 COMMD1	 inactivation	 impaired	 the	
formation	of	 a	 stable	CCC	 complex	 (Starokadomskyy	et	al.,	 2013;	Phillips-Krawczak	et	
al.,	 2015)	 and	 this	 study	 showed	 that	 a	 COMMD1	 loss-of-function	 mutation	 in	 dogs	
resulted	in	hypercholesterolaemia	due	to	disruption	to	the	CCC	complex	(Bartuzi	et	al.,	
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2016).	Further	 investigation	suggested	 that	plasma	LDL	 levels	were	 increased	 in	mice	
expressing	either	a	hepatic-specific	knockout	of	COMMD1	or	COMMD9	due	to	disruption	
to	 the	 CCC	 complex	 (Bartuzi	 et	 al.,	 2016)	 highlighting	 further	 that	 COMMD	 family	
members	are	important	regulators	of	endosomal	trafficking.		
	
Evidence	 from	 these	 studies,	 as	 well	 as	 immunocytochemistry	 (Klomp	 et	 al.,	 2003),	
would	 suggest	 that	 COMMD1	 is	 located	 in	 endosomal	 compartments.	 A	 potential	
mechanism	 for	 how	 COMMD1	 is	 recruited	 to	 the	 endosomal	 compartments	 was	
proposed	 by	 Burkhead	 et	 al.	 who	 identified	 that	 COMMD1	 specifically	 binds	 the	
signalling	 and	 regulatory	 lipid,	 phosphatidylinositol	 4,5-bisphosphate	 (PIP2),	
subsequently	localises	to	endosomal	compartments	thus	contributing	to	protein/vesicle	
sorting	 (Burkhead	et	al.,	2009).	 In-house	studies	have	shown	that	COMMD10	similarly	
binds	PIP2,	as	well	as	phosphatidic	acid	 (PA)	and	phosphatidyl	 serine	 (PS)	 (Cheung	&	




been	 linked	 to	 the	 recruitment	 of	 proteins	 to	 different	 organelles	 (Sigal	 et	 al.,	 1994;	
Yeung	et	al.,	2009).	This	would	suggest	 that	a	number	of	COMMD	family	members	are	




shown	 to	 regulate	 the	 epithelial	 sodium	 channel	 (ENaC).	 It	 has	 been	 described	 that	
COMMD1,	3	and	9	down-regulate	ENaC,	most	likely	through	the	ubiquitin-ligase	Nedd4-













Arf1	 (ADP-ribosylation	 factor	 1)	 is	 a	 highly	 conserved	 small	 GTPase	 that	 regulates	
protein	 trafficking	 at	 the	 Golgi	 complex	 (Gillingham	 &	 Munro,	 2007;	 Donaldson	 &	
Jackson,	 2011;	 Cherfils,	 2014).	 In	 its	 GTP-bound	 (active)	 state	 Arf1	 recruits	 the	 COPI	
coat	 to	 the	 cis-Golgi	 promoting	 vesicle	 formation	 for	 transport	 throughout	 the	 Golgi	






























At	 the	 beginning	 of	 this	 PhD	 project	 preliminary	 evidence	 suggested	 a	 role	 for	
COMMD10	in	the	trafficking	of	proteins	to	the	cell	membrane.	It	has	been	observed	that	









co-localise	 suggesting	 a	 role	 for	 COMMD10	 in	 protein	 trafficking.	 Therefore	
further	co-localisation	studies	were	performed	with	Arf1	as	well	as	other	protein	
trafficking-associated	 proteins,	 such	 as	 transferrin-546	 and	 Rab1a.	 Due	 to	 the	
fact	 the	other	COMMD	 family	members	had	been	 implicated	 in	 the	endocytosis	
and	 recycling	pathways	 the	 effect	 of	 a	 stable	COMMD10	KD	on	 transferrin-546	
endocytosis	and	recycling	was	tested.	
	
2. Is	 COMMD10	a	novel	 regulator	of	 epithelial	 sodium	channel	 trafficking	 to	
and	from	the	plasma	membrane?	
As	 COMMD1/3	 and	 9	 have	 already	 been	 shown	 to	 down-regulate	 ENaC	 it	was	
hypothesised	 that	 COMMD10	 similarly	 regulates	 ENaC.	 To	 analyse	 this,	
electrophysiology	was	used	to	determine	the	effect	of	COMMD10,	under	various	
conditions,	 on	 ENaC	 activity	 in	 a	 model	 epithelia.	 As	 it	 had	 been	 shown	 that	
COMMD1	 increased	 ENaC	 ubiquitination	 it	 was	 hypothesised	 that	 COMMD10	
would	also	increase	ENaC	ubiquitination.	To	investigate	this	the	effect	of	a	stable	
COMMD10	 knockdown	 on	 Nedd4-2	 protein	 levels,	 as	 well	 as	 the	 ENaC	
ubiquitination	state,	was	determined.		
	
A	 large	 number	 of	 ENaC	 regulators	 are	 regulated	 by	 the	 mineralocorticoid	
aldosterone.	Therefore	 the	effect	of	 aldosterone	on	COMMD10	protein	 levels	 in	
M1CCD	 cells	 was	 performed	 to	 identify	 whether	 COMMD10	 is	 an	 aldosterone-
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Polyclonal	 Rat	 1:1000	 	

























StressMarq	SPC-404	 Polyclonal	 Rabbit	 1:1000	 	




Anti-GAPDH	 GAPDH	 Genetex	GT239	 Monoclonal	 Mouse	 1:2000	 	


























Santa-Cruz	sc-16745-R	 Polyclonal	 Rabbit	 1:1000	 	
































































cDNA	 Vector		 Epitope	tag	 Comment	 Reference	





















































COMMD1-FLAG	 pMT3	 C-terminal	FLAG	 -	 (Biasio	et	al.,	2004)	














































DsRed-Rab7a	 pDsRed2-C1	 N-terminal	DsRed	 -	
(Choudhury	et	al.,	
2002)	

































37°C	 in	 a	 shaker	 set	 at	 220	 r.p.m.	 Bacteria	 (E.coli,	 DH5α,	 Life	 Technologies,	 Victoria,	
Australia)	 from	 1.5	mL	 of	 the	 overnight	 culture	were	 pelleted	 by	 centrifugation	 (in	 a	
bench	top	centrifuge)	(Eppendorf,	5415R)	for	5	min	at	13,000	r.p.m.	The	remaining	0.5	
mL	 of	 bacterial	 culture	was	made	 into	 a	 glycerol	 stock	 by	 the	 addition	 of	 20%	 (v/v)	
glycerol.	After	centrifugation	the	pellet	was	resuspended	in	250	µL	buffer	P1	(provided	
by	manufacturer)	and	was	added	to	by	250	µL	buffer	P2	(supplied	by	manufacturer)	and	
mixed	 by	 slow	 inversion	 5-10	 times.	 The	 neutralisation	 buffer	 (N3)	 (supplied	 by	
manufacturer)	(350	µL)	was	added	and	again	the	tube	was	mixed	by	slowly	inversion	5-
10	 times.	 Mixes	 were	 then	 centrifuged	 for	 10	 min	 at	 13,000	 r.p.m	 to	 pellet	 cell	
membranes	 and	 debris.	 The	 supernatant	 was	 added	 to	 spin	 columns	 (provided	 by	




13,000	 r.p.m	 and	 secondly	 for	 2	min	 at	 13,000	 r.p.m	 to	 remove	 residual	wash	 buffer.	
DNA	 was	 then	 eluted	 from	 the	 columns	 through	 the	 addition	 of	 50	 µL	 buffer	 EB	















In	 short,	100	mL	LB	medium	with	appropriate	antibiotic	was	 inoculated	with	a	 single	
colony	and	grown	overnight	at	37°C	in	a	shaker	set	at	220	r.p.m.	The	overnight	culture	
was	pelleted	by	centrifugation	(Heraeus,	multifuge	3	S-R)	 for	15	min	at	5,000	x	g.	The	
pellet	was	 resuspended	 in	8	mL	re-suspension	buffer	RES	 (supplied	by	manufacturer)	
and	 then	 8	mL	LYS	 buffer	 (provided	 by	manufacturer).	Mixes	were	 then	 incubated	 at	
room	temperature	for	5	mins	before	8	mL	buffer	NEU	(supplied	by	manufacturer)	was	
added.	 Mixes	 were	 loaded	 onto	 a	 NuceloBond®	 Xtra	 column	 (which	 was	 earlier	
equilibrated	with	12	mL	EQU	buffer).	The	column	was	allowed	to	empty	by	gravity	flow	
before	 being	washed	 in	 5	mL	 EQU	 buffer.	 The	 column	 underwent	 another	wash	 step	
with	the	addition	of	8	ml	WASH	buffer	(supplied	by	manufacturer).	DNA	was	then	eluted	
from	the	column	with	5	mL	elution	buffer	ELU	(supplied	by	manufacturer).	Isopropanol	


























Five	mammalian	cell	 lines	have	been	used	 in	 this	study:	HEK293T,	FRT,	U2OS,	M1CCD	





antigen	 that	 binds	 to	 SV40	 enhancers	 of	 expression	 vectors	 to	 increase	 protein	











HEK293,	 HEK293T	 and	 U2OS	 cells	 were	 maintained	 in	 DMEM	 (Dulbecco’s	 Modified	
Eagle	Medium)	(Gibco	Cat,	Victoria,	Australia.	 	No.	12800-017)	supplemented	with	3.7	
g/L	 sodium	bicarbonate	 (NaHCO3)	and	10%	Fetal	Bovine	Serum	(FBS)	 (Gibco,	Cat.	No	
.16091-148).	 U2OS	 cells	 stably	 expressing	 shRNA	 were	 maintained	 in	 the	 same	






FRT	 cells	 stably	 expressing	 a	 control	 shRNA	 and	 a	 COMMD10	 shRNA	were	made	 and	
used	(see	2.4.4).	FRT	cells	are	able	to	form	a	polarised	epithelia	when	grown	on	filters	
and	are	used	 in	 this	 study	 to	determine	 the	effects	of	a	stable	COMMD10	KD	on	ENaC	
current.	
	




same	 media	 with	 the	 addition	 of	 2	 µg/mL	 puromycin	 (to	 select	 and	 maintain	




AR42J	 is	 a	 rat	pancreatic	 cell	 line	derived	 from	a	 tumour	of	 the	 rat	exocrine	pancreas	
(Gonzalez,	 2011).	 This	 is	 a	 pluripotent	 cell	 line	 capable	 of	 being	 differentiated	 into	
different	 populations	 of	 pancreatic	 cells	 (Eum	 et	al.,	 2003)	 and	was	 planned	 on	 being	






M1CCD	 is	a	mouse	cortical	 collecting	duct	 cell	 line	 that	has	 retained	many	phenotypic	
properties	of	the	cortical	collecting	duct	and	is	used	as	a	model	to	study	mechanisms	of	
ion	 transport	 (Stoos	et	al.,	 1991)	 and	 is	 used	 in	 this	 study	 to	 determine	 the	 effects	 of	
aldosterone	on	protein	levels	of	COMMD1	and	COMM10.	M1CCD	cells	were	maintained	






(Sigma	 Cat.No.	 P4417)	 and	 then	 incubated	 with	 1	 mL	 trypsin-EDTA	 (0.25%	 Trypsin,	
1mM	EDTA)	(Life	Technologies	Cat.No.	25200-056).	Incubation	time	with	trypsin	varied	











For	 the	 long-term	 storage	 of	 cells	 in	 the	 -80°C	 freezer	 and	 liquid	 nitrogen,	 cells	were	
trypsinised	 and	 recovered	 by	 centrifugation	 (as	 above).	 The	 cell	 pellet	 was	 then	
resuspended	 in	 freezing	 medium	 (normal	 growth	 medium	 with	 10%	 DMSO	
(dimethylsulfoxide))	and	transferred	to	cryovials.	Cells	were	frozen,	in	the	-80°C	freezer	
and	 then	 transferred	 to	 the	 liquid	nitrogen	 for	 long-term	storage	or	kept	 in	 the	 -80°C	
where	cells	would	not	lose	viability	for	up	to	one	year.		
	











genetically	 modified	 cells.	 Introduced	 DNA/RNA	 exist	 in	 cells	 whether	 stably	 or	
transiently.	In	stably	transfected	cells	introduced	DNA	integrates	into	the	host	genome,	
whereas	 RNA	 (shRNA	 in	 this	 study),	 if	 viral,	 is	 reverse	 transcribed	 and	 integrated	 as	
	 49	
DNA,	but	both	are	still	expressed	after	host	cells	replicate	(Glover	et	al.,	2005).	Normally	
in	 a	 stable	 transfection	 a	 selectable	 marker,	 such	 as	 an	 antibiotic,	 is	 used	 to	 sustain	
introduced	 DNA/RNA	 expression	 after	 cells	 replicate.	 Transient	 transfection,	 on	 the	
other	hand,	introduces	DNA/RNA	for	a	brief	period	of	time	and	is	lost	after	cell	division.	















Lipofectamine™	3000	 (Life	Technologies,	Cat.No.	L3000015)	was	used	 in	 this	 study	 to	
transiently	 transfect	 FRT	 cells	 for	 Ussing	 (see	 2.9),	 biotinylation	 (see	 2.5.7)	 and	
ubiquitination	 studies	 (see	2.5.6).	 Cells	were	 seeded	 at	 a	 density	 of	 4-5	 x	 105	cells	 for	
Ussing	 and	 biotinylation	 experiments,	 and	 at	 1	 x	 106	 for	 ubiquitin	 assays,	 before	
incubation	 overnight.	 The	 next	 day	 3	 µL	 Lipofectamine™	 3000	 was	 added	 to	 50	 µL	
serum	 free	 media	 and	 incubated	 for	 5	 min.	 Concurrently	 2	 µg	 DNA	 and/or	 20	 ρmol	
siRNA	was	added	to	50	µL	serum	free	media.	The	Lipofectamine	and	DNA/siRNA	mixes	
were	 then	 added	 together,	mixed	 thoroughly	 (by	 vortex)	 and	 incubated	 for	20	min	 at	
room	 temperature	 to	 allow	 the	 formation	 of	 Lipofectamine-DNA/siRNA	 complexes.	























effects	 of	 a	 stable	 COMMD10	 knockdown	 to	 be	 analysed.	 In	 this	 study	 the	 stable	





for	 COMMD10	 shRNA#2	 (shC10#2))	 and	 incubated	 overnight	 (for	 sequences	 and	
development	of	 shRNA	see	Appendix	 I).	The	 following	day	cells	were	 transfected	with	
the	pLKOtrc	plasmid	encoding	shRNA,	as	well	as	plasmids	encoding	lentiviral	envelope	
and	 lentiviral	 packaging	 plasmids	 to	 promote	 virus	 particle	 production,	 using	 CaCl2	
(table	 2.1)	 (see	 2.4.3)	 and	 were	 incubated	 in	 full	 growth	 media	 supplemented	 with	
chloroquine	 (25	 μM)	 (to	 prevent	 lysosomal	 degradation	 of	 DNA	 through	 inhibition	 of	
lysosomal	DNases	by	neutralising	lysosome	pH	(Juhasz,	2012))	for	9	hr.	Media	was	then	
removed	and	replaced	by	fresh,	full	growth	media	and	cells	were	incubated	for	2	days	to	





After	 2	 days	 the	 virus-containing	media	 from	 each	HEK293T	 cell	 plate	was	 collected,	
passed	through	a	0.22	μM	Millipore™	filter	supplemented	with	3	μg/mL	polybrene	(to	




this	 point	 on,	 cells	 successfully	 infected	with	 virus	 and	with	 stable	 integration	 of	 the	
shRNA	encoding	plasmid	were	selected	through	their	puromycin	(2	μg	/	mL)	resistance.	
















Volumes	in	μL		 shC10#1	 shC10#2	 shControl	
pLKOtrcrshC10#1	(1	μg)	 31.25	 ---	 ---	
pLKOtrcrshC10#2	(1	μg)	 ---	 50	 ---	
pLKOtrcshControl	(1μg)	 ---	 ---	 11.4	




Lentiviral	packaging	plasmid	(pRSV	Rev)	 38.5	 38.5	 38.5	
2M	CaCl2	 61	 61	 61	
mqH2O	(up	to	500	μL)	 298.15	 279.4	 318	
2xHBSS	 500	 500	 500	









1µg/mL	pepstatin))	 for	10-15	min	on	a	platform	shaker	on	 ice.	Cell	 lysates	were	 then	
centrifuged	at	13,000	r.p.m	for	10	min	in	a	benchtop	microcentrifuge	to	pellet	cell	debris	






The	 DC™	 (Detergent	 Compatible)	 Protein	 assay	 kit	 (Bio-Rad,	 Cat.No.	 500-0116)	 was	
used	 to	 determine	 the	 protein	 concentration	 of	 cell	 lysates	 to	 ensure	 equal	 input	 of	




Purified	 BSA	 (Bovine	 Serum	 Albumin)	 (Sigma	 Aldrich	 Cat.No.	 A7906)	 was	 diluted	 to	
concentrations	 between	0	 and	1	mg/mL	 to	 create	 standards	 to	 generate	 a	 calibration	
curve	 for	 the	assay.	 	Reagent	S’	was	prepared	by	adding	20	µL	reagent	S	 (supplied	by	
manufacturer)	 for	 every	 1	 mL	 of	 reagent	 A	 (supplied	 by	 manufacturer)	 that	 was	
required.	Samples	and	BSA	standards	(5	µL	of	each)	were	added,	in	triplicate,	into	a	96-
well	 plate	 and	 combined	with	 25	 µL	 reagent	 S’	 in	 each	 well.	 Reagent	 B	 (supplied	 by	
manufacturer)	 (200	µL)	was	 added	 to	 each	well	 and	 the	plate	was	 incubated	at	 room	
temperature	 for	 10	 min	 with	 occasional	 shaking.	 The	 absorbance	 of	 each	 well	 at	 a	













5%	 SDS,	 26%	 glycerol,	 0.8%	 bromophenol	 blue)	 with	 1/100	 volume	 of	 2-
mercaptoethanol	 (Sigma,	 Cat.	 No.	 200-464-6)	 and	 denatured	 by	 heating	 at	 95°C	 for	 5	
min	 in	a	heat	block	before	being	centrifuged	(for	10	sec	at	13,000	r.p.m	in	a	benchtop	
microcentrifuge)	to	collect	condensate.	A	pre-stained	protein	marker	(Kaleidoscope	pre-
stained	 protein	 marker,	 Bio-Rad,	 Cat.No.161-0324	 (immunoblotting)	 or	 Novex	 Sharp	
unstained	protein	marker,	Invitrogen.	Cat.	No.	LC5801	(Coomassie	staining))	was	loaded	
onto	 each	 gel	 to	 allow	 the	 estimation	 of	 protein	 molecular	 weight.	 The	 gels	 were	




using	 a	 30%	 Acrylamide/Bis	 solution	 (Bio-Rad	 Cat.No.	 161-0156)	 (described	 in	 table	
2.2).	 For	 the	 analysis	 of	 proteins	purified	 from	E.coli,	 gels	 of	 0.75	mm	 thickness	were	
used.	The	gels	were	subsequently	run	at	150	V	for	75-90	min	before	being	stained	with	









(0,1%	 Coomassie	 Brilliant	 Blue,	 40%	 methanol,	 10%	 acetic	 acid)	 and	 heating	 in	 the	
microwave	 for	 ~15	 sec	 before	 incubating	 at	 room	 temperature	 for	 10-15	 mins	 on	 a	
platform	shaker	running	at	50-60	r.p.m.	After	staining	the	Coomassie	blue	solution	was	
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Following	 SDS-PAGE,	 proteins	 from	 polyacrylamide	 gels	 were	 transferred	 to	 0.2	 µm	
polyvinlylidene	difluoride	(PVDF)	membrane	(Roche,	Cat.	No.	3010040001).	The	PVDF	
was	 first	 activated	 in	 methanol	 for	 10-15	 sec,	 then	 washed	 in	 mQH2O	 and	 lastly	
incubated	 in	 transfer	 buffer	 (20%	methanol,	 25	mM	Tris-base,	 192	mM	 glycine).	 The	






8%	 10%	 12%	 4%	
1.5	M	Tris	pH	
8.8	
2.5	 2.5	 2.5	 -	
0.5	M	Tris	pH	
6.8	
-	 -	 -	 1.25	
30%	
acrylamide/Bis	
2.66	 3.34	 4	 0.665	
10%	SDS	 0.1	 0.1	 0.1	 0.05	
H2O	 4.7	 4	 3.33	 3	




0.05	 0.05	 0.05	 0.025	
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Once	 the	 transfer	 had	 finished	 the	 PVDF	 membrane	 was	 removed	 from	 the	 transfer	
sandwich	 and	 placed	 in	 blocking	 buffer	 (5%	 non-fat	 milk	 powder	 in	 TBS	 with	 0.1%	














film	 (Radiographic	 Supplies	Cat.No.16501454).	Exposure	 times	varied	 from	5	 sec	 to	1	
hour	 depending	 on	 the	 intensity	 of	 the	 signal	 as	well	 as	which	 primary	 antibody	 had	
been	used.	The	films	were	subsequently	developed	in	developer	solution	(Radiographic	























To	 quantify	 the	 intensity	 of	 signals	 obtained	 from	 immunoblotting	 X-ray	 film	 was	
scanned	and	subsequently	analysed.	ImageJ	was	used	to	measure	the	density	of	protein	
bands.	 Raw	 data	was	 exported	 and	 protein	 expression	 (relative	 to	 loading	 control,	 β-
actin)	was	determined	using	Excel.	The	control	mean	optical	density,	normally	control	
KD	cells,	was	normalised	 to	one	and	protein	bands	were	compared	 to	 this	normalised	
control.	Data	are	presented	as	mean	±	standard	deviation	(SD).	Statistical	analysis	was	
conducted	 using	 the	 computer	 software	 programme	 GraphPad	 Prism	 (GraphPad	
software).	A	one-sample	 t-test	has	been	used	 to	analyse	any	 changes	 in	protein	 levels	















Triton	X-100	supplemented	with	MG132	and	protease	 inhibitors	 (aprotinin,	 leupeptin,	
pepstatin,	 PMSF).	 Lysate	 protein	 concentration	 was	 then	 determined	 using	 the	 DC™	
(Detergent	Compatible)	Protein	assay	kit	(see	section	2.5.1),	and	40	μg	of	protein	lysate	
was	kept	aside	to	check	for	whole	cell	expression	of	ubiquitinated	proteins	by	western	
blot.	Equal	protein	amounts	of	 the	remaining	cell	 lysates	were	 incubated	with	anti-HA	
(haemagglutinin)	 antibody	 (2.5	 μg/ml)	 for	 2	 hr	 at	 room	 temperature,	 to	
immunoprecipitate	β-HA	ENaC,	and	then	with	30	μL	of	protein	G-Agarose	beads	(Sigma	
Aldrich	Cat.No.	P3296	5ML)	 for	1	hour	 at	 room	 temperature	 to	 capture	 the	 antibody-
ENaC	complex.	Beads	were	then	washed	4	times	in	PBS	+	0.2%	SDS	+	0.2%	Triton	X-100.	
Immunoprecipitated	 β-HA	 ENaC	 was	 eluted	 from	 the	 protein	 G-agarose	 beads	 by	




For	 ubiquitination	 assays,	 ubiquitinated	 ENaC	 was	 quantified	 by	 densitometry	 (as	
described	 in	 2.5.6)	 and	 normalised	 to	 ENaC	 protein	 levels	 in	 whole	 cell	 lysate.	 ENaC	
protein	 levels	 in	 control	 KD	 cells	 were	 normalised	 to	 1	 and	 protein	 bands,	 and	
ubiquitinated	 ENaC	were	 compared	 to	 the	 normalised	 control.	 Data	 are	 presented	 as	
mean	±	standard	deviation	(SD).	Statistical	analysis	was	conducted	using	the	computer	








of	 ENaC	 found	 in	 the	 plasma	membrane	 in	 FRT	 control	 and	 C10	 KD	 cells.	 Biotin	 is	 a	
small,	water-soluble	vitamin	that	binds	with	high	affinity	to	avidin.	A	modified	version	of	
biotin,	EZ-Link®	Sulfo-NHS-LC	biotin	(Thermo	Fisher	Cat.No.21335),	 is	commonly	used	












(Detergent	 Compatible)	 Protein	 assay	 kit	 (see	 section	 2.5.1),	 and	 40	 μg	 of	 lysate	was	
retained	to	check	 for	protein	expression	by	western	blot.	400	μg	 lysate	was	 incubated	
with	 20	 μL	 Neutravidin®	 Ultra	 Link®	 beads	 (Thermo	 Fisher	 53150)	 for	 1	 hour	 to	
separate	 biotin-labelled	 surface	 proteins	 from	 cytosolic	 fractions.	 The	 mixture	 was	
centrifuged	at	1,000	rpm	for	1	min	to	pellet	the	beads	and	biotinylated	proteins.	40	μL	of	
supernatant	was	retained	 in	a	new	tube	 to	analyse	cytosolic	proteins	by	western	blot.	
Beads	were	washed	 4	 times	 in	 PBS	 +	 1%	Triton	 before	 being	 incubated	with	 sample	
buffer	 at	 100°C	 for	 15	 mins	 to	 elute	 biotinylated	 proteins	 from	 the	 beads.	 Surface	











M1CCD	 cells	 were	 treated	 with	 150	 μg/mL	 cycloheximide	 (Sigma,	 Cat.No.	 C1988),	
cycloheximide	+	10	μM	MG132	(proteasome	inhibitor)	or	cycloheximide	+	chloroquine	
(lysosome	inhibitor)	and	were	subsequently	lysed	(as	described	in	2.5.1.1)	at	15	minute	
intervals	up	 to	75	min.	Protein	 concentrations	were	 then	determined	 (as	described	 in	
2.5.1.2)	 and	 protein	 expression	 was	 determined	 by	 SDS-PAGE	 (see	 2.5.2)	 and	











al.,	 1999;	Masilamani	 et	 al.,	 1999;	 Naray-Fejes-Toth	 et	 al.,	 1999;	 Loffing	 et	 al.,	 2001b;	
Fakitsas	 et	 al.,	 2007).	 To	 establish	 whether	 COMMD10	 is	 an	 aldosterone-regulated	
protein	M1CCD	 cells	were	 treated	with	 aldosterone	 (10	μM)	 in	 serum-free	media	 and	
subsequently	 lysed	at	0,	30	min,	1	hour,	3	hour,	6	hour	and	24-hour	 timepoints.	Cells	
were	 subsequently	 lysed	 and	 protein	 concentrations	 determined	 (see	 2.5.1.2)	 before	
protein	 levels	were	analysed	by	SDS-PAGE	(see	2.5.2)	and	 immunoblotting	(see	2.5.4).	
















(to	 increase	 protein	 yield	 (Vasina	 &	 Baneyx,	 1996).	 Cells	 were	 recovered	 by	
centrifugation	at	3,000	x	g	 for	15	min	at	4°C	 in	a	benchtop	centrifuge.	The	cell	pellets	
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were	 then	 resuspended	 in	 1	 mL	 TBS	 (supplemented	 with	 10µg/mL	 PMSF,	 2µg/mL	




at	 4°C	 in	 a	 benchtop	 centrifuge.	 The	 supernatant	was	 then	 incubated	with	 75-100	 µL	
glutathione-agarose	bead	slurry	(Sigma,	Cat.No.	G4510)	at	4°C	for	30	min	on	a	rotator.	
The	 beads	 were	 recovered	 by	 centrifugation	 at	 1,000	 r.p.m.	 for	 30	 sec	 at	 4°C	 (in	 a	
benchtop	 microcentrifuge)	 and	 the	 supernatant	 was	 removed.	 The	 beads	 were	 then	
washed	4	times	in	500	µL	TBS	+	1%	Triton.	Fusion	proteins	were	then	eluted	from	the	









in	 section	 2.10.1.	 The	 eluted	 fusion	 protein	 was	 concentrated	 using	 a	 centrifugation	
protein	concentrator	(Millipore,	Ampicon®	Centrifugal	Filters,	Cat.No.UFC503096).	The	
concentrated	fusion	protein	was	diluted	in	sterile	TBS.	These	concentrating	and	diluting	
steps	 were	 repeated	 three	 times	 to	 remove	 glutathione	 from	 the	 fusion	 protein.	 The	




mg/mL	with	 sterile	 TBS.	 Fusion	 protein	 (250	 µg)	was	mixed	with	 Freund’s	 complete	
adjuvant	 (Sigma	 Aldrich	 Cat.No.F5881)	 (250	 µL)	 under	 sterile	 conditions	 and	 was	
injected	 sub-cutaneously	 into	 two	 female	 Wistar	 rats.	 	 Two	 weeks	 after	 the	 initial	
immunisation	 the	rats	 received	a	booster	of	250	µg	 fusion	protein	 in	250	µL	Freund’s	
incomplete	 adjuvant	 (Sigma	 Aldrich	 Cat.No.F5506).	 After	 another	 two	weeks	 the	 rats	











Tissues	 embedded	 in	 paraffin	 were	 cut	 and	 mounted	 onto	 microscope	 slides	 by	 the	
Department	of	Histology,	University	of	Otago.	Tissue	sections	were	deparaffinised	for	3	




blocked	 in	 4%	 BSA,	 2%	 NGS	 (normal	 goat	 serum)	 in	 PBS	 for	 30	 min	 at	 room	
temperature.		Primary	antibody	(in	blocking	buffer)	was	then	added	to	the	sections	(see	
section	 2.1	 for	 dilutions)	 and	 slides	 were	 incubated	 overnight	 at	 4°C	 in	 a	 humidified	
chamber.	Sections	were	then	washed	for	2	x	5	min	in	PBS	before	being	incubated	with	
secondary	antibody	in	blocking	buffer	(see	section	2.1	for	dilutions)	for	45	min	at	room	










and	 were	 incubated	 for	 72	 hr.	 Cells	 were	 washed	 in	 PBS	 and	 then	 fixed	 with	 4%	
paraformaldehyde	(PFA)	in	PBS	for	2	x	1	min	and	1	x	30	min.	Cells	were	subsequently	
washed	 again	 in	 PBS	 for	 3	 x	 5	min	 before	 being	 permeabilised	 in	 0.2%	Triton	 X-100	
(v/v)	 in	 PBS	 for	 30	 min	 at	 room	 temperature	 on	 a	 shaker.	 Permeabilisation	 was	
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followed	 by	 washes	 in	 PBS	 before	 cells	 were	 blocked	 in	 2%	 NGS,	 4%	 BSA	 and	 0.2%	
Triton	X-100	in	PBS	for	30	min	at	room	temperature.	Appropriate	primary	antibody	was	
added	 (see	 section	 2.1	 for	 dilutions)	 and	 cells	 were	 incubated	 overnight	 at	 4°C	 on	 a	
shaker	in	a	humidified	chamber.	After	incubation	with	the	primary	antibody	cells	were	
washed	 with	 PBS	 for	 3	 x	 5	 min	 and	 then	 incubated	 with	 an	 appropriate	 secondary	




2	min.	 Coverslips	were	mounted	onto	 a	microscope	 slide	before	being	 counterstained	






Transferrin	 is	 a	 plasma	 glycoprotein	 that	 binds	 iron	 in	 the	 blood	 and	 assists	 in	 the	
cellular	 uptake	 of	 iron	 through	 its	 interaction	with	 the	 transferrin	 receptor	 (Ponka	&	
Lok,	 1999;	 Moos	 &	 Morgan,	 2000).	 The	 binding	 of	 iron-containing	 transferrin	 to	 the	




and	 the	 plasma	 membrane;	 transferrin	 is	 frequently	 used	 as	 a	 marker	 for	
early/recycling	endosomes.	
	
For	 endocytosis	 experiments,	 cells	 were	 incubated	 with	 50	 µg/mL	 Tf-546	 (Life	
Technologies	Cat.No.	T23364)	diluted	in	full	growth	media	for	0,	1,	2	or	5	min	at	37°C,	
then	 were	 fixed	 in	 4%	 PFA	 before	 being	mounted	 and	 counterstained	 with	 DAPI	 (as	
described	 in	2.11).	For	Tf-546	uptake	assays,	100	cells	were	counted	 for	each	cell	 line	
(control	and	C10	KD)	for	each	timepoint	and	number	of	cells	with	transferrin	present	is	
represented	as	number	out	of	100.	The	time	taken	for	control	and	C10	KD	cells	to	exhibit	
25	 and	 50%	 transferrin	 uptake	 were	 calculated	 using	 a	 line	 of	 best	 fit	 on	 GraphPad	
Prism	 (GraphPad	 software).	 Data	 are	 presented	 as	 mean	 ±	 standard	 deviation	 (SD).	
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Statistical	 analysis	was	 conducted	using	 the	 computer	 software	programme	GraphPad	
Prism.	Unpaired	t-tests	have	been	used	to	determine	any	changes	between	control	and	
C10	 KD	 uptake	 values	 at	 each	 timepoint.	 The	 P	 values	 of	 the	 statistical	 tests	 were	
recorded	and	regarded	as	significant	if	P<0.05.		
	
For	 recycling	 experiments,	 cells	were	 incubated	with	 50	 µg/mL	Tf-546	 in	 full	 growth	
media	for	5	mins	before	media	was	removed	and	cells	were	incubated	with	PBS	at	37°C	
for	15	or	30	min	 to	 “chase”	 the	 transferrin	 through	 the	 recycling	pathway.	Cells	were	
then	fixed	in	4%	PFA	before	being	mounted	and	counterstained	with	DAPI	(as	described	
in	 2.11).	 For	 Tf-546	 recycling	 assays,	 cells	 were	 blindly	 scored	 by	 a	 lab	 member	 to	
prevent	 bias	 using	 the	 scoring	 system	 0	 =	 no	 transferrin	 observed,	 1	 =	 cytoplasmic	
transferrin,	 2	 =	 punctate	 transferrin.	 Scoring	was	 then	 compared	 as	 an	 overall	 group	
between	control	and	C10	KD	cells	and	also	at	individual	scoring	levels	between	control	
and	C10	KD	cells	at	the	same	timepoint.	Data	arepresented	as	mean	±	standard	deviation	
(SD).	 Statistical	 analysis	 was	 conducted	 using	 the	 computer	 software	 programme	
GraphPad	 Prism	 (GraphPad	 software)	 by	 2-way	 ANOVA	 to	 determine	 changes	 in	
transferrin	 localisation	 between	 control	 and	 C10	 KD	 cells	 at	 each	 timepoint,	 both	






For	 co-localisation	 experiments,	 cells	 were	 incubated	 with	 50	 µg/mL	 Tf-546	 in	 full	







Fluorescently	 labelled	 proteins	 in	 cells	 were	 analysed	 with	 an	 upright	 Zeiss	 LSM510	
(Axioplan)	confocal	or	a	Nikon	A1+	inverted	confocal	(in	the	Otago	Centre	for	Confocal	
Microscopy)	 and	were	 excited	by	488	nm,	 543	nm	or	633	nm	 laser	 lines.	 The	63x	oil	
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Plugin).	 The	 correlation	 coefficients	 used	 in	 this	 study	 are	 Pearson’s	 correlation	
coefficient	 (PCC)	 and	 the	 Mander’s	 correlation	 coefficient	 (MCC).	 PCC	 measures	 the	
overall	 overlap	 of	 the	 pixels	 with	 values	 ranging	 from	 1	 (perfect	 correlation)	 to	 -1	
(perfect	inverse	correlation)	(Dunn	et	al.,	2011).	MCC	provides	a	measure	of	the	fraction	
of	 one	 probe	 that	 colocalises	 with	 a	 second	 probe.	 MCC1	 gives	 an	 indication	 of	 the	







Cat.No.COR3801)	 at	 a	 density	 of	 4x105	 cells	 per	 Snapwell™	 and	 were	 incubated	
overnight.	Epithelia	were	transfected	with	plasmids	encoding	α,	β-HA	and	γ	ENaC	(0.067	
μg	 of	 each	 subunit)	 and,	 experiment	 depending,	 plasmids	 encoding	 COMMD1-FLAG,	
COMMD10-HA,	βY620A-HA	ENaC	(instead	of	β-HA	ENaC)	or	20	ρm	Nedd4-2	siRNA	using	
Lipofectamine™	3000	(see	2.4.3).	The	total	amount	of	DNA	transfected	was	kept	equal	at	
2	 μg	 by	 adding	 empty	 pMT3	 vector.	 Six	 hr	 after	 transfection,	 serum	 free	 media	 was	
replaced	 by	 full	 growth	 media	 supplemented	 with	 10	 μM	 amiloride	 (a	 specific	 ENaC	
inhibitor).	 	 Na+	 current	 across	 the	 epithelium	was	measured	 72	 hr	 after	 transfection	
using	modified	Ussing	chambers	 (figure	2.1B)	 connected	 to	a	multichannel	V/A	clamp	
(Physiologic	Instruments)	via	a	DI-720	data	acquisition	system	(DataQ	instruments)	and	









37°C	 and	bubbled	with	O2.	 The	 epithelia	were	 clamped	under	 short-circuit	 conditions	




















were	 compared	 to	 the	 normalised	 control.	 Data	 are	 presented	 as	 mean	 ±	 standard	











FRT	 cells	 were	 grown	 and	 transfected	 on	 Snapwell	 filters	 (A).	 3	 days	 post-transfection	 FRT	
epithelia	 were	mounted	 into	 the	modified	 Ussing	 chamber	 set-up	 (B).	 Apical	 and	 basolateral	
sides	 of	 the	 chamber	were	 bathed	 in	 1	 x	 Ringer’s	 solution	with	 O2	 being	 bubbled	 through	 to	
ensure	circulation	of	the	Ringers.	The	epithelia	were	clamped	under	short-circuit	conditions	and	
the	 amiloride-sensitive	 short	 circuit	 current	 (Isc-amil)	 was	 measured.	 The	 Isc-amil	 was	















































COMMD10	 (Copper	Metabolism	Murr1	Domain	 containing	protein	10)	 is	 a	member	of	
the	 COMMD	 family	 of	 proteins,	 which	 are	 found	 in	 most	 eukaryotes	 (Burstein	 et	 al.,	
2005)	 suggesting	 the	 family	 play	 a	 key	 role	 in	 critical	 cellular	 processes.	 COMMD1	
(originally	 named	Murr1)	was	 the	 first	 family	member	 to	 be	 identified	 and	 has	 been	
shown	 to	 have	 a	 number	 of	 different	 functions,	 including	 the	 regulation	 of	 copper	
homeostasis	(de	Bie	et	al.,	2005).	Functions	for	the	other	family	members,	have,	for	the	
most	 part,	 not	 been	 described	 in	 great	 detail	 and	 this	 is	 the	 case	 for	 COMMD10.	 As	
described	 in	 the	 Introduction	 this	 project	 focused	 on	 expanding	 our	 knowledge	 of	
COMMD10’s	 cellular	 function.	 To	 assist	 with	 this	 approach	 a	 key	 first	 step	 was	 to	
attempt	to	develop	an	antibody	that	would	recognise	endogenous	COMMD10	and	would	
reduce	the	reliance	on	the	use	of	the	epitope-tagged	COMMD10.	At	the	beginning	of	this	
project	 a	 Genetex	 COMMD10	 antibody	 (see	 section	 2.1	 for	 details)	 was	 commercially	
available.	 However,	 although	 this	 antibody	 detected	 endogenous	 COMMD10	 through	




COMMD3	 (Liu	 et	 al.,	 2013)	 and	 COMMD9	 (Liu	 et	 al.,	 2013)	 in-house,	 development	 of	
COMMD10	 antiserum	 was	 performed	 (for	 method	 see	 2.6).	 In	 brief	 GST-COMMD10	
fusion	protein,	the	antigen,	produced	in	E.coli	was	purified	on	glutathione-agarose	beads	
and	 was	 subsequently	 injected	 intravenously	 into	 two	 female	 Wistar	 rats.	 After	
receiving	two	boosters	of	 fusion	protein	rats	were	culled	and	antiserum	was	collected.	









of	 anti-GST	 antibodies	 within	 the	 serum,	 as	 was	 seen	 with	 the	 COMMD1/3	 and	 9	
antiserum.	Therefore	GST	 fusion	protein,	on	glutathione-agarose	beads,	was	 incubated	
with	 diluted	 antiserum	 to	 “pre-clear”	 the	 antiserum	 of	 anti-GST	 antibodies.	 This	
antiserum	 pre-cleared	 with	 GST	 specifically	 recognised	 GST-COMMD10	 (figure	 3.1B).	
However	the	pre-cleared	antiserum	was	unable	to	detect	endogenous	COMMD10	in	any	
cell	 lysate	 (FRT	 or	 U2OS)	 (data	 not	 shown).	 	 This	 result	 confirmed	 that	 the	 rat	 anti-




was	 performed.	 Purified	 GST,	 GST-COMMD1	 and	 GST-COMMD10	 were	 spotted	 onto	
nitrocellulose	at	 concentrations	of	1000,	500,	100,	10,	1	 and	0.1	ng.	Neat	 (i.e.	 straight	
serum)	 antiserum	 detected	 GST,	 GST-COMMD1	 and	 GST-COMMD10	 at	 1000	 ng	 only	
(figure	3.2)	whereas	antiserum	pre-cleared	with	GST	detected	GST-COMMD10	down	to	
100	 ng	 (figure	 3.2).	 Although	 the	 antiserum	 is	 highly	 specific	 and	 sensitive	 to	 GST-
COMMD10	it	is	unable	to	detect	endogenous	COMMD10	and	therefore	could	not	be	used	
in	 immunoblotting	 or	 immunohistochemistry	 (IHC)/immunocytochemistry	 (ICC)	
experiments	in	this	project.		Therefore	ICC	experiments	were	conducted	using	epitope-
tagged	 COMMD10	 and	 immunoblotting	 experiments	 were	 conducted	 using	 a	
commercial	polyclonal	COMMD10	antibody	(see	section	2.1	for	details).	 It	was	 initially	
planned	 to	 use	 this	 polyclonal	 COMMD10	 antibody	 for	 both	 IHC/ICC	 and	
immunoblotting	experiments	but,	similarly	to	our	in-house	developed	antiserum,	it	was	
































A	 -	 GST,	 GST-COMMD1	 and	 GST-COMMD10	 fusion	 proteins	 were	 analysed	 by	 SDS-PAGE	 and	
western	 blotting	 using	 anti-COMMD10	 antiserum.	 n	 =	 2.	 B	 –	 GST,	 GST-COMMD1	 and	 GST-
COMMD10	 fusion	 protein	were	 analysed	 by	 SDS-PAGE	 and	western	 blotting	 using	 COMMD10	








































RNAi	 (RNA	 interference)	 is	 used	 extensively	 as	 an	 experimental	method	 to	 study	 the	
function	 of	 endogenously	 expressed	 genes	 by	 silencing	 gene	 expression	 (Paddison,	
2008).	In	this	study	RNAi	involved	introducing	a	plasmid	encoding	shRNA	(short	hairpin	
RNA)	 into	 HEK392T	 cells	 (for	 method	 see	 2.4.4)	 generating	 lentiviral	 particles	
containing	either	the	control	or	COMMD10	shRNA	sequences.	These	lentiviral	particles	
were	then	used	to	infect	FRT	and	AR42J	cells	to	create	stable	control	or	COMMD10	KD	
(C10	 KD	 cell	 lines).	 Following	 the	 infection	 of	 the	 FRT	 or	 AR42J	 cells,	 cells	 that	 had	
successfully	 integrated	 plasmid	 into	 their	 genome	 were	 selected	 through	 their	
puromycin	 resistance.	 The	 advantage	 of	 using	 shRNA	 over	 siRNA	 (small	 interfering	
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The	 stable	 knockdown	 of	 COMMD10	 in	 FRT	 and	 AR42J	 cells	 was	 used	 to	 provide	









To	 determine	 the	 efficiency	 of	 the	 COMMD10	 knockdown	 western	 blotting	 was	
employed.	 It	 was	 observed	 that	 in	 C10	 KD	 cells	 there	 was	 an	 approximate	 95%	






During	 this	 study,	 a	 control	 and	 C10	 KD	 in	 U2OS	 cells	 were	 also	 used.	 These	 were	
produced	 in	 a	 similar	 method	 to	 the	 FRT	 and	 AR42J	 cells	 described	 earlier	 except	 a	








immunoblotting	 and	 anti-COMMD10	 antibody	 (Genetex).	 Intensity	 of	 signals	 obtained	 from	
immunoblotting	was	determined	and	ImageJ	was	used	to	measure	the	density	of	protein	bands.	
Raw	data	was	exported	and	protein	level,	relative	to	loading	control	(β-actin),	was	determined.	
Data	 shown	 as	 mean	 ±	 standard	 deviation	 (SD)	 relative	 to	 control	 cells.	 One-sample	 t-test.	






Arf1	 (ADP-ribosylation	 factor	 1)	 is	 a	 highly	 conserved	 small	 GTPase	 that	 regulates	
protein	 trafficking	 at	 the	 Golgi	 complex	 (Gillingham	 &	 Munro,	 2007;	 Donaldson	 &	
Jackson,	 2011;	 Cherfils,	 2014).	 In	 its	 GTP-bound	 (active)	 state	 Arf1	 recruits	 the	 COPI	
coat	 to	 the	 cis-Golgi	 promoting	 vesicle	 formation	 for	 transport	 throughout	 the	 Golgi	






cells	 (see	 1.3.3)	 suggesting	 COMMD10	 localises	 to	 the	 cis-Golgi.	 Further	 to	 this	 a	 TAP	
(Tandem	 Affinity	 Purification)	 screen	 identified	 that	 COMMD10	 interacts	 with	 many	
COPI-associated	 proteins,	 including	 Arf1	 (Burstein	 &	 Starokadomskyy,	 unpublished	






briefly	 studied	 (Burstein	 &	 McDonald,	 unpublished	 work).	 Arf1	 has	 been	 shown	 to	
localise	 to	 the	 cis-Golgi	 and	 the	 ER	 (reviewed	 in	 (Donaldson	 &	 Honda,	 2005))	 and	
COMMD10	has	been	shown	to	have	a	largely	cytoplasmic	localisation	(Mao	et	al.,	2011;	
Starokadomskyy	 et	 al.,	 2013).	 Further	 analysis	 of	 co-localisation	 between	 COMMD10	
and	 Arf1	 in	 U2OS	 cells	 was	 performed.	 U2OS	 cells	 were	 transfected	 with	 plasmids	
encoding	 COMMD10-HA	 and	 Arf1-DsRed	 and	 standard	 immunocytochemical	 staining	
procedures	were	 applied	 (see	 section	2.8).	 COMMD10-HA	was	detected	using	 anti-HA	
and	fluorophore-conjugated	secondary	antibodies	and	nuclei	were	counterstained	with	
DAPI.	 Subcellular	 locations	 of	 COMMD10	 and	 Arf1	 were	 then	 viewed	 using	 a	 Zeiss	
LSM510	confocal	microscope.	It	was	observed	that	COMMD10	was	localised	throughout	
the	cell	and	co-localised	with	Arf1	(shown	by	the	yellow	fluorescence)	in	a	perinuclear	
location	 (figure	 3.4A	 -	merge).	 This	 co-	 localisation	 became	more	 apparent	with	 a	 3D	
reconstruction	 from	 z-stack	 images	 showing	 high	 co-localisation,	 of	 Arf1	 and	
COMMD10-HA,	in	a	Golgi-like	localisation	(figure	3.4B).	This	result	supports	preliminary	









HA	was	 detected	 using	 anti-HA	 and	AlexaFluor-488	 conjugated	 secondary	 antibody	 (A).	 A	 3D	








Arf1	 resulting	 in	 the	 association	 of	 Arf1-GTP	 with	 the	 membrane	 (Donaldson	 &	
Klausner,	 1994).	 Hydrolysis	 of	 this	 Arf-bound	 GTP	 prompts	 the	 release	 of	 the	
subsequent	Arf1-GDP	and	COPI	 from	the	membrane	 into	 the	cytoplasm	(Jacques	et	al.,	
2002).	Due	to	this	change	in	localisation	of	Arf1,	dependent	on	its	activity	state,	the	co-





(Teal	 et	 al.,	 1994))	 and	 Arf1-T31N-DsRed	 (a	 constitutively	 inactive	 Arf1	 mutant	
(Dascher	&	Balch,	1994)),	the	co-localisation	of	COMMD10	with	active	and	inactive	Arf1	
was	analysed.	U2OS	cells	were	 transfected	with	plasmids	encoding	COMMD10-HA	and	





It	 was	 observed	 that	 Arf1-Q71I	 exhibited	 a	 tight,	 Golgi-like	 staining	 (as	 has	 been	
previously	described	(Szul	et	al.,	2005;	Jeyifous	et	al.,	2009;	Maas	et	al.,	2012))	and	co-
localised	with	 COMMD10	 in	 a	 perinuclear	 location	 (figure	 3.5A).	 This	was	 highlighted	
further	 through	 a	 3D	 cross-section	 of	 a	 z-stacked	 image	 (figure	 3.5C,	 which	 was	
observed	 consistently	 over	 three	 independent	 experiments).	 On	 the	 other	 hand,	
however,	 Arf1-T31N	 showed	 cytoplasmic	 staining	 (as	 has	 been	 previously	 described	





JACoP	 (Just	 Another	 Co-Localisation	 Plugin)	 on	 ImageJ.	 	 PCC	 is	 used	 to	 measure	 the	
overall	 overlap	 of	 the	 pixels	 with	 values	 ranging	 from	 1	 (perfect	 correlation)	 to	 -1	
(perfect	inverse	correlation).	MCC-M1	measures	the	overlap	of	probe	one	(green	in	this	
study)	with	probe	two	(red	 in	 this	study)	and	MCC-M2	measures	the	overlap	of	probe	
two	with	 probe	 one.	 It	 was	 determined	 that	 Arf1-Q71I	 showed	 a	 significantly	 higher	
level	 of	 co-localisation	 with	 COMMD10	 than	 Arf1-T31N	 (figure	 3.5E).	 MCC-M2	 also	
identified	that	there	is	an	almost	perfect	correlation	of	Arf1-Q71I	with	COMMD10	which,	




































Arf1-T31N-DsRed	 (B).	 COMMD10-HA	 was	 detected	 using	 anti-HA	 and	 AlexaFluor-488	
conjugated	secondary	antibody.	Cells	were	then	visualised	by	confocal	microscopy.	Scale	bar	=	











hypothesised	 that	COMMD10	 is	either	crucial	 for	 the	recruitment	of	active	Arf1	 to	 the	
cis-Golgi	or	 is	 important	 in	keeping	active	Arf1	at	 the	cis-Golgi.	To	 test	 this	U2OS	cells	




using	 ImageJ.	 Although	 no	 obvious	 changes	 in	 Arf1	 or	 Arf1-T31N	 localisation	 were	
observed	 in	 U2OS	 control	 and	 U2OS	 C10	 KD	 cells	 (figure	 3.6B	 –	 top	 two	 panels)	 it	
appeared	there	was	a	change	in	 localisation	of	Arf1-Q71I	 in	U2OS	C10	KD	cells	(figure	
3.6B	–	bottom	panel).	It	can	be	seen	that	in	U2OS	cells	Arf1-Q71I	had	a	tight,	perinuclear	
staining	 (as	 was	 described	 earlier	 (figure	 3.5A))	 but	 in	 U2OS	 C10	 KD	 cells	 this	 tight	
staining	 was	 lost	 and	 it	 appeared	 as	 though	 the	 staining	 became	 more	 dispersed	
throughout	 the	 cell.	 To	 quantify	 the	 suspected	 change	 in	 the	 percentage	 area	 of	
Arf1/Arf1-T31N/Arf1-Q71I	 staining	 in	 U2OS	 and	 U2OS	 C10	 KD	 cells	 analysis	 using	
ImageJ	 was	 undertaken.	 Quantification	 of	 Arf1	 staining	 confirmed	 there	 was	 no	
significant	 difference	 in	 either	Arf1	 (p=0.89)	 or	Arf1-T31N	 (p=0.94)	 staining	 between	
U2OS	and	U2OS	C10	KD	cells	but	 there	was	a	highly	significant	 increase	 in	the	area	of	
staining	 of	 Arf1-Q71I	 in	 U2OS	 C10	 KD	 cells	 compared	 to	 control	 KD	 cells.	 Results	
suggested	 an	 almost	 50%	 increase	 in	 the	 area	 of	 Arf1-Q71I	 staining	 in	 C10	 KD	 cells	
suggesting	 that	either	a	COMMD10	KD	may	cause	a	change	 in	 localisation	of	 the	Golgi	
body	or	prevents	Arf1	recruitment	to	the	Golgi	membrane.	This	suggests	that	COMMD10	

























membranes,	 as	 COPB1	 is	 a	 major	 coat	 protein	 for	 COPI	 vesicles,	 and	 is	 essential	 for	
retrograde	Golgi	to	endoplasmic	reticulum	transport.	Activation	of	Arf1	recruits	COPB1	




Starokadomskyy,	 unpublished	 work).	 To	 determine	 this	 U2OS	 cells	 were	 transfected	
with	 plasmids	 encoding	 COMMD10-HA	 and	 COPB1-YFP	 and	 standard	




















3.3.2	 COMMD10	 does	 not	 co-localise	 with	 or	 alter	 the	 localisation	 of	 other	 ARF	 family	
members		
	
Arf1	 is	 a	 member	 of	 the	 ARF	 family	 of	 proteins	 consisting	 of	 six	 (Arf1-Arf6),	 highly	
conserved	 proteins	 (Donaldson	 &	 Jackson,	 2011).	 The	 family	 members	 control	




Daley	 et	al.,	 2005;	 Chun	 et	al.,	 2008).	 Both	 of	 these	 family	members,	 along	with	 Arf1,	
were	 identified	 as	 interacting	 partners	 of	 COMMD10	 in	 a	 TAP	 screen	 (Burstein	 &	
Starokadomskyy,	unpublished	work).	In	this	study	co-localisation	of	COMMD10	and	Arf4	
and	5,	and	the	localisation	of	Arf4	and	Arf5	in	U2OS	and	U2OS	C10	KD	cells	was	analysed	
and	 it	was	 hypothesised,	 based	 on	 the	 Arf1	 results,	 that	 COMMD10	would	 co-localise	
with	Arf4	and	5,	and	Arf4	and	5	would	similarly	show	a	change	in	localisation	in	C10	KD	
cells.	To	analyse	 this,	U2OS	cells	were	 transfected	with	plasmids	encoding	COMMD10-
HA	 and	Arf4-DsRed	 or	 Arf5-DsRed	 (co-localisation	 experiments)	 or	 U2OS	 control	 and	
C10	KD	 cells	were	 transfected	with	 plasmids	 encoding	Arf4	 or	Arf5	 only	 (localisation	
experiments)	before	standard	immunocytochemistry	protocol	was	applied	(see	section	
2.12).	 Results	 suggest,	 however,	 that	 COMMD10	 does	 not	 co-localise	with	 either	 Arf4	
(figure	 3.8	 Ai)	 or	 Arf5	 (figure	 3.8	 Aii)	 and	 that	 a	 COMMD10	 KD	 does	 not	 alter	 the	
localisation	of	Arf4	or	Arf5	(figure	3.8	B)	although	it	should	be	noted	that	active	mutants	
were	 not	 used	 in	 this	 experiment	 (unlike	 the	 Arf1	 experiment)	 as	 these	 were	 not	
available	in	the	lab.	This	could	suggest	therefore	that	a	COMMD10	KD	does	not	cause	a	
change	in	localisation	of	the	Golgi	body	but	may	be	influential	in	recruiting	Arf1-GTP	to	
the	Golgi	 and	 that	 any	 effect	 COMMD10	has	 on	Arf1	 is	 not	 shared	 throughout	 the	Arf	








antibody.	 Scale	 bar	=	15	μM.	N	=	3	 for	Arf4	 experiment,	N	=	2	 for	Arf5	 experiment.	B	 -	U2OS	
control	 and	U2OS	C10	KD	 cells	were	 transfected	with	plasmids	 encoding	Arf4-DsRed	or	Arf5-













the	 localisation	 of	 4	 of	 these	 family	members	was	 analysed:	 Rab1a,	 Rab5a,	 Rab7	 and	
	 84	
Rab11a	 (see	 table	 3.1	 for	 localisation	 and	 function	 information)	 of	 which	 Rab1a	 and	

















































cells	 were	 transfected	 with	 plasmids	 encoding	 COMMD10-HA	 and	 Rab1a-GFP	 and	
standard	 immunocytochemistry	 protocol	was	 applied	 (see	 section	 2.12).	 However,	 no	
co-localisation	 between	 COMMD10	 and	 Rab1a	 was	 observed	 (figure	 3.9A)	 suggesting	
that	COMMD10	does	not	 localise	 to	 the	ER	or	 the	cis-Golgi.	 In	 support	of	COPB1,	Arf4	
and	Arf5	studies	there	was	no	change	in	Rab1a	localisation	in	U2OS	C10	KD	cells	(figure	












The	Rab	protein	 family	 crucially	 regulate	 various	 protein	 trafficking	 processes.	 Rab5a	





in	 protein	 localisation	 (as	 seen	 with	 active	 Arf1).	 Similarly	 to	 the	 results	 seen	 with	
Rab1a,	no	change	in	localisation	was	observed	(figure	3.10)	suggesting	COMMD10	does	
not	 interact	 with	 any	 of	 the	 Rab	 proteins	 studied.	 It	 should	 be	 taken	 into	 account	
however	 that	 in	 the	Arf1	 study	 the	 change	 in	 localisation	was	observed	when	using	 a	
GTP-bound	mutant	Arf1	(constitutively	active)	whereas	the	Rab	proteins	used	in	these	
studies	 were	 wild	 type,	 therefore,	 no	 solid	 conclusion	 can	 be	 drawn.	 Studies	 to	
investigate	 whether	 COMMD10	 co-localises	 with	 Rab5a,	 Rab7	 and	 Rab11a	 were	


























































does	 not	 happen	 at	 the	 Golgi	 or	 the	 endoplasmic	 reticulum	 (figure	 3.7	 –	 3.9)	 as	
COMMD10	did	not	co-localise	with,	or	alter	the	localisation	of,	other	small	GTPases,	such	
as	Arf4/5	and	Rab1a	 (figure	3.8	–	3.9)	 suggesting	an	Arf1-specific	 role	 for	COMMD10.	






Arf1	 localises	 not	 just	 to	 the	 cis-Golgi	 but	 also	 to	 the	 trans-Golgi	 network	 (TGN)	
(Robinson	et	al.,	2011).	Kondo	et	al.	(2012)	and	Nakai	et	al.	(2013)	highlighted	that	Arf1	
was	required	 for	 the	retrograde	 transport	of	proteins	 from	the	recycling	endosome	 to	
the	TGN	(Kondo	et	al.,	2012;	Nakai	et	al.,	2013).	Kumari	et	al.	(2008)	and	Bhagatji	et	al.	
(2009)	have	shown	that	Arf1	 is	required	 for	 the	endocytosis	of	GPI-anchored	proteins	
from	 the	 plasma	membrane	 to	 the	 endosome	 (Kumari	 &	Mayor,	 2008;	 Bhagatji	 et	al.,	








may	 regulate	 endosomal	 trafficking	 and	 recycling	 (Starokadomskyy	 et	 al.,	 2013).	
Miyayama	 et	al.	 (2010)	 described	 COMMD1	 as	 being	 crucial	 for	 the	movement	 of	 the	
copper	transporter,	ATP7B,	from	endosomal	vesicles	to	the	trans-Golgi	(Miyayama	et	al.,	
2010),	and	Phillips-Krawczak	et	al.	 (2015)	 identified	COMMD1	as	being	able	 to	 form	a	





that	 COMMD10	 interacts	 with	 two	 endosomal	 proteins;	 Rab11b	 and	 IST1	 (ESCRT-III	
associated	 factor),	 which	 when	 taken	 with	 other	 evidence,	 suggests	 that	 COMMD10,	
similarly	 to	 COMMD1	 and	 COMMD9,	 may	 also	 regulate	 endosomal	 trafficking	 and	
recycling.	
	
Transferrin	 is	 a	 serum	 glycoprotein	 that	 binds	 iron	 atoms	 and	 delivers	 them	 to	 cells	
through	 receptor-mediated	 endocytosis	 (Ponka	 &	 Lok,	 1999).	 Binding	 of	 iron-loaded	
transferrin	to	a	transferrin	receptor	on	the	cell	surface	results	in	the	endocytosis	of	this	
transferrin-iron-receptor	complex	to	the	endosome.	The	acidic	environment	within	the	





al.,	2002;	Wustner,	2006).	Transferrin	recycling	 from	endosomal	compartments	 to	 the	
plasma	membrane	 has	 been	 suggested	 to	 be	 recycled	 through	 Retromer	 (Chen	 et	 al.,	







localisation	 studies	 between	 COMMD10	 and	 transferrin-Alexafluor-546	 were	
performed.	U2OS	cells	were	transfected	with	a	plasmid	encoding	COMMD10-HA	and,	5	
min	prior	to	fixation,	were	incubated	with	transferrin-546	(as	it	is	believed	that	after	5	
min	 transferrin	 would	 be	 localised	 to	 endosomal	 compartment	 (Ciechanover	 et	 al.,	
1983)	 before	 standard	 immunocytochemical	 staining	 procedures	 were	 applied	 (see	
section	 2.12).	 COMMD10-HA	 was	 detected	 using	 anti-HA	 and	 fluorophore-conjugated	





–	white	 arrow)	 but	 there	was	 no-colocalisation	 observed	 for	 transferrin	 found	 on	 the	




This	 intracellular	 co-localisation,	 taken	with	 the	 known	data	 that	 COMMD10	 interacts	
with	 ccdc22	 and	 ccdc93	 (ccdc93	 has	 been	 shown	 to	 localise	 to	 the	 early	 endosome	
(Phillips-Krawczak	et	al.,	2015)),	suggests	COMMD10	localises	to	the	endosome.	It	could	
be	hypothesised,	therefore,	that	COMMD10	may	play	a	role	in	endosomal	trafficking	and	














A	 -	 U2OS	 cells	 were	 transfected	 with	 a	 plasmid	 encoding	 COMMD10-HA.	 COMMD10-HA	 was	
detected	 using	 anti-HA	 and	 AlexaFluor-488	 conjugated	 secondary	 antibody.	 Cells	 were	
incubated	with	 transferrin-Alexafluor-546	 for	 5	min	 prior	 to	 fixing.	 Scale	 bar	 =	 15	 μm.	White	
arrow	 indicates	 intracellular	 co-localisation.	Blue	arrows	 indicate	 lack	of	 co-localisation	at	 the	
plasma	 membrane.	 B	 -	 Quantification	 of	 co-localisation,	 through	 PCC	 (Pearson’s	 correlation	







Each	 member	 of	 the	 COMMD	 family,	 including	 COMMD10,	 has	 been	 shown	 to	 bind	
ccdc22	 and	 ccdc93	 (Starokadomskyy	 et	al.,	 2013)	 and	was	 subsequently	 identified	 as	
part	of	 the	CCC	complex.	This	CCC	complex	 is	recruited	 to	endosomes	 through	FAM21	
(Harbour	et	al.,	 2012)	and	disruption	 to	 this	CCC	complex	 results	 in	endosomal	 traffic	
mis-localisation	 (Phillips-Krawczak	 et	al.,	 2015).	 FAM21	 is	 part	 of	 the	WASH	 complex	
(Wiskott-Aldrich	syndrome	protein	and	SCAR	homologue	complex)	that	 is	recruited	to	
endosomes	 by	 Retromer.	 Retromer	 consists	 of	 a	 cargo	 selection	 complex	 comprising	
VPS26,	 VPS29	 and	 VPS35	 and	 the	 sorting	 nexins	 (SNX1,	 2,	 5	 and	 6),	 which	 facilitate	
generation	 of	 cargo-loaded	 vesicles	 at	 the	 endosome	 (Cullen	 &	 Korswagen,	 2012).	
Retromer	has	been	identified	as	playing	a	crucial	role	in	the	endosomal	trafficking	and	
recycling	 of	 a	 number	 of	 proteins,	 including	 the	 mannose-6	 phosphate	 receptor	
(Seaman,	 2004;	Harbour	et	al.,	 2010),	 the	 transferrin	 receptor	 (Chen	et	al.,	 2013)	 and	
the	 amyloid	 precursor	 protein	 (Sullivan	 et	 al.,	 2011).	 This	 suggests	 therefore	 that	







localisation,	 of	 other	 Retromer	 components	 (Phillips-Krawczak	 et	al.,	 2015;	 Bartuzi	 et	
al.,	2016).	Therefore,	to	investigate	whether	a	stable	COMMD10	KD	alters	protein	levels	
of	 Retromer	 components,	 protein	 levels	 of	 various	 recycling-associated	 proteins	were	
determined	by	immunoblotting	in	FRT	control	and	C10	KD	cells.	In	brief,	protein	lysates	





protein	 levels	 reduce	 so	 the	 fact	 that	 COMMD1	 protein	 levels	 have	 reduced	 is	 not	
unexpected	(Li	et	al.,	2015).	This	suggests	that	by	reducing	COMMD10	protein	levels	the	
Retromer	 complex	 is	 disrupted	 providing	 evidence	 that	 COMMD10	 may,	 similarly	 to	
	 93	
COMMD1	 (COMMD1	 has	 been	 shown	 to	 be	 crucial	 for	 the	 transport	 of	 the	 copper	





as	 of	 yet,	 been	 implicated	 with	 Retromer	 in	 mammalian	 cells	 and	 therefore	 it	 was	
unknown	whether	 the	COMMD10	KD	would	alter	Snx4	protein	 levels.	 It	was	observed	
however,	that	ccdc22	and	Snx4	levels	were	not	significantly	different	in	FRT	control	and	
COMMD10	KD	cells	 (figure	3.13A-B).	This	 lack	of	 change	 in	 ccdc22	protein	 levels	was	
surprising	as	it	had	been	previously	described	that	COMMD1	deficient	fibroblasts	had	a	
significant	reduction	 in	ccdc22	protein	 level	 (Phillips-Krawczak	et	al.,	2015),	 therefore	







using	 immunoblotting	 and	 anti-COMMD1	 antibody.	 Data	 shown	 as	 mean	 ±	 SD	 relative	 to	



























A.	 FRT	 control	 and	 COMMD10	 KD	 cells	 were	 lysed	 and	 ccdc22/Snx4	 protein	 levels	 were	












family	members.	COMMD	 family	members	 are	known	 to	be	 able	 to	 interact	with	 each	
other	(Burstein	et	al.,	2005)	so	it	was	believed	that,	similarly	to	COMMD1,	protein	levels	
of	COMMD3	would	also	be	reduced.	This	however	was	not	the	case	and	COMMD3	levels	





al.,	 2005).	 	This	 also	provides	more	evidence	 that	COMMD	 family	members	don’t	play	
redundant	roles.	Previous	work	has	shown	that	COMMD3	and	COMMD9	down-regulate	
ENaC	 (Liu	 et	al.,	 2013)	making	 them	 suitable	 COMMD	proteins	 to	 analyse	 however,	 it	
would	be	interesting	to	determine	the	effect	of	the	stable	C10	KD	on	protein	levels	of	all	







































As	 it	has	been	shown	 that	COMMD1	 increases	ENaC	ubiquitination,	and	reduces	ENaC	
populations	 at	 the	 plasma	 membrane	 (Ke	 et	 al.,	 2010;	 Chang	 et	 al.,	 2011),	 and	 that	
COMMD10	 localises	 to	 the	 endosome	 it	 was	 hypothesised	 that	 COMMD10	 regulates	
endocytotic	 pathways.	 To	 investigate	 this	 the	 endocytosis/uptake	 of	 transferrin-
Alexafluor-546	was	analysed	in	U2OS	control	and	C10	KD	cells.	Transferrin	 is	a	serum	
glycoprotein	 that	 binds	 iron	 atoms	 and	 delivers	 them	 to	 cells	 through	 receptor-
mediated	 endocytosis	 and,	when	 iron	 has	 been	 released	 in	 the	 endosome,	 is	 recycled	
back	 to	 the	plasma	membrane	(for	 further	details	see	3.5)	making	 transferrin	a	useful	
model	 to	study	endocytosis	and	recycling.	U2OS	cells	have	been	shown	 to	express	 the	
transferrin	receptor	(Beck	et	al.,	2011)	allowing	the	use	of	the	U2OS	COMMD10	KD	cells	
to	 analyse	 any	 changes	 in	 the	 rate	 of	 transferrin	 receptor	 endocytosis	 (i.e.	 plasma	
membrane	 to	 endosome	 trafficking).	 Endocytosis	 of	 the	 transferrin	 receptor,	 once	








As	 expected,	 after	 0	 min,	 both	 U2OS	 control	 and	 U2OS	 C10	 KD	 cells	 showed	 no	
transferrin	 uptake	 (figure	 3.15A	 -	 top	 left	 panel	 and	 figure	 3.15B).	 After	 1-minute	
incubation	with	transferrin-546	C10	KD	cells	showed	a	significant	increase	in	number	of	
cells	with	 transferrin	uptake	compared	 to	 the	control	cells	 (9.3%	±	2.5	vs	2.3%	±	1.5)	
(figure	3.15A	–	top	right	panel	and	figure	3.15B	-	highlighted	by	white	arrow).	This	effect	
was	 exacerbated	after	 two	min	 incubation	with	 transferrin	where	COMMD10	KD	cells	







C10	 KD	 cells	 exhibited	 a	 significantly	 increased	 rate	 of	 transferrin	 uptake	with	 U2OS	
control	KD	cells	 slower	 to	reach	both	25%	(2.572	min	±	0.11	vs	1.82	min	±	0.20)	and	
50%	 (3.74	 min	 ±	 0.08	 vs	 3.16	 min	 ±	 0.23)	 transferrin	 uptake	 (figure	 3.16A-B).	 This	
initial	 increase	 in	 transferrin	 uptake	 suggests	 that	 a	 COMMD10	 KD	 increases	 plasma	






































results	 highlight	 increased	 number	 of	 cells	with	 transferrin	 uptake	 (%)	 in	U2OS	C10	KD	 cells	

































plasma	 membrane	 and	 the	 endosome,	 or	 between	 endosomal	 compartments	 (figure	
3.17A-B).		
	





















A	 –	 Scoring	 system	 for	 transferrin	 -recycling	 assay.	 0	 	 =	 no	 transferrin	 present.	 1	 =	 disperse	
cytoplasmic	 transferrin.	 2	 =	 punctate	 staining	 suggesting	 transferrin	 in	 endosomal	













Images	 were	 blindly	 scored	 by	 a	 lab	member	 to	 prevent	 bias	 and	 subsequent	 scores	
were	analysed.	Cells	with	no	transferrin	incubation,	as	expected,	showed	no	transferrin	
present	 (figure	 3.18A).	 After	 5	 min	 incubation,	 however,	 C10	 KD	 cells	 showed	 a	
significantly	reduced	amount	of	cytoplasmic	 transferrin,	 compared	 to	control	KD	cells,	
and	 an	 increase	 in	 the	 amount	 of	 punctate	 transferrin	 staining	 (figure	 3.18B).	 This	
suggests	 an	 increased	 amount	 of	 transferrin	 in	 endosomal	 structures;	 possibly	 due	 to	




a	 reduction	 in	 cytoplasmic	 transferrin	 and	 an	 increase	 in	 the	 amount	 of	 punctate	
transferrin	 staining,	 compared	 to	 control	 KD	 cells	 (figure	 3.18C).	 By	 this	 stage	 it	was	
hypothesised	that	the	transferrin	would	have	begun	being	recycled	back	to	the	plasma	
membrane	 and	 therefore	 both	 U2OS	 control	 and	 C10	 KD	 cells	 would	 show	 mostly	
cytoplasmic	transferrin.	This	increase	in	punctate	transferrin	localisation	suggests	that	a	
COMMD10	KD	delays	the	trafficking	of	the	transferrin	from	the	endosome	to	the	plasma	
membrane.	 Further	 evidence	 for	 this	was	 provided	 in	 cells	 that	were	 “chased”	 for	 30	
min	after	transferrin	incubation.	C10	KD	cells	showed	a	highly	significant	increase	in	the	
amount	 of	 punctate	 staining	 compared	 to	 control	 KD	 cells	 suggesting	 that	 a	 lack	 of	
COMMD10	 impairs	 the	 recycling	 of	 the	 transferrin	 receptor	 back	 to	 the	 plasma	
membrane	(figure	3.18D).	The	higher	percentage	of	U2OS	control	KD	cells	showing	no	
transferrin	(compared	to	C10	KD	cells)	highlights	that	the	transferrin	receptor	is	being	
recycled	 back	 to	 the	 plasma	 membrane	 more	 slowly	 in	 cells	 with	 a	 COMMD10	
knockdown.	 In	 support	of	 this,	 the	 time	 taken	 for	50%	of	 cells	 to	 show	no	 transferrin	
present	almost	doubled	in	COMMD10	KD	cells	(31.17	mins	±	1.30	vs	53.17	mins	±	1.01)	
(figure	3.19)	suggesting	impairment	in	recycling	in	COMMD10	KD	cells.	This	leads	to	the	








plus	either	a	15	min	chase	 (C)	or	a	30	min	chase	 (D)	and	 images	were	blindly	 scored.	Graphs	
correspond	to	images	directly	above	them.	Scale	bar	=	15	μM.	Data	shown	as	mean	±	SD.	Two-







Figure	 3.19	 COMMD10	 KD	 delays	
transferrin	recycling	
Time	taken	for	50%	U2OS	control	and	











role	 in	protein	 trafficking.	Results	described	 in	 this	 chapter	confirmed	 that	COMMD10	
co-localises	with	Arf1	(especially	with	an	active	Arf1	mutant)	(figures	3.4	and	3.5)	and	
highlight	 that	 a	 COMMD10	 KD	 alters	 the	 localisation	 of	 active	 Arf1	 (figure	 3.6)	
suggesting	COMMD10	localises	to	the	cis-Golgi	and	plays	a	role	in	recruiting	active	Arf1	
to	 the	 Golgi	 or	 in	 keeping	 active	 Arf1	 at	 the	 Golgi	 membrane.	 Lack	 of	 co-localisation	
between	 COMMD10	 and	 COPB1	 (figure	 3.7)	 or	 COMMD10	 and	 Rab1a	 (figure	 3.9)	
contradicted	Arf1	results	and	suggested	 that,	 in	 fact,	COMMD10	did	not	 localise	 to	 the	
cis-Golgi	 and	 may	 play	 an	 Arf-specific	 role.	 Localisation	 studies	 of	 Arf4	 and	 Arf5	
however,	 showed	no	change	 in	 localisation	 in	COMMD10	KD	cells	 (figure	3.8)	 thereby	
suggesting	 an	 Arf1-specific	 role	 for	 COMMD10,	 although	 to	 be	 able	 to	 definitively	
conclude	 this	 experiments	 with	 active	 and	 inactive	 mutants	 of	 Rab1a,	 Arf4	 and	 Arf5	
have	to	be	performed.			
	
Recent	 studies	 have	 highlighted	 a	 role	 for	 Arf1	 at	 the	 endosome,	 and	 co-localisation	
between	COMMD10	and	the	endosomal	marker;	transferrin-546	(figure	3.11),	suggested	
any	Arf1-COMMD10	role	may	be	occurring	at	the	endosomes.	The	effect	of	a	COMMD10	
KD	 on	 protein	 levels	 of	 some	 recycling-associated	 proteins	 (figure	 3.12)	 provided	
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further	 evidence	 of	 a	 role	 for	 COMMD10	 at	 the	 endosome	 although	 not	 all	 of	 the	
recycling-associated	proteins	analysed	exhibited	a	change	(figures	3.13	and	3.14).	
	
Further	 studies	 with	 transferrin-546	 highlighted	 that	 a	 COMMD10	 KD	 caused	 an	
increased	 rate	 of	 endocytosis	 of	 the	 transferrin-receptor	 (i.e.	 increased	 plasma	
membrane	 to	endosome	 trafficking)	 (figures	3.15	and	3.16)	adding	 further	 support	 to	
the	 notion	 that	 COMMD10	 plays	 a	 role	 at	 the	 endosome.	 It	 was	 also	 observed	 that	 a	
COMMD10	 KD	 significantly	 delayed	 recycling	 of	 the	 transferrin-receptor	 back	 to	 the	
plasma	membrane	(figures	3.18	and	3.19)	therefore	suggesting	that	COMMD10	plays	a	
role	 at	 the	 endosome	 and	 possibly	 regulates	 the	 endosomal	 and	 recycling	 trafficking	
pathways	(results	for	this	chapter	are	summarised	in	figure	3.20).		
	
A	 number	 of	 membrane-resident	 proteins,	 such	 as	 ion	 channels,	 are	 recycled	 to	 and	
from	the	plasma	membrane	 in	a	highly	regulated	process.	One	of	 these	proteins	 is	 the	
Epithelial	 Sodium	 Channel	 (ENaC).	 ENaC	 is	 a	 heterotrimeric	 Na+	 channel	 crucially	




Recent	 studies	 have	 shown	 that	 COMMD	 proteins	 are	 able	 to	 form	 a	 complex	 with	
ccdc22	and	ccdc93	(CCC	complex)	 that,	 through	Retromer,	 regulates	 the	recycling	of	a	
number	 of	 proteins.	 Results	 from	 this	 chapter	 suggest	 that	 COMMD10	 also	 aids	 in	














COMMD10	co-localised	with	Arf1	 (and	specifically	Arf1-Q71I)	 suggesting	a	 role	 for	COMMD10		
at	the	cis-Golgi.	However,	COMMD10	did	not	co-localise	with	Arf4,	Arf5,	Rab1a	or	COPB1	(four	
other	 ER/cis-Golgi)	 suggesting	 that	 perhaps	 COMMD10	 does	 not	 localise	 to	 the	 ER	 or	 the	 cis-
Golgi.	 It	 was	 subsequently	 determined	 that	 COMMD10	 co-localised	 with	 transferrin-546	
suggesting	 COMMD10	 localises	 to	 endosomal	 compartments.	 Further	 evidence	 for	 this	 was	
provided	 by	 determining	 that	 a	 COMMD10	 knockdown	 altered	 the	 levels	 of	 two	 recycling-
associated	 proteins,	 COMMD1	 and	 Vps35.	 A	 COMMD10	 knockdown	 also	 appeared	 to	 suggest	
that	 COMMD10	 regulates	 the	 endocytosis	 and	 recycling	 of	 the	 transferrin	 receptor	 suggesting	







































(Arteaga	 &	 Canessa,	 2005;	 Bhalla	 &	 Hallows,	 2008).	 Through	 its	 role	 in	 sodium	
reabsorption,	ENaC	is	important	in	the	control	of	salt	and	water	homeostasis	as	well	as	
the	 regulation	 of	 blood	 pressure	 and	 total	 blood	 volume	 (Rossier	 et	 al.,	 2002).	
Consequently,	 dysfunction	 of	 ENaC	 has	 been	 linked	 to	 blood	 pressure	 abnormalities	
(Palmer,	1992;	Shimkets	et	al.,	1994;	Chang	et	al.,	1996;	Strautnieks	et	al.,	1996),	which	
highlights	 the	 importance	 of	 controlling	 ENaC	 numbers	 at	 the	 plasma	 membrane;	
through	 both	 protein	 synthesis	 and	 through	 regulation	 of	 ENaC	 endocytosis	 and	
recycling.			
	
Ubiquitination,	 and	 thus	 endocytosis,	 of	 ENaC	 occurs	 through	 the	 E3	 ubiquitin	 ligase	
Nedd4-2.	 PY	 motifs	 located	 in	 the	 C-terminal	 domains	 of	 the	 ENaC	 subunits	 directly	
interact	with	 the	WW	domains	 of	 the	Nedd4-2	 protein	 resulting	 in	 the	 ubiquitination	
and	down	regulation	of	ENaC	activity	(Staub	et	al.,	1996;	Goulet	et	al.,	1998;	Staub	et	al.,	
2000;	 Snyder	 et	 al.,	 2001).	 The	 ubiquitinated	 ENaC	 is	 retrieved	 from	 the	 plasma	
membrane	 and	 trafficked	 to	 the	 early	 endosome	 (Wang	 et	 al.,	 2006).	 In	 Liddle’s	





Following	 endocytosis,	 a	 decision	 is	made	 in	 endosomal	 compartments	 regarding	 the	
fate	of	the	ENaC	channels	(reviewed	in	(Butterworth	et	al.,	2009;	Butterworth,	2010)).	
These	 channels	 that	 have	 been	 retrieved	 from	 the	 apical	 membrane	 are	 able	 to	 be	
recycled	 once	 they	 have	 been	 deubiquitinated	 (Butterworth	 et	 al.,	 2007).	 The	 exact	
mechanisms	 of	 how	 these	 deubiquitinated	 ENaC	 channels	 traffic	 back	 to	 the	 apical	
membrane	 is	 not	 thoroughly	 understood	 although	 one,	 relatively	 newly,	 described	
protein	 complex	 implicated	 in	 endosomal	 sorting	 and	 recycling	 is	 the	 Retromer	
complex.	Retromer	consists	of	a	cargo	selection	complex	comprising	VPS26,	VPS29	and	
VPS35	and	 the	 sorting	nexins	 (SNX1,	2,	5	and	6),	which	 facilitate	generation	of	 cargo-
loaded	 vesicles	 at	 the	 endosome	 (Cullen	 &	 Korswagen,	 2012).	 Retromer	 recruits	 the	
WASH	complex,	which,	in	turn,	recruits	the	CCC	complex,	through	FAM21	(Family	with	






Retromer	 has	 been	 implicated	 in	 facilitating	 the	 recycling	 of	 a	 number	 of	 membrane	
proteins	and	all	COMMD	family	members	have	recently	been	shown	to	be	involved	with	
Retromer,	 through	 the	 CCC	 complex,	 suggesting	 therefore	 that	 all	 of	 the	 family	 are	
capable	 of	 forming	 this	 CCC	 complex	 (Starokadomskyy	 et	al.,	 2013;	Wan	 et	al.,	 2015),	
and	 thus	 could	 be	 vital	 for	 endosomal	 trafficking	 and	 recycling.	 Three	COMMD	 family	
members	have	been	shown	to	regulate	the	epithelial	sodium	channel	(ENaC):	COMMD1,	













a	 suitable	model	 to	 study	 ENaC	 abundance	 and	 activity	 at	 the	 apical	membrane.	 FRT	
cells	 do	 not	 endogenously	 express	 ENaC	 (Snyder,	 2000)	making	 these	 cells	 a	 suitable	
tool	 to	 study	 post-transcriptional	 regulation	 of	 ENaC	 activity,	 which	 would	 therefore	
provide	 evidence	 as	 to	 whether	 COMMD10	 regulates	 ENaC.	 	 FRT	 epithelia	 grown	 on	
Snapwell™	filters	and	transfected	with	plasmids	encoding	αβγENaC	are	able	to	generate	
an	 ENaC	 current	 in	 Ussing	 chamber	 studies	 under	 short-circuit	 conditions	 (Snyder,	
2000;	Snyder	et	al.,	2004;	Lee	et	al.,	2009;	Lee	et	al.,	2011).	ENaC	current	can	be	rapidly,	
specifically	 and	 reversibly	 blocked	 by	 the	 addition	 of	 5	 μM	 amiloride	 (a	 potassium	
sparing	diuretic)	(Salako	&	Smith,	1970).	This	change	in	current	caused	by	amiloride	is	
termed	 the	 amiloride-sensitive	 short-circuit	 current	 (Isc-amil)	 and	 provides	 an	
indication	of	ENaC	numbers	and/or	activity	at	the	apical	membrane	(the	smaller	the	Isc-
	 110	
amil	 the	 smaller	 the	 number	 of	 ENaC	 channels	 at	 the	 membrane)	 (for	 method	 and	
example	Ussing	chamber	trace	see	2.13).		As	well	as	measuring	the	short-circuit	current	
the	 transepithelial	 resistance	 (RT)	 is	 also	 monitored	 throughout	 Ussing	 chamber	
experiments	 to	provide	an	 indication	of	 the	 integrity	of	 the	epithelia	 (i.e.	 formation	of	
tight	 junctions	between	cells),	and	thus	 the	ability	 to	resist	 the	 flow	of	 ions	across	 the	
epithelium.	The	higher	the	resistance	the	more	tight	junctions	that	have	formed	between	




resistances	 lower	than	300	Ω.cm2	were	omitted	 from	analyses	so	as	 to	ensure	that	 Isc-






To	 investigate	 whether	 a	 stable	 COMMD10	 KD	 had	 an	 effect	 on	 ENaC	 current,	 FRT	
control	and	C10	KD	cells	growing	on	Snapwell™	filters	were	transfected	with	plasmids	
encoding	αβ-HAγ	ENaC	(0.067	μg	of	each	subunit)	and	incubated	for	three	days	to	allow	
the	 formation	 of	 a	 confluent,	 polarised,	 epithelial	 monolayer.	 FRT	 control	 epithelia	
















lower	 than	 for	 control	KD	epithelia	 (1	 for	 control	 epithelia	 vs	0.49	±	0.01	 for	C10	KD	
epithelia,	N	=	17,	p<0.0001)	(figure	4.1	A-B)	suggesting	that	a	lack	of	COMMD10	reduces	
ENaC	 populations	 present	 at	 the	 apical	 membrane	 and	 may,	 therefore,	 affect	 ENaC	
trafficking	to	and	 from	the	plasma	membrane,	however	without	direct	evidence	of	 the	
effect	of	the	COMMD10	KD	on	ENaC	gating	it	is	not	possible	to	draw	a	solid	conclusion.		
There	 are	 a	 number	 of	 reasons	 as	 to	 why	 the	 Isc-amil	 was	 reduced.	 It	 could	 be	
hypothesised	 that	 the	 knockdown	 alters	 ENaC	 trafficking	 through	 the	Golgi,	 increases	
ENaC	 ubiquitination	 and	 thus	 endocytosis	 through	 Nedd4-2	 or	 that	 the	 knockdown	
disrupts	ENaC	recycling	from	endosomal	compartments	to	the	plasma	membrane.	This	
result	was	surprising	as	it	had	been	previously	described	that	a	transient	knockdown	of	
COMMD1,	 using	 siRNA,	 increased	 Isc-Amil	 (Ke	 et	 al.,	 2010),	 and	 overexpression	 of	
COMMD3	or	COMMD9	decreased	Isc-Amil	in	FRT	cells	(Liu	et	al.,	2013)	and	therefore	it	
was	 hypothesised	 that	 a	 COMMD10	 KD	 would	 also	 increase	 the	 Isc-Amil.	 In-house	
studies	 have	 also	 identified	 that	 a	 transient	 knockdown	 of	 COMMD10	 (with	 siRNA),	




Experiments	 were	 performed	 on	 untransfected	 FRT	 control	 KD	 and	 C10	 KD	 cells	 to	
highlight	 that	 there	 was	 no	 amiloride	 effect	 when	 ENaC	 was	 not	 present.	 Both	 the	
current	 (figure	 4.1	 Di)	 and	 transepithelial	 potential	 difference	 (figure	 4.1	 Dii)	 were	
analysed	 and	 it	 was	 observed	 that	 there	 were	 no	 changes,	 following	 the	 addition	 of	






FRT	 control	 and	 C10	 KD	 cells	 were	 grown	 on	 Snapwell	 filters	 and	 transfected	with	 plasmids	
encoding	 α,	 β-HA,	 and	 γ	 ENaC	 (0.067	 μg	 of	 each	 plasmid).	 A	 –	 Representative	 Isc	 profile	 for	
control	 and	 COMMD10	 KD	 epithelia.	 The	 addition	 of	 amiloride	 (5	 μM)	 is	 indicated	 and	 the	
subsequent	 change	 in	 current	was	 calculated	 and	 termed	 Isc-amil.	 B	 –	 Pooled	 data	 for	 Isc-amil	
control	and	C10	KD	epithelia	transfected	with	plasmids	encoding	αβ-HAγ	ENaC.	Data	shown	as	
mean	±	SD	relative	to	Isc-Amil	in	FRT	control	KD	epithelia.	One-sample	t-test.	****p<0.0001.	N	=	














incubated	 for	 three	 days	 to	 allow	 the	 formation	 of	 a	 confluent,	 polarised,	 epithelial	
monolayer.	The	 total	 amount	of	plasmid	DNA	 transfected	 into	 cells	was	kept	 constant	
through	the	addition	of	empty	pMT3	vector.		
	
No	 changes	 in	 RT	 were	 observed	 between	 the	 four	 experimental	 groups	 (692	 ±	 155	
Ω.cm2	 for	FRT	 control	KD	epithelia;	 742	±	136	Ω.cm2	for	C10	KD	epithelia;	 764	±	118	
Ω.cm2		for	control	KD	epithelia	with	overexpression	of	COMMD10;	667	±	146	Ω.cm2		for	







protein	 levels	was	determined	by	western	blotting	 (figure	4.2	Aii)).	This	 suggests	 that	
the	 effect	 of	 the	 stable	 COMMD10	 knockdown	 is	 directly	 reversible	 and	 also	 suggests	
that	restoring	COMMD10	protein	 levels	 is	able	to	 increase	ENaC	numbers	at	the	apical	
membrane	 providing	 evidence	 that	 COMMD10	 can	 regulate	 ENaC	 populations	 at	 the	
plasma	membrane.	
	
Interestingly,	 overexpression	 of	 COMMD10	 in	 FRT	 control	 KD	 epithelia	 significantly	
reduced	Isc-Amil	compared	to	FRT	control	KD	epithelia	(1	for	FRT	control	vs	0.77	±	0.06	
for	FRT	control	+	COMMD10,	N	=	6,	p<0.01)	(figure	4.2	A-B).	This	correlates	with	studies	
investigating	 the	 effect	 of	 transient	 overexpression	 of	 COMMD1,	 COMMD3	 and	
COMMD9,	as	well	as	transient	COMMD10	KD	data,	whereby	all	four	have	been	shown	to	









FRT	 control	 and	 C10	 KD	 cells	were	 grown	 on	 Snapwell	 filters	 and	 transfected	with	 plasmids	
encoding	αβ-HAγ	ENaC	or	αβ-HAγ	ENaC	and	COMMD10-HA.	Ai	–	Representative	 Isc	profile	 for	
control	 and	 COMMD10	 KD	 epithelia	 with	 and	 without	 COMMD10	 overexpression	 (C10).	 The	
addition	of	amiloride	(5	μM)	is	indicated	and	the	subsequent	change	in	current	was	calculated.	















After	determining	 that	 the	 Isc-Amil	 in	FRT	C10	KD	epithelia	 can	be	 rescued	by	adding	
COMMD10	 back	 into	 the	 epithelia,	 the	 effect	 of	 adding	 COMMD10’s	 family	 member,	
COMMD1	 into	 FRT	 control	 and	 FRT	 C10	 KD	 cells	 was	 analysed.	 COMMD1	 was	 the	
founding	member	of	the	COMMD	family	and	has	various	described	functions,	including	
the	most	 recently	described	 role	 as	 a	 regulator	of	membrane	protein	 endocytosis	 and	
recycling	 (Joyce	 et	 al.,	 2001;	 van	 De	 Sluis	 et	 al.,	 2002;	 Ganesh	 et	 al.,	 2003;	 Tao	 et	 al.,	
2003;	Ke	et	al.,	2010;	Chang	et	al.,	2011;	Phillips-Krawczak	et	al.,	2015).	Since	 the	 link	
between	 COMMD1	 and	 protein	 recycling	 was	 established	 it	 has	 been	 described	 that	
COMMD10	 is	also	able	 to	bind	 to	 the	 recycling	associated	proteins	ccdc22	and	ccdc93	
and	 plays	 a	 role	 in	 the	 CCC	 complex	 (Starokadomskyy	 et	 al.,	 2013).	 Taking	 this	 into	
account,	along	with	the	fact	that	COMMD1	protein	levels	were	significantly	lower	in	C10	
KD	cells	compared	to	FRT	control	cells	(see	3.5.2.1)	it	was	questioned	whether	COMMD1	










The	 addition	 of	 COMMD1	 did	 not	 affect	 the	 RT	 of	 the	 epithelia	 (710	 Ω.cm2	 ±	 46	 for	
control	epithelia;	723	Ω.cm2	±	156	for	control	epithelia	+	COMMD1;	828	Ω.cm2	±	79	for	
C10	 KD	 epithelia;	 613	 Ω.cm2	 ±	 103	 for	 C10	 KD	 epithelia	 +	 COMMD1,	 N	 =	 4)	 which	






COMMD1	decreased	 Isc-amil	 in	 C10	KD	 epithelia	 (1	 for	 control	 KD	 epithelia	 vs	 0.37	 ±	
	 116	
0.04	 for	 C10	 KD	 epithelia	 +	 COMMD1,	 N	 =	 4,	p<0.0001)	 (figure	 4.3	 A-B),	 and	 further	
decreased	 the	 Isc-amil	 in	C10	KD	epithelia	 (0.52	±	0.06	 for	C10	KD	epithelia	vs	0.37	±	
0.04	for	C10	KD	epithelia	+	COMMD1,	N	=	4,	p<0.05)	(figure	4.3	A-B)	suggesting	that	the	






This	 suggests	 therefore,	 that	 instead	 of	 rescuing	 the	 Isc-Amil	 there	 is	 a	 significant,	
cumulative	effect	of	the	COMMD10	knockdown	and	the	overexpression	of	COMMD1	and	
could	 provide	 evidence	 that	 COMMD	 family	 members	 do	 not	 play	 redundant	 roles,	
however	 at	 this	 moment	 in	 time	 this	 result	 can	 only	 suggest	 COMMD10	 is	 not	 a	

















–	 Isc-Amil	 in	 control	 and	 COMMD10	 KD	 epithelia	 transfected	with	 plasmids	 encoding	 αβ-HAγ	
ENaC	alone	or	αβ-HAγ	ENaC	and	COMMD1.	Data	shown	as	mean	±	SD	relative	to	Isc-Amil	in	FRT	
control	 epithelia.	 One-way	 ANOVA	 with	 multiple	 comparisons	 and	 Tukey’s	 post-hoc	 test.	










ENaC)	 or	 other	 organelles,	 such	 as	 the	 lysosome	 or	 endosome.	 For	 ENaC,	 individual	
subunits	 are	 translated	 by	 ribosomes	 on	 the	 ER	 and	 subsequently	 assembled	 into	 a	
heterotrimeric	 αβγ	 ENaC	 complex.	 This	 complex	 formation	 then	 allows	 ENaC	 to	 be	
trafficked	 to	 the	 Golgi	 body	 (Hughey	 et	 al.,	 2004a;	 Hughey	 et	 al.,	 2004b).	 As	 ENaC	
transits	 the	 Golgi	 it	 undergoes	 maturation	 through	 proteolytic	 cleavage	 and	 glycan	
processing	 (Rotin	 et	 al.,	 2001;	 Ergonul	 et	 al.,	 2006)	 which	 is	 crucial	 to	 form	 a	 fully	
functional,	 active	 channel	 at	 the	 plasma	 membrane.	 There	 are	 a	 number	 of	 serine	
proteases	that	have	been	reported	to	cleave/activate	αβγENaC	including	furin	(Hughey	
et	al.,	 2004a;	 Hughey	 et	al.,	 2004b;	 Kleyman	 et	al.,	 2009),	 channel-activating	 protease	
(Vallet	et	al.,	 1997;	Vallet	et	al.,	 1998),	prostasin	 (Vuagniaux	et	al.,	 2000;	Adachi	et	al.,	
2001;	 Vallet	 et	 al.,	 2002;	 Vuagniaux	 et	 al.,	 2002)	 and	 trypsin	 (Diakov	 et	 al.,	 2008;	
Nesterov	 et	 al.,	 2008;	 Haerteis	 et	 al.,	 2014)	 highlighting	 how	 important	 trafficking	
through	 the	Golgi	 is	 in	 forming	a	 fully	 functional,	 active	ENaC	channel.	 Some	evidence	










As	 it	 was	 observed	 that	 a	 stable	 COMMD10	 KD	 reduced	 ENaC	 current	 it	 was	
hypothesised	that	this	was	due	to	either	effects	through	anterograde	trafficking	of	ENaC	







BFA	 is	 a	 fungal	 metabolite	 that	 rapidly	 blocks	 anterograde	 traffic	 between	 the	
endoplasmic	reticulum	and	the	Golgi	by	causing	a	collapse	of	the	Golgi	apparatus.	This	is	
due	 to	 the	 inability	 to	 form	 COPI	 vesicles	 through	 BFA’s	 inhibition	 of	 Arf1	 thus	
preventing	the	association	of	coatomer	subunits	with	COPI	vesicles	involved	in	ER-Golgi	
trafficking	 (Fujiwara	 et	 al.,	 1988;	 Lippincott-Schwartz	 et	 al.,	 1989;	 Donaldson	 et	 al.,	
1992;	Helms	&	Rothman,	1992;	Scheel	et	al.,	1997;	Sata	et	al.,	1999).	In	terms	of	ENaC,	
BFA	treatment	will	prevent	the	insertion	of	new	channels	into	the	plasma	membrane.	It	
can	 be	 inferred	 that	 the	 Isc-Amil	 in	 BFA-treated	 epithelia	 would	 therefore	 represent	
current	 generated	 from	 ENaC	 channels	 already	 present	 in	 the	 plasma	 membrane,	 or	
recycling	 of	 ENaC	 channels	 from	 the	 endosome	 to	 the	 plasma	membrane.	 It	 has	 been	
previously	 shown	 that	 initial	 BFA	 treatments	 do	 not	 affect	 the	 recycling	 of	 ENaC	
trafficking	 from	 endosomal	 compartments	 (Butterworth	 et	 al.,	 2005a).	 It	 was	
hypothesised	that,	in	C10	KD	epithelia,	if	the	Isc-Amil	did	not	change	after	BFA	treatment	
then	 the	 COMMD10	 KD	must	 affect	 ENaC’s	 anterograde	 trafficking,	 but	 if	 the	 Isc-Amil	
reduced	further,	suggesting	a	cumulative	effect	of	the	COMMD10	KD	and	BFA,	then	it	is	
possible	 that	disruption	 to	ENaC’s	 endocytosis	 or	 recycling	may	be	 the	 reason	 for	 the	
reduction	in	Isc-Amil	seen	in	C10	KD	epithelia.		
	
To	 test	 the	 effect	 of	 BFA	 on	 FRT	 control	 and	 C10	 KD	 epithelia,	 cells	 were	 grown	 on	
Snapwell	 filters	 and	 transfected	 with	 plasmids	 encoding	 α,	 β-HA	 and	 γ	 ENaC.	 Ussing	
chamber	experiments	were	then	started	and,	once	the	current	plateaued,	amiloride	was	
added	 to	 determine	 the	 initial	 amiloride	 response	 and	 ENaC	 cell	 surface	 population.	
Next,	amiloride	was	washed	out	and	epithelia	were	incubated	with	and	without	BFA	for	


















(0.48	 ±	 0.03	 for	 C10	 KD	 epithelia	 vs	 0.47	 ±	 0.03	 for	 C10	 KD	 epithelia	 without	 BFA	
incubation,	N	=	4,	p	=	0.99)	(figure	4.4	C	–	D),	highlighting	that	there	was	no	effect	on	Isc-




test	 this	 the	 Isc-Amil	 in	 C10	 KD	 epithelia,	 before	 and	 after	 incubation	 with	 BFA,	 was	
analysed.	 It	 was	 observed	 that	 the	 incubation	 of	 C10	 KD	 epithelia	 with	 BFA	 had	 a	
cumulative	effect,	and	thus	caused	a	significant	reduction	in	Isc-Amil	(0.48	±	0.03	for	C10	
KD	epithelia	vs	0.09	±	0.03	for	C10	KD	epithelia	+	BFA,	N	=	4,	p<0.01)	(figure	4.4	C	–	D)	
suggesting	 that	 a	 lack	 of	 COMMD10	 caused	 an	 additional	 effect	 that	 was	 BFA	
independent	 and	 not	 involved	 in	 anterograde	 trafficking.	 There	was	 also	 a	 significant	
difference	 in	 Isc-Amil	between	control	and	C10	KD	epithelia	with	BFA	(0.48	±	0.04	 for	
control	epithelia	+	BFA	vs	0.09	±	0.03	for	C10	KD	epithelia	+	BFA,	N	=	4,	p<0.01).	This	
suggests	 that	 a	 COMMD10	 KD	may	 not	 alter	 ENaC’s	 trafficking	 through	 the	 Golgi	 but	
could	alter	the	endocytosis	of	ENaC	from	the	plasma	membrane,	or	the	recycling	of	ENaC	
from	 endosomes	 back	 to	 the	 plasma	 membrane	 as	 it	 is	 understood	 that	 BFA	 only,	
initially,	 blocks	 forward	 trafficking	 and	 therefore	 recycling	 from	 endosomal	
compartments	 to	 the	 plasma	 membrane	 can	 still	 occur	 (i.e.,	 ENaC	 recycling	 occurs	
independently	of	the	Golgi).	However,	it	cannot	be	concluded	that	the	BFA	treatment	has	
completely	shut	down	anterograde	 trafficking	of	ENaC,	although	 the	50%	reduction	 in	
BFA-treated	control	cells	is	similar	to	a	previous	study	(Pruliere-Escabasse	et	al.,	2007).	
It	would	be	useful	 to	perform	 timecourse	 studies	with	BFA	 to	determine	 the	maximal	
effect	of	BFA	on	the	ENaC	current	to	be	able	to	fully	conclude	that	the	stable	CD10	KD	
isn’t	 affecting	 ENaC	 trafficking	 through	 the	 Golgi	 however,	 there	 is	 still	 a	 cumulative	
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epithelia	 were	 incubated	 with	 or	 without	 BFA	 for	 20	 min	 to	 block	 anterograde	 trafficking.	
Epithelia	were	then	blocked	again	with	amiloride	to	determine	the	effect	of	BFA	incubation.		B	-	
Representative	Isc	profile	for	control	and	COMMD10	KD	epithelia	prior	to	incubation	of	epithelia	











To	 provide	 further	 evidence	 as	 to	 whether	 COMMD10	 regulates	 anterograde	 ENaC	
trafficking	 (i.e.	 through	 the	 Golgi),	 the	 effect	 of	 the	 inhibition	 of	 two	 phospholipids,	






acid)	 and	 PS	 (phosphatidylserine),	 and	 to	 various	 other	 phosphatidylinositol	 variants	
(Cheung	and	McDonald,	unpublished	data),	two	phospholipids	linked	to	ENaC	regulation	
(Zhang	 et	 al.,	 2010).	 PA	 is	 able	 to	 bind	 and	 inhibit	 ENaC,	 possibly	 via	 endothelin	
mediated	signalling	 (Zhang	et	al.,	2010)	and	has	also	been	shown	to	play	a	 role	 in	 the	
formation	 of	 COPI	 vesicles	 (Yang	 et	 al.,	 2008).	 PS	 appears	 to	 up-regulate	 ENaC,	most	
likely	through	TNF-α	(tumour	necrosis	factor	α)	(Zhang	et	al.,	2010).	It	could,	therefore,	







PIK93	 or	 FIPI	 (or	 vehicle	 only)	 for	 20	 min	 (as	 effects	 are	 seen	 rapidly	 with	 each	
inhibitor;	 PIK93	 (Toth	 et	 al.,	 2006)	 and	 FIPI	 (Antonescu	 et	 al.,	 2010))	 prior	 to	 the	
beginning	of	Ussing	chamber	experiments.	It	was	hypothesised	that	if	changes	in	Isc-amil	










type	 epithelia	 +	 vehicle	 vs	 1.26	 ±	 0.07	 for	 wild-type	 epithelia	 +	 FIPI,	 N	 =	 4,	 p<0.01)	
(figure	4.5	A	–	B)	and	that	inhibition	of	PI4KIIIβ	caused	a	significant,	decrease	in	Isc-Amil	
(1	 for	 control	 epithelia	 +	 vehicle	 vs	 0.70	 ±	 0.13	 for	 control	 epithelia	 +	 PIK93,	 N	 =	 4,	
p<0.05)	 (figure	 4.5	 A	 –	 B).	 These	 effects	 seen	with	 FIPI	 and	 PIK93,	 although	 causing	
changes	in	Isc-Amil,	are	much	smaller	than	those	seen	in	C10	KD	cells.	This	adds	further	
support	to	the	suggestion	that	COMMD10	does	not	affect	ENaC’s	trafficking	through	the	
Golgi	 body,	 and	 thus	may	not	 affect	 the	 anterograde	 trafficking	of	ENaC.	Phosphatidic	
acid	has	been	shown	to	be	involved	in	the	formation	of	COPI	vesicles	and	the	fact	that	
inhibition	 of	 PA	 causes	 an	 increase	 in	 Isc-amil	 compared	 to	 the	 reduction	 in	 Isc-amil	
observed	 in	 C10	 KD	 epithelia	 adds	 further	 evidence	 to	 suggest	 that	 COMMD10	 is	 not	





Based	 on	 these	 results	 it	 can	 be	 hypothesised	 that	 COMMD10	 does	 not	 regulate	
anterograde	trafficking	of	ENaC	and,	therefore,	this	avenue	was	not	further	investigated.	
As	COMMD1	has	been	shown	to	down-regulate	ENaC	through	Nedd4-2,	thus	increasing	
endocytosis,	 and	 the	 COMMD	 family	 have	 been	 implicated	 in	 protein	 recycling	 from	
endosomal	 compartments	 to	 the	 plasma	 membrane,	 experiments	 now	 investigate	












































2001;	 Wiemuth	 et	 al.,	 2007;	 Eaton	 et	 al.,	 2010).	 Ubiquitination	 of	 ENaC,	 at	 the	 cell	
surface,	occurs	 through	 the	E3	ubiquitin	 ligase	Nedd4-2.	WW	domains	of	 the	Nedd4-2	
protein	interact	with	PY	motifs	located	in	the	C-terminal	domains	of	the	ENaC	subunits	
(Kamynina	 et	al.,	 2001).	 This	 interaction	 results	 in	 the	 ubiquitination	 and	 subsequent	
endocytosis	 of	 ENaC.	 SGK1	 (serum-	 and	 glucocorticoid-	 regulated	 kinase	 1)	 prevents	
ENaC	 ubiquitination	 through	 the	 phosphorylation,	 and	 thus	 inhibition,	 of	 Nedd4-2	








such	 as	 various	 chloride	 channels	 (Embark	 et	al.,	 2004;	 Hryciw	 et	al.,	 2004;	 He	 et	al.,	
2008),	potassium	channels	(Henke	et	al.,	2004;	Baltaev	et	al.,	2005;	Ekberg	et	al.,	2007;	
Jespersen	 et	 al.,	 2007)	 and	 sodium	 channels,	 including	 ENaC	 (Harvey	 et	 al.,	 2001;	
Kamynina	et	al.,	2001;	Fotia	et	al.,	2004;	van	Bemmelen	et	al.,	2004;	Rougier	et	al.,	2005).	




significantly	 faster	 rate	 of	 endocytosis	 of	 the	 transferrin	 receptor	 it	was	hypothesised	
that	 in	 C10	 KD	 cells	 there	 was	 similarly	 an	 increased	 rate	 of	 ENaC	 endocytosis.	 To	
provide	evidence	to	support	this	hypothesis	the	protein	levels	of	Nedd4-2	in	FRT	control	
and	 C10	 KD	 cells	 were	 analysed.	 It	 was	 observed	 that	 Nedd4-2	 protein	 levels	 were	
significantly	higher	in	C10	KD	cells	(1	for	FRT	control	cells	vs	1.77	±	0.2	for	C10	KD	cells,	









protein	 levels	 were	 determined	 by	 immunoblotting	 with	 anti-Nedd4-2	 antibody	 (for	










As	 it	was	observed	that	Nedd4-2	protein	 levels	were	significantly	 increased	in	C10	KD	
cells	 it	 was	 hypothesised	 that	 this	 would	 result	 in	 increased	 ENaC	 ubiquitination	 in	
these	 cells.	 To	 test	whether	 this	was	 the	 case	 an	 ubiquitination	 assay	was	 performed	
(see	2.6	 for	 full	method).	 In	brief,	FRT	control	and	C10	KD	cells	were	transfected	with	
plasmids	 encoding	 α,	 β-HA	 and	 γ	 ENaC,	 incubated	 for	 24	 hr	 and	 subsequently	 lysed.	








p<0.01)	 (figure	 4.7	 A).	 Although	 this	 blot	 appears	 as	 a	 smear,	 this	 is	 common	 with	
ubiquitination	assays	and	the	P4D1	antibody	(Weimuth	et	al.,	2007;	Li	et	al.,	2017;	Wu	et	
al.,	2017;	Zhang	et	al.,	2017).	This	suggests	 that	ENaC	 is	endocytosed	 faster	 in	C10	KD	
cells	due	to	increased	ubiquitination	by	Nedd4-2.	It	could	therefore	be	hypothesised	that	
COMMD10	would	normally	inhibit	Nedd4-2’s	ubiquitination	of	ENaC;	although	whether	
COMMD10	 has	 an	 ENaC	 specific	 effect	 would	 be	 interesting	 to	 investigate	 (see	
discussion).	Overexpression	of	COMMD1	has	been	shown	to	increase	the	ubiquitination	
of	ENaC	(Ke	et	al.,	2010),	and	COMMD3	and	COMMD9	have	been	shown	to	decrease	the	
amount	of	ENaC	at	 the	plasma	membrane	 (Liu	et	al.,	 2013)	 (suggesting	an	 increase	 in	
ENaC	ubiquitination)	whereas	 the	 stable	 C10	KD	 increased	ENaC	ubiquitination.	 This,	
therefore,	 provides	 further	 evidence	 that	 COMMD10	 appears	 to	 play	 a	 unique	 role	
compared	 to	 other	 COMMD	 family	 members	 and	 supports	 immunoblotting	 data	 (see	
3.5.2.1	 and	 3.5.2.3),	 where	 the	 COMMD10	 KD	 alters	 COMMD1	 proteins	 levels	 but	 not	
COMMD3	 levels,	 and	 the	 fact	 that	COMMD1	cannot	 rescue	 the	 Isc-amil	 seen	 in	C10	KD	
epithelia	(see	4.1.2	and	4.1.3).		
	
It	 should	 also	 be	 noted	 that	 throughout	 all	 ubiquitin	 assays	 levels	 of	 β-HA	ENaC,	 and	
presumably	 total	ENaC,	were	consistently	 lower	 in	C10	KD	cells	 (1	 for	control	cells	vs	









were	 lysed	 and	 total	 cellular	 β-HA	 ENaC	was	 immunoprecipitated	with	 anti-HA	 antibody	 and	
protein	G-agarose	beads	before	proteins	were	separated	by	SDS-PAGE.	A	-	Ubiquitin	levels	were	
determined	using	anti-P4D1	antibody.	B	-	ENaC	levels	were	then	determined	by	immunoblotting	













Following	 ubiquitination	 of	 ENaC,	 by	 Nedd4-2,	 ENaC	 is	 endocytosed	 from	 the	 plasma	
membrane	 to	 the	 endosome	 via	 a	 clathrin-mediated	 pathway	 (Wang	 et	 al.,	 2006).	 As	
there	was	an	increase	in	ubiquitination	of	the	β-ENaC	subunit,	the	C10	KD	cells,	 it	was	
hypothesised	 that	 there	 would	 be	 a	 decrease	 in	 ENaC	 population	 at	 the	 plasma	
membrane.	To	analyse	ENaC	levels	at	the	plasma	membrane	in	FRT	control	and	C10	KD	
cells	a	biotinylation	assay	was	performed.	 In	brief	FRT	control	and	C10	KD	cells	were	
transfected	 with	 plasmids	 encoding	 α,	 β-HA	 and	 γ	 ENaC	 and	 were	 subsequently	
incubated	 with	 EZ-link®-Sulfo-NHS-LC	 biotin.	 Cells	 were	 then	 lysed	 and	 lysates	 were	
subsequently	 incubated	 with	 Neutravidin	 beads	 to	 separate	 surface	 and	 cytosolic	
proteins.	Proteins	were	then	separated	by	SDS-PAGE	and	ENaC	levels,	both	membrane	
and	total,	were	determined	by	immunoblotting	using	anti-HA	antibody.	
It	 was	 observed	 that	 a	 COMMD10	 KD	 reduced	 plasma	 membrane	 ENaC	 levels,	 as	
predicted	 (figure	 4.8).	 This	 suggests	 that	 a	 stable	 COMMD10	 KD	 increases	 ENaC	
endocytosis	 from	 the	 plasma	 membrane	 through	 increased	 ENaC	 ubiquitination.		
Unfortunately,	 possibly	 due	 to	 low	 ENaC	 levels	 at	 the	 plasma	 membrane,	 this	
experiment	was	only	completed	once	(although	attempted	6	times),	due	to	difficulty	in	
detecting	 ENaC	 in	 the	 cell	 surface	 fraction,	 and	 therefore	 further	 experiments	 are	
needed	for	any	solid	conclusion	to	be	made.	Another	possible	reason	for	low	ENaC	levels	
at	the	plasma	membrane	could	be	due	to	the	high	passage	number	of	cells	used	in	this	
study	 (passage	 numbers	 from	 19-27	 were	 used).	 Previously,	 in-house	 studies	 have	
observed	that	ENaC	expression	drastically	reduces	after	around	passage	20	(McDonald,	
unpublished	 work).	 It	 has	 been	 described	 that	 as	 passage	 number	 of	 cells	 the	
transfection	 efficiency	 decreases	 (Madeira	 et	 al.,	 2010;	 Aydin	 et	 al.,	 2012;	 de	 Los	
Milagros	 Bassani	 Molinas	 et	 al.,	 2014).	 However,	 these	 results	 suggest	 that	 a	 stable	









FRT	 control	 and	 C10	 KD	 cells,	 transfected	 with	
plasmids	encoding	α,	β-HA	and	γ	ENaC,	were	incubated	
with	 biotin	 before	 being	 lysed	 and	 incubated	 with	
Neutravidin®	 beads	 to	 separate	 out	 cytosolic	 and	
plasma	 membrane	 proteins.	 Proteins	 were	 then	
separated	 by	 SDS-PAGE	 and	 ENaC	 levels,	 both	





4.3.3	 COMMD10	 KD	 decreases	 SGK1	 protein	 levels	 but	 increases	 phosphorylated	 SGK1	
protein	levels	
	
SGK1	 prevents	 ubiquitination	 of	 ENaC	 through	 phosphorylation	 of	 Nedd4-2	 (as	
described	 earlier)	 and	 thus	 increases	 ENaC	 cell	 surface	 expression	 and	 ENaC	 activity	
(Alvarez	de	la	Rosa	et	al.,	1999;	Chen	et	al.,	1999;	Naray-Fejes-Toth	et	al.,	1999).	SGK1	is	
able	to	phosphorylate	Nedd4-2	in	three	positions,	at	RXRXXS/T	(where	X	is	any	amino	
acid)	 consensus	 sequences	 (Debonneville	 et	 al.,	 2001;	 Snyder	 et	 al.,	 2002).	 For	 the	
phosphorylation	 for	Nedd4-2	 to	 occur	 SGK1	must	 itself	 be	 phosphorylated	 (by	PDK1)	
which	 causes	 SGK1’s	 activation	 (to	 pSGK1)	 (Tessier	 &	 Woodgett,	 2006).	
Phosphorylation	of	Nedd4-2	promotes	the	interaction	of	Nedd4-2	with	a	14-3-3	protein	
dimer	 (a	phospho-protein	binding	protein)	preventing	Nedd4-2’s	 interaction	with	and	





To	 analyse	whether	 SGK1	 and	 pSGK1	 protein	 levels	 in	 FRT	 control	 and	 C10	 KD	 cells	
differed	 immunoblotting	was	used.	 In	agreement	with	 the	hypothesis	protein	 levels	of	
SGK1	decreased	(1	for	control	cells	vs	0.78	±	0.1	for	C10	KD	cells,	N	=	3,	p<0.01)	(figure	
4.9)	 providing	 further	 evidence	 that	 a	 COMMD10	 knockdown	 promoted	 ENaC	
ubiquitination	through	Nedd4-2.	Interestingly	however,	levels	of	pSGK1	increased	(1	for	
control	 cells	 vs	 1.58	 ±	 0.1	 for	 C10	 KD	 cells,	 N	 =	 4,	 p<0.01)	 (figure	 4.9)	 which	would	

























A	 stable	 COMMD10	 KD	 increased	 the	 protein	 level	 of	 Nedd4-2	 as	 well	 as	 ENaC	






and	 is	 endocytosed	 to	 endosomal	 compartments	 before	 being	 recycled	 back	 to	 the	
plasma	membrane,	thus	allowing	the	use	of	FRT	control	and	C10	KD	cells	to	analyse	any	
changes	 in	 the	 rate	 of	 transferrin	 receptor	 endocytosis.	 Using	 the	 same	 protocol	 as	
described	for	U2OS	control	and	U2OS	C10	KD	cells	(see	section	3.5.3)	FRT	control	and	
C10	KD	cells	were	incubated	with	transferrin-546	for	0,	1,	2	and	5	min	prior	to	fixation	




stable	COMMD10	KD	 increases	 the	rate	of	Tf-546	uptake	(see	3.5.3).	Therefore,	 it	was	
hypothesised	that	FRT	C10	KD	cells	would	similarly	exhibit	an	increased	rate	of	Tf-546	




cells	 (figure	 4.10	 A	 –	 top	 left	 panel	 and	 B).	 After	 1-minute,	 similarly	 to	 the	 results	








546	uptake	suggests	 that	a	COMMD10	KD	may	 increase	endocytosis	of	ENaC	 from	the	











have	reached	their	maximum	uptake	values.	 	This	 increased	rate	of	 transferrin	uptake	
suggests	that	a	COMMD10	KD	increases	plasma	membrane	to	endosome	trafficking	and	
provides	more	 evidence	 that	 the	 reduction	 in	 Isc-Amil	 seen	 in	 C10	 KD	 cells	 is	 due	 to	
increased	endocytosis	of	ENaC	from	the	plasma	membrane	to	the	endosome	(see	figure	
4.12	 for	 summary	 figure)	 This	 is	 supported	 by	 the	 fact	 that	 there	 is	 an	 increase	 in	
Nedd4-2	protein	levels,	and	subsequent	ENaC	ubiquitination,	in	C10	KD	cells.	However,	
endocytosis	 of	 the	 transferrin	 receptor	 is,	 in	 general,	 ligand-induced,	 (although	 the	
































suggesting	 an	 increase	 in	 ENaC	 endocytosis	 from	 the	 plasma	 membrane	 to	 endosomal	
compartments.	 To	 correlate	 with	 this	 the	 rate	 of	 Tf-546	 uptake	 in	 C10	 KD	 cells	 was	 also	
increased,	and	knowing	that	Tf-546	and	ENaC	follow	similar	pathways	through	the	endosomal	
compartments	it	could	be	hypothesised	that	the	reduction	in	Isc-amil	in	C10	KD	epithelia	may	be	























siRNA	used	 in	 this	 study	 has	 previously	 been	used	 and	 shown	 to	 increase	 Isc-Amil	 by	
approximately	3	times	in	FRT	epithelia	and	approximately	4	times	in	H441	epithelia	(a	




ρmol),	 incubated	 for	72	hr	at	37°C	before	 the	 Isc-Amil	was	measured	using	 the	Ussing	
chamber.	
	
Treatment	 of	 ENaC-expressing	 FRT	 control	 and	 C10	 KD	 cells	 with	 control/Nedd4-2	
siRNA	 did	 not	 alter	 the	 RT	 of	 the	 FRT	 epithelia	 (888	 Ω.cm2	 ±	 163	 for	 control	 KD	
epithelia;	795	Ω.cm2	±	140	for	control	KD	epithelia	+	Nedd4-2	siRNA;	844	Ω.cm2	±	197	
for	C10	KD	epithelia;	 684	±	147	Ω.cm2	 for	C10	KD	epithelia	+	Nedd4-2	 siRNA,	N	=	4)	
(figure	 4.13	 C)	 suggesting	 the	 presence	 of	 siRNA	 does	 not	 affect	 the	 integrity	 of	 the	
epithelial	monolayer.		
	 138	












is	 only	 able	 to	 partially	 rescue	 Isc-Amil	 in	 C10	 KD	 epithelia.	 Therefore	 it	 can	 be	
hypothesised	that	a	COMMD10	KD	does	affect	ENaC	ubiquitination	and	endocytosis,	but	
COMMD10	may	 also	 have	 another	 role	 in	 regulating	ENaC	 trafficking	 to	 and	 from	 the	
plasma	membrane	 such	 as	 in	 the	 recycling	 pathway,	 through	 Retromer.	 As	 expected,	
ENaC-expressing	 FRT	 control	 KD	 epithelia	 with	 Nedd4-2	 siRNA	 exhibited	 an	













FRT	 control	 and	C10	KD	 cells	were	 grown	on	 a	 Snapwell	 filter	 and	 transfected	with	plasmids	
encoding	α,	β-HA	and	γ	ENaC	+	control	siRNA	or	αβ-HAγ	ENaC	and	Nedd4-2-specific	siRNA.	A	–	
Representative	 Isc	 profile	 for	 ENaC-expressing	 control	 and	 COMMD10	 KD	 epithelia	 with	 and	
without	 Nedd4-2	 siRNA.	 The	 addition	 of	 amiloride	 (5	 μM)	 is	 indicated	 and	 the	 subsequent	









Mutations	 in	 the	PY	motif	 of	 either	 β	 or	 γ	 ENaC	 subunits	 leads	 to	 an	 accumulation	 of	
ENaC	 at	 the	 cell	 surface	 resulting	 in	 increased	 sodium	 reabsorption	 in	 the	 kidney	
(Snyder	et	al.,	1994;	Hansson	et	al.,	1995;	Ma	et	al.,	2008;	Rotin	&	Staub,	2011).	The	PY	
motif	 directly	 interacts	with	 the	WW	domains	of	 the	Nedd4-2	protein	 resulting	 in	 the	
ubiquitination	 and	 down	 regulation	 of	 ENaC	 activity	 (Staub	 et	 al.,	 1996;	 Goulet	 et	 al.,	
1998;	 Staub	 et	 al.,	 2000;	 Snyder	 et	 al.,	 2001).	 This	 clinical	 manifestation	 is	 termed	




Previous	 work	 has	 highlighted	 that	 mutating	 PY	motifs	 in	 the	 C-terminal	 domains	 of	
ENaC	subunits	 increases	 Isc-Amil	(Snyder	et	al.,	1995).	 It	was	observed	that	a	PY	motif	
mutation	in	either	the	α,	β	or	γ	ENaC	subunit	increased	Isc-Amil	by	about	1.5	times	and	
accumulation	of	mutants	did	not	have	an	additive	effect	on	 Isc-Amil.	For	 this	reason	 in	







control	 and	 C10	 KD	 cells	 were	 transfected	 with	 plasmids	 encoding	 α,	 β-HA	 and	 γ	 or	
αβY620A-HAγ	ENaC,	and	differences	in	Isc-Amil	were	analysed.		
	












the	 transient	 Nedd4-2	 KD	 experiment,	 blocking	 Nedd4-2	 binding	 and	 subsequent	
ubiquitination	with	the	βY620A	mutation	rescued	Isc-Amil	in	C10	KD	cells	(0.49	±	0.03	for	
C10	KD	 epithelia	 vs	 1.29	 ±	 0.05	 for	 C10	KD	 cells	 expressing	with	 βY620A	 ENaC,	 N	 =	 4,	
p<0.001)	(figure	4.14	B	–	C).	However,	as	was	observed	in	siNedd4-2	studies,	Isc-Amil	in	
C10	 KD	 epithelia	was	 not	 rescued	 to	 the	 same	 levels	 as	 control	 epithelia	 (expressing	
βY620A)	 (1.29	±	0.05	 for	C10	KD	epithelia	with	βY620A	vs	1.57	±	0.1	 for	control	epithelia	
with	βY620A,	N	=	4,	p=0.07)	(figure	4.14	B	–	C).	Although	the	difference	 in	 Isc-Amil	seen	
between	 control	 and	 C10	 KD	 epithelia	 transfected	 with	 βY620A	 was	 not	 significantly	
















FRT	 control	 and	C10	KD	 cells	were	 grown	on	 a	 Snapwell	 filter	 and	 transfected	with	plasmids	
encoding	α,β-HA	and	γ	ENaC	or	αβy620A-HAγ	ENaC.	A	–	partial	sequence	of	C-terminal	domain	of	




αβy620A-HAγ	ENaC.	Data	shown	as	mean	±	SD	relative	 to	 Isc-Amil	 in	FRT	control	epithelia.	One-
way	 ANOVA	 with	 multiple	 comparisons	 and	 Tukey’s	 post-hoc	 test.	 **p<0.01,	 ***p<0.001,	









(Li	 et	 al.,	 2015).	 Each	 member	 of	 the	 COMMD	 family,	 including	 COMMD10,	 has	 been	









endocytosis	 and,	 when	 iron	 has	 been	 released	 in	 the	 endosome,	 transferrin	 and	 its	
receptor	are	recycled	back	to	the	plasma	membrane	making	it	a	useful	model	to	study	
endosomal	 trafficking	 and	 recycling.	 Recycling	 times	 of	 the	 transferrin	 receptor	 vary	
greatly	 between	 cell	 lines	 (from	 7.5	 min	 to	 over	 50	 min)	 (Ciechanover	 et	 al.,	 1983;	
Hopkins,	1983;	Sheff	et	al.,	2002;	Zhou	et	al.,	2014).	 In	this	study	FRT	control	and	C10	
KD	 cells	 were	 incubated	 with	 transferrin	 for	 5	 min	 (this	 is	 where	 the	 maximal	
transferrin	uptake	was	observed	in	endocytosis	studies)	and	then	incubated	in	PBS	for	a	
further	15	or	30	min	 to	 allow	cells	 to	 recycle	 transferrin	 (as	described	 in	3.5.4).	 Cells	
were	then	fixed	and	analysed	by	fluorescence	microscopy.	The	scoring	system	designed	
for	U2OS	studies	was	similarly	used	in	this	experiment	(see	figure	3.17	for	examples	of	
each	 scoring	 level).	 Images	were	blindly	 scored	by	a	 lab	member	 to	prevent	bias,	 and	
subsequent	scores	were	analysed.		
	
Cells	 with	 no	 transferrin	 incubation,	 as	 expected,	 showed	 no	 intracellular	 transferrin	
present	 (figure	 4.15	 A).	 After	 5	 min	 incubation,	 however,	 C10	 KD	 cells	 showed	 a	
significantly	reduced	amount	of	cytoplasmic	transferrin	and	an	increase	in	the	amount	
of	 punctate	 transferrin	 staining	 (figure	 4.15	B).	 This	 suggests	 an	 increased	 amount	 of	
transferrin	in	endosomal	structures;	possibly	due	to	the	fact	C10	KD	cells	had	shown	an	
	 144	
increased	 rate	 of	 transferrin	 uptake	 and	 therefore	would	 have	 been	 expected	 to	 have	
begun	trafficking	to	the	endosome	earlier.		
	
Similarly	 to	 experiments	with	 U2OS	 control	 and	 C10	 KD	 cells,	 FRT	 C10	 KD	 cells	 that	
were	“chased”	for	15	min	after	transferrin	incubation	showed	a	significant	reduction	in	
cytoplasmic	transferrin	and	an	increase	in	punctate	transferrin	localisation	(figure	4.15	
C).	As	was	described	earlier,	 it	was	hypothesised	 that	at	 this	 timepoint	 the	 transferrin	
receptor	would	have	begun	recycling	back	to	the	plasma	membrane	and	both	cell	lines	
would	show	mainly	cytoplasmic	transferrin.	This	increase	in	punctate	transferrin	in	C10	
KD	 cells	 suggests	 that	 a	 COMMD10	 KD	 knockdown	 delays	 the	 trafficking	 of	 the	
transferrin	receptor	from	the	endosome	to	the	plasma	membrane.	 In	addition,	C10	KD	
cells	 “chased”	 for	30	min	after	 transferrin	 incubation	showed	a	significant	decrease	 in	
the	 number	 of	 cells	 showing	 no	 transferrin	 compared	 to	 control	 KD	 cells	 (i.e.	 less	
recycling	of	the	transferrin	receptor	back	to	the	plasma	membrane)	(figure	4.15	D).	 In	
support	 of	 this	 there	 was	 also	 a	 significant	 increase	 in	 the	 amount	 of	 punctate	
transferrin	in	C10	KD	cells	compared	to	control	KD	cells.	This	adds	further	evidence	to	
the	theory	that	a	COMMD10	KD	delays	the	recycling	of	the	transferrin	receptor.	Further	
analysis	 of	 the	 time	 taken	 for	 50%	 of	 FRT	 control	 and	 C10	 KD	 cells	 to	 show	 no	





This	delay	 in	transferrin	recycling	suggests	 that	ENaC	recycling	 in	FRT	C10	KD	cells	 is	
also	impaired	and	slower	than	in	control	KD	cells	and	could,	therefore,	contribute	to	the	
reduction	 in	 Isc-Amil	 observed	 in	 C10	 KD	 epithelia.	 These	 results	 are	 consistent	 with	
those	observed	in	U2OS	C10	KD	cells,	suggesting	that	COMMD10	has	a	core	function	in	
protein	 trafficking	 in	all	 cell	 types.	Unpublished	data	 (Burstein,	unpublished	data)	has	






FRT	control	and	C10	KD	cells	were	 incubated	with	 transferrin	 for	0	min	(A),	5	min	(B)	or	5	









































2010;	Chang	et	al.,	 2011;	 Liu	et	al.,	 2013),	 but	 very	 little	 is	 known	about	COMMD10	
and	whether	 it	 too	plays	a	role	 in	regulating	ENaC.	 It	was	observed	that	there	was	a	













Stable	COMMD10	knockdown	significantly	 increased	Nedd4-2	protein	 levels	and	 the	
ubiquitination	of	ENaC	suggesting	an	increase	of	endocytosis	of	ENaC	from	the	plasma	
membrane	to	the	endosome	(see	4.3.1).	Studies	with	the	transferrin	receptor	showed	
that	 there	 is	an	 increased	 rate	of	 transferrin	uptake,	 thus	endocytosis,	 in	both	U2OS	
C10	 KD	 (see	 3.5.3)	 and	 FRT	 C10	 KD	 cells	 (see	 4.3.4),	 which	 then	 leads	 to	 the	
hypothesis	 that	 COMMD10	 regulates	 ENaC	 endocytosis.	 Preventing	 ENaC	
ubiquitination	 (and	 thus	 endocytosis)	 through	 Nedd4-2	 siRNA	 (see	 4.4.1)	 or	 the	
Liddle’s	mutant,	 βY620A,	 (see	 4.4.2)	 in	Ussing	 chamber	 recordings	 shows	 that	 the	 Isc-
Amil	 is	 only	 partially	 rescued	 in	 C10	 KD	 epithelia.	 This	 suggests	 that	 COMMD10	
regulates	 ENaC	 endocytosis	 but	 may	 also	 have	 another	 role	 in	 maintaining	 ENaC	
numbers	at	the	plasma	membrane.	Analysis	of	the	recycling	of	the	transferrin	receptor	
in	U2OS	C10	KD	 (see	 3.5.4)	 and	 FRT	C10	KD	 (see	 4.4.3)	 cells	 suggests	 that	 there	 is	
delayed	 recycling	 of	 the	 transferrin	 receptor	 which	 together	 with	 the	 increased	






The	main	hormone	 that	 controls	ENaC	activity	 is	 the	mineralocorticoid	 aldosterone,	
although	the	effects	of	aldosterone	vary	and	appear	to	be	tissue-specific	(Escoubet	et	
al.,	 1997;	Hager	 et	al.,	 2001;	 Loffing	 et	al.,	 2001b;	 Greig	 et	al.,	 2002).	 Aldosterone	 is	
secreted	 in	 low-sodium	 and	 low	 blood	 pressure	 conditions	 to	 promote	 sodium	
reabsorption,	most	prominently	in	the	distal	tubule	of	the	kidney.	The	distal	tubule	is	
crucial	for	the	fine-tuning	of	solute	reabsorption,	including	sodium,	in	the	kidney	and	
aldosterone	 drives	 this	 sodium	 reabsorption	 through	 its	 up-regulation	 of	 ENaC.	
Aldosterone	 has	 both	 short	 and	 long-term	 effects	 on	 ENaC	 regulation	 including	
increasing	transcription	of	SGK1	(to	down-regulate	the	activity	of	the	ubiquitin	ligase	





(GR/MR)	 located	 in	 the	 cytoplasm.	 Once	 ligand-bound,	 the	 receptor-aldosterone	
complex	enters	the	nucleus	through	a	nuclear	pore	and	binds	to	a	hormone	response	
element	(HRE)	(also	called	steroid	response	element	(SRE))	in	the	promoter	region	of	











–	 location	 NC_000005.10),	 which	 has	 not	 been	 previously	 reported,	 highlighted	 a	
possible	 TATA	 box	 promoter	 region	 located	 approximately	 250	 bp	 upstream	 of	 the	
translation	start	site	(TSS)	(figure	4.17	A).	 	The	TATA	box	is	a	cis-regulatory	element	
found	in	approximately	25%	of	human	gene	promoter	regions	and	is	the	binding	site	
for	 transcription	 factors	 or	 histones	 and	 has	 the	 core	 DNA	 sequence	 5’	 TATAAA	 3’	
(Lifton	et	al.,	1978;	Smale	&	Kadonaga,	2003;	Yang	et	al.,	2007).	The	TATA	box	binding	






the	 COMMD10	 TSS,	 is	 an	 imperfect	 HRE,	 typically	 termed	 a	 half-site	 (whereby	 only	
half	 of	 the	 general	 consensus	 sequence	 is	 found),	 with	 the	 sequence	 5’	
CTAAATTCCTGTTCT	3’.	The	 location	and	sequence	of	 this	HRE	 is	very	similar	 to	 the	
HRE	described	 in	 the	promoter	region	of	 the	human	SGK1	gene	(Itani	et	al.,	2002b).	
Another	 imperfect	 HRE	 sequence	 is	 located	 approximately	 750	 bp	 upstream	 of	 the	






by	 Zilliacus	 et	 al.	 (Zilliacus	 et	 al.,	 1995).	 Presence	 of	 HRE	 sequences	 suggest	 that	
COMMD10	may	 be	 able	 to	 be	 regulated	 by	 aldosterone	 and	 	 which	 could	 therefore	
provide	further	evidence	that	COMMD10	may	be	a	regulator	of	ENaC	activity.	Analysis	
of	the	5’	flanking	region	of	the	COMMD10	gene	from	various	other	species	highlighted	
that	 these	 half-site	 HRE	 sequences	 are	 similarly	 found	 in	 mouse,	 rat,	 chicken,	 bat,	
chimpanzee	 and	 zebrafish	 (see	 appendix	 II),	 although	 these	 sequences	 too	 are	
imperfect	 HRE	 sequences.	 This	 suggests	 an	 evolutionarily	 conserved	 role	 for	 these	
HREs	in	COMMD10	function.		
	
Due	 to	 the	 identification	of	potential	HRE	 sequences	 in	 the	5’	 flanking	 region	of	 the	
COMMD10	gene	 the	effect	of	 aldosterone	 treatment	on	COMMD10	protein	 level	was	
analysed	 in	 the	mouse	 cortical	 collecting	duct	 cell	 line	 (M1CCD).	 In	brief,	 cells	were	
incubated	 with	 aldosterone	 for	 0,	 0.5,	 1,	 3,	 6	 or	 24	 hr	 before	 being	 lysed	 and	
COMMD10	protein	 levels	were	 subsequently	 analysed	by	 immunoblotting.	 Based	 on	
electrophysiology	 results,	 suggesting	 when	 COMMD10	 is	 stably	 knocked	 down	 that	
ENaC	levels	reduce,	it	was	hypothesised	that	COMMD10	protein	levels	would	increase,	
due	to	 the	 increase	 in	ENaC	activity,	under	aldosterone	stimulation.	However,	 it	was	






aldosterone	 stimulation	 COMMD10	 synthesis	 ceases	 or	 its	 degradation	 is	 promoted	
but	 that	 this	 effect	 stops	 at	 some	 point	 between	 6	 and	 24-hr	 post-aldosterone	





As	 it	 has	 been	 shown	 that	 as	 COMMD10	 is	 knocked	 down	 ENaC	 activity	 reduces,	
through	 increased	 ENaC	 ubiquitination,	 it	 was	 hypothesised	 that	 an	 increase	 in	
COMMD10	levels	would	increase	ENaC	activity.	Therefore,	since	aldosterone	increases	
ENaC	 activity	 it	 was	 hypothesised	 that	 aldosterone	 would	 similarly	 increase	
COMMD10	 levels.	 However,	 this	 did	 not	 occur	 (figure	 4.17	 B-C),	 which	 raises	 the	
question	 as	 to	 why	 electrophysiology	 data	 suggests	 that	 COMMD10	 is	 required	 for	











and	 blue	 highlights	 a	 TATA	 promoter	 box.	 Translation	 start	 site	 is	 indicated	 in	 bold.	 SRE	 =	
Steroid	response	element.	B	–	M1CCD	cells	were	incubated	with	aldosterone	for	0,	0.5,	1,	3,	6	
or	 24	 hr	 and	 subsequently	 lysed.	 COMMD10	 protein	 levels	 were	 then	 determined	 by	









After	 identifying	 that	 COMMD10	 is	 regulated	 by	 aldosterone	 it	 was	 important	 to	
identify	 whether	 other	 COMMD	 family	 members	 are	 similarly	 regulated	 by	
aldosterone.	 Analysis	 of	 the	 5’	 flanking	 regions	 of	 the	 COMMD1	 human	 and	mouse	
gene	suggested	the	absence	of	HREs	in	either	human	or	mouse	sequence	(up	to	2000	
bp	upstream	of	 the	TSS)	 (see	 appendix	 III)	 suggesting	COMMD1	 is	 not	 regulated	by	
aldosterone,	 and	 also	 that	 different	 COMMD	 family	 members	 may	 be	 uniquely	
regulated	at	the	transcriptional	level.	Analysis	of	the	5’	flanking	regions	of	the	human	
and	mouse	COMMD4/5	and	6	genes	highlight	they	too	have	an	absence	of	HRE	sites.	5’	
flanking	 regions	 of	 the	 human	 and	 mouse	 COMMD3	 gene	 show	 HREs	 located	
approximately	1200	and	1500	bp	upstream	of	the	transcription	start	site	respectively.	
The	human	and	mouse	5’	flanking	regions	of	the	COMMD9	gene	similarly	contain	HREs	
located	 approximately	 350	 and	 1700	 bp	 upstream	 of	 the	 transcription	 start	 site	
respectively.	 Analysis	 of	 the	 5’	 flanking	 regions	 of	 the	 human	 and	mouse	 genes	 for	
COMMD2/7	and	8	highlight	possibly	HRE	sites	 located	up	 to	~2000	bp	upstream	of	
the	transcription	start	site,	however	due	to	antibody	availability	only	COMMD1,	3	and	
9	 protein	 levels,	 after	 aldosterone	 treatment,	were	 analysed.	 To	 determine	whether	
aldosterone	 is	 able	 to	 regulate	 COMMD1/3	 or	 9	 M1CCD	 cells	 were	 incubated	 with	
aldosterone	 for	 0,	 0.5,	 1,	 3,	 6	 or	 24	 hr	 before	 being	 lysed	 and	 protein	 levels	
subsequently	 analysed	by	 immunoblotting.	Unfortunately	 endogenous	COMMD3	and	
COMMD9	were	unable	 to	be	detected	 in	M1CCD	cells	 so	 the	effect	of	aldosterone	on	
COMMD3	and	COMMD9	protein	levels	remains	unknown.	However,	COMMD1	protein	
levels	 were	 determined	 and	 interestingly	 they	 remain	 unchanged	 throughout	 the	
aldosterone	 timecourse	 (figure	 4.18	 A	 –	 B).	 This	 suggests	 that	 COMMD1	 is	 not	
regulated	 by	 aldosterone,	 and	 also	 provides	 further	 evidence	 that	 COMMD	 family	
members	 are	 differently	 regulated.	 It	 is	 interesting	 to	 note	 that	 COMMD1	 has	 been	
shown	to	down-regulate	ENaC	through	Nedd4-2	(Ke	et	al.,	2010)	so	perhaps	it	would	
have	been	expected	that	COMMD1	levels	might	diminish	under	aldosterone	treatment,	







lysed.	 COMMD1	 protein	 levels	 were	 then	 determined	 by	 immunoblot	 and	 anti-COMMD1	
antibody.	 N=2.	 B	 -	 COMMD1	 protein	 levels	 relative	 to	 β-actin	 loading	 control	 and	 0	 min	







levels	 although	 it	 is	 unknown	 whether	 this	 is	 because	 there	 is	 an	 increase	 in	
COMMD10	 degradation,	 or	 because	 aldosterone	 prevents	 further	 COMMD10	
transcription.	To	answer	this	question,	the	endogenous	rate	of	COMMD10	degradation	
was	 determined.	 Cycloheximide	 is	 a	 glutarimide	 antibiotic	 commonly	 used	 in	
experiments	 to	 determine	 the	 half-life	 of	 proteins.	 Cycloheximide	 specifically	 blocks	
translation	 of	 mRNA	 thereby	 inhibiting	 eukaryotic	 protein	 synthesis	 although	 the	
exact	 inhibition	mechanism	 is	 not	 completely	 understood	 (Schneider-Poetsch	 et	 al.,	








To	 determine	 the	 half-life	 (t1/2)	 of	 COMMD10	 in	 the	 M1CCD	 cell	 line,	 cells	 were	
incubated	with	cycloheximide	(cyclo)	(150μg/mL	(as	previously	used	in-house))	for	0,	
15,	 30,	 45,	 60	 or	 75	 min	 and	 subsequently	 lysed	 before	 levels	 of	 COMMD10	 were	
analysed	by	immunoblotting	(figure	4.19	A	–	B).	COMMD10	protein	levels	(relative	to	




al.,	 2003;	 Zhou	 &	 Snyder,	 2005;	 Bogusz	 et	 al.,	 2006;	 Liu	 &	 McDonald,	 unpublished	









being	 lysed.	 COMMD10	protein	 levels	were	 then	 determined	 by	 immunoblotting	 using	 anti-
COMMD10	antibody.	N	=	4.	 	B	–	COMMD10	protein	 levels	 relative	 to	β-actin	 loading	control	
and	0	min	timepoint	were	determined.	One	outlier	 from	the	15	min	timepoint	was	removed	
using	Grubbs	test	(p<0.05).	Data	shown	as	mean	±	SD.	N	=	3-4.	C	-	COMMD10	decay	(%	of	zero	
timepoint)	 was	 plotted	 and	 COMMD10	 half-life	 was	 determined	 using	 the	 exponential	 one-











treatment	of	M1CCD	cells	 (see	4.17	A	and	4.19	A	respectively)	shows	that	 the	 initial	
decrease	in	COMMD10	protein	level	under	aldosterone	treatment	is	very	similar	to	the	
decrease	 seen	when	 cells	were	 treated	with	 cycloheximide.	 Therefore	 the	 half-lives	
were	 calculated	 for	 both	 cycloheximide-treated	 and	 aldosterone-treated	 cells	 (as	
described	in	4.5.2.1).	It	was	hypothesised	that	if	COMMD10	half-lives	were	similar	in	




aldosterone	 treatment	 and	 with	 cycloheximide	 treatment	 (18.4	 mins	 ±	 7.4	 for	























Ubiquitinated	proteins	 are	 targeted	 for	 degradation	by	 the	proteasome	or	 lysosome	
(Kisselev	 et	 al.,	 1999;	 Arancibia-Carcamo	 et	 al.,	 2009).	 It	 is	 highly	 likely	 though,	 as	
COMMD10	 is	 found	 intracellularly,	 that,	 if	COMMD10	 is	ubiquitinated,	 that	 it	will	be	
degraded	in	the	proteasome.	As	of	yet,	however,	it	has	not	been	determined	whether	
COMMD	 proteins	 are	 ubiquitinated	 and	 degraded	 in	 the	 proteasome,	 apart	 from	
COMMD1,	which	has	been	 shown	 to	be	ubiquitinated	and	 subsequently	degraded	 in	
the	 proteasome	 through	 the	 ubiquitin	 ligase	 XIAP	 (X-linked	 inhibitor	 of	 apoptosis	




μM)	 or	 the	 addition	 of	 the	 lysosome	 inhibitor	 chloroquine	 (20	 μg/mL)	 to	 prevent	
degradation	 of	 ubiquitinated	 proteins	 by	 the	 proteasome.	 It	 was	 therefore	
hypothesised	 that	 if	 COMMD10	 is	 ubiquitinated,	 and	 subsequently	 degraded	 in	 the	
proteasome,	 then	 protein	 levels	 would	 not	 change	 upon	 cycloheximide	 +	 MG132	
treatment	 but	 would	 decrease,	 as	 observed	 with	 cycloheximide	 treatment,	 with	
cycloheximide	+	chloroquine	treatment.	It	was	observed	that	COMMD10	protein	levels	
remained	 unchanged	 upon	 treatment	 of	 cells	 with	 cycloheximide	 +	 MG132	 (t1/2	 =	
275000	 mins	 ±	 150000	 for	 cycloheximide	 +	 MG132	 vs	 23.5	 mins	 ±	 5.8	 for	
cycloheximide-treated,	N	=	3-4,	<0	p.0001)	(figure	4.21	A	and	C)	suggesting	COMMD10	
is	ubiquitinated	and	subsequently	degraded	in	the	proteasome,	but	an	ubiquitin	assay	
would	 need	 to	 be	 performed	 to	 confirm	 this	 (see	 discussion).	 In	 support	 of	 this,	
COMMD10	 protein	 levels	 reduced	 at	 the	 same	 rate	 in	 cycloheximide	 and	
cycloheximide	+	 chloroquine	 treated	 cells	 (t1/2	 =	23.5	mins	±	5.8	 for	 cycloheximide-
treated	vs	28.8	mins	±	8.8	for	cycloheximide	+	chloroquine,	N	=	3,	p=0.44)	(t1/2	=	28.8	





observed.	 However,	 these	 results	 still	 suggest	 that	 COMMD10	 is	 degraded	 in	 the	
proteasome.		
	
These	 results	 suggest	 that	 COMMD10	 is	 regulated	 by	 aldosterone,	 which	 prevents	
COMMD10	 transcription,	 but	 does	 not	 appear	 to	 increase	 COMMD10	 degradation,	
















decay	 equation	 on	GraphPad	Prism	 (cycloheximide	 data	 taken	 from	 figure	 4.18).	Half-life	 is	
defined	as	the	time	when	COMMD10	protein	levels	have	reduced	by	50%	(indicated	by	dotted	
line).	 Two-way	 ANOVA	 with	 Sidak’s	 multiple	 comparisons	 test.	 #	 =	 significance	 between	









plays	 a	 role	 in	 regulating	 ENaC.	 Results	 from	 chapter	 3	 suggested	 that	 COMMD10	
localises	 to	 the	endosome	(figure	3.11),	 affects	protein	 levels	of	 recycling	associated	
proteins	 (including	 COMMD1)	 (figures	 3.12-3.13),	 and	 increases	 endocytosis	 and	




It	 was	 observed	 that	 there	 was	 a	 significant	 reduction	 in	 Isc-Amil	 in	 stable	 C10	 KD	
epithelia	 (figure	 4.1)	 suggesting	 that	 a	 COMMD10	 KD	 reduces	 the	 amount	 of	 ENaC	
channels	 present	 at	 the	 plasma	 membrane.	 This	 effect	 can	 be	 rescued	 by	 adding	
COMMD10	 (figure	 4.2),	 but	 not	 COMMD1	 (figure	 4.3),	 back	 into	 the	 C10	 KD	 cells	
suggesting	that	different	COMMD	family	members	could	be	regulated	differently	and	
have	unique	 functions.	To	analyse	whether	 the	 reduction	 in	 Isc-Amil	 seen	 in	C10	KD	
epithelia	was	due	to	a	disruption	to	the	anterograde	trafficking	(ER	to	Golgi	to	plasma	
membrane)	 of	 ENaC,	 cells	 were	 incubated	with	 the	 anterograde	 trafficking	 blocker,	
BFA,	and	the	effect	was	analysed.	It	was	observed	that	there	was	a	cumulative	effect	of	
the	 BFA	 and	 the	 COMMD10	 KD	 (figure	 4.4)	 suggesting	 that	 the	 knockdown	 of	
COMMD10	does	not	interfere	with	the	anterograde	trafficking	of	ENaC.	
	
It	 was	 observed	 that	 there	was	 an	 increase	 in	 ENaC	 ubiquitination	 in	 C10	 KD	 cells	
suggesting	an	 increase	 in	ENaC	endocytosis	 (figure	4.7).	Results	with	 the	 transferrin	
receptor	has	shown	that	there	is	an	increased	rate	of	endocytosis	in	both	U2OS	C10	KD	
(figures	3.15-3.16)	and	FRT	C10	KD	cells	(figures	4.10-4.11),	which	then	leads	to	the	
hypothesis	 that	 COMMD10	 regulates	 ENaC	 endocytosis.	 Inhibition	 of	 ENaC	
ubiquitination	 (and	 thus	 endocytosis)	 through	 Nedd4-2	 siRNA	 (figure	 4.13)	 or	 the	





ENaC	numbers	at	 the	plasma	membrane.	Analysis	of	 the	 recycling	of	 the	 transferrin	
receptor	in	U2OS	C10	KD	(figures	3.18-3.19)	and	FRT	C10	KD	(figures	4.15-4.16)	cells	
suggests	that	there	is	delayed	recycling	of	the	transferrin	receptor	which	could	help	to	
explain	 why	 there	 is	 a	 reduction	 in	 Isc-Amil	 in	 C10	 KD	 epithelia.	 Taking	 this	 data	
together	 it	 is	 suggested	 that	COMMD10	 regulates	 two	points	of	 the	ENaC	 trafficking	






Numerous	 regulators	 of	 ENaC	 are	 themselves	 regulated	 by	 aldosterone.	 The	 novel	
identification	of	HRE/SRE	sequences	 in	 the	5’	 flanking	region	of	 the	COMMD10	gene	
(in	various	species)	suggested	too	that	COMMD10	could	be	regulated	by	aldosterone	
(figure	4.17).	Treatment	of	M1CCD	cells	with	aldosterone	highlighted	this.	COMMD10	
protein	 levels	drastically	 reduced	upon	aldosterone	stimulation	but	 levels	 recovered	
after	 approximately	 24	 hr.	 Interestingly	 there	 was	 no	 effect	 of	 aldosterone	 on	
COMMD1	(figure	4.18)	providing	 further	evidence	 that	COMMD	 family	members	are	
differently	regulated.		
	
Treatment	 of	 M1CCD	 cells	 with	 cycloheximide	 (or	 cycloheximide	 +	 MG132)	
highlighted	 that	 COMMD10	 has	 a	 relatively	 short	 t1/2	 and	 is	 degraded	 in	 the	





















































function.	 Unpublished	 work	 has	 identified	 that	 a	 COMMD10	 knockout,	 in	 mice,	 is	
embryonically	lethal	and	COMMD10	is	widely	expressed,	in	human	and	mouse	tissues,	
suggesting	 it	 plays	 a	 crucial	 cellular	 role	 but	 no	 study	 has	 yet	 been	 conducted	 to	
investigate	 this.	Preliminary	data	suggested	 that	COMMD10	and	Arf1	co-localise	and	
that	COMMD10	interacts	with	a	number	of	ER/Golgi	associated	proteins,	such	as	Arf1,	
4	 and	 5	 (Burstein	&	 Starokadomskyy,	 unpublished	work)	 supporting	 a	 role	 in	 COPI	
vesicle	formation	and	anterograde	protein	trafficking.	Recent	evidence	has	implicated	
the	COMMD	family	as	part	of	the	large	recycling-associated	complex,	Retromer	(Li	et	
al.,	 2015),	 and	 COMMD10	 is	 recruited	 into	 this	 complex	 in	 a	 COMMD9-dependant	
manner	 (Starokadomskyy	 et	al.,	 2013;	 Li	 et	al.,	 2015;	 Phillips-Krawczak	 et	al.,	 2015;	
Bartuzi	 et	 al.,	 2016).	 	 Retromer	 facilitates	 the	 recycling	 of	 a	 number	 of	 membrane	


















Preliminary	 data	 (from	 the	 laboratory	 of	 our	 collaborator	 Professor	 Ezra	 Burstein)	
suggested	 that	 COMMD10	 interacts	with	 COPI-vesicle	 associated	 proteins	 at	 the	 cis-
Golgi,	thus	mediating	protein	trafficking	between	the	cis-Golgi	and	the	ER.	COMMD10	
was	found	to	be	co-localised	with	Arf1	and	a	proteomic	screen	identified	interaction	of	
COMMD10	with	a	number	of	other	COPI-associated	proteins	 (see	 figure	1.8),	 but	no	
further	 studies	 had	 been	 undertaken	 to	 discover	 a	 cellular	 role	 for	 COMMD10.	 To	
determine	whether	COMMD10	localises	to	the	cis-Golgi,	and	to	develop	the	findings	of	




It	 was	 observed	 that	 COMMD10	 co-localised	 with	 Arf1,	 in	 particular	 with	 the	
constitutively	active	Arf1-Q71I	mutant.	When	Arf1	 is	 activated,	by	binding	GTP,	 it	 is	
recruited	to	the	cis-Golgi	membrane	(Teal	et	al.,	1994),	therefore	it	was	hypothesised	
that	COMMD10	 localises	 to	 the	cis-Golgi.	The	 fact	 that	COMMD10	did	not	 co-localise	
with	 the	 constitutively	 inactive	 Arf1	 mutant	 (T31N)	 added	 further	 support	 to	 this	
hypothesis,	 as	 it	 has	 been	 well	 described	 that	 inactive	 Arf1	 is	 localised	 to	 the	
cytoplasm	(Vasudevan	et	al.,	1998).	Arf1	localises,	at	the	ER/cis-Golgi,	with	Arf4	(Chun	
et	al.,	 2008;	Ben-Tekaya	et	al.,	 2010),	Arf5	 (Donaldson	&	 Jackson,	 2011)	 and	COPB1	
(Honda	et	al.,	2005)	 (as	well	as	other	cis-Golgi	associated	proteins	 (Szul	et	al.,	2005;	
Krauss	 et	 al.,	 2008),	 three	 COPI-associated-proteins	 that	 were	 all	 identified	 in	 a	
COMMD10	TAP	screen	(Burstein	&	Starokadomskyy,	unpublished	work).	Therefore,	to	
provide	 further	evidence	 that	COMMD10	 localises	 to	 the	cis-Golgi/ER	co-localisation	
studies	were	 performed	 between	 COMMD10	 and	Arf4,	 Arf5,	 COPB1	 and	Rab1a	 (see	
section	3.3,	figures	3.7,	3.8	and	3.9).	It	was	observed	that	COMMD10	did	not	co-localise	
with	Arf4,	Arf5,	COPB1	or	Rab1a	 therefore	 suggesting,	 contradictory	 to	Arf1	 results,	




It	 is	 important,	 however,	 to	 acknowledge	 that	 co-localisation	 studies	 were	 not	
conducted	with	the	active	forms	of	Rab1a,	Arf4	or	Arf5,	and	as	it	was	noted	earlier	the	








To	 provide	 further	 evidence	 of	 an	 interaction	 between	 COMMD10	 and	 Arf1	 the	




of	 Arf1-Q71I	 in	 C10	 KD	 cells.	 Instead	 of	 a	 tight,	 perinuclear	 localisation	 that	 was	









proteins.	Unfortunately	our	 laboratory	does	not	possess	either	 the	active	or	 inactive	
mutants	 of	 Arf4,	 Arf5	 or	Rab1a,	 all	 of	which	when	 active	 are	 present	 at	 the	 ER/cis-
Golgi	(Allan	et	al.,	2000;	Chun	et	al.,	2008;	Popoff	et	al.,	2011),	so	the	effect	on	a	C10	
KD	on	these	is	unknown	and	therefore	it	cannot	be	concluded	that	COMMD10	does	not	
play	 a	 role	 with	 these	 proteins.	 However,	 since	 the	 localisation	 of	 COPB1	 did	 not	
change	this	would	suggest	that	a	C10	KD	does	not	cause	a	change	in	localisation	of	all	
cis-Golgi	associated	proteins.	It	has	previously	been	described	that	knockdown	of	Arf1	
caused	 no	 significant	 change	 in	 the	 localisation	 of	 the	 whole	 Golgi	 body,	 so	 it	 is	
	 167	
possible	 that	 if	 a	 C10	 KD	 does	 disrupt	 Arf1	 that	 this	 would	 not	 cause	 a	 change	 in	
localisation	of	the	cis-Golgi	(Nakai	et	al.,	2013).		
		
Although	 the	 C10	 KD	 causes	 an	 increase	 in	 area	 of	 Arf1-Q71I	 localisation	 it	 is	 still	
unknown	 whether	 the	 C10	 KD	 changes	 Arf1-Q71I’s	 localisation	 from	 one	 cellular	
compartment	 to	 another.	 Therefore,	 co-localisation	 studies	 between	 Arf1-Q71I	 and	
cis-Golgi	markers,	such	as	GM130	(Mazzulli	et	al.,	2016;	Raza	et	al.,	2016),	as	well	as	
















at	 the	 cis-Golgi,	 recent	 studies	 suggest	 roles	 for	 Arf1	 at	 the	 TGN	 and	 in	 endosomal	
compartments	 (Kumari	&	Mayor,	2008;	Bhagatji	et	al.,	 2009b;	Robinson	et	al.,	 2011;	
Kondo	et	al.,	2012;	Nakai	et	al.,	2013).	Therefore	if	COMMD10	does	interact	with	Arf1	
this	may	not	occur	at	the	cis-Golgi	and	could	explain	why	no	co-localisation	was	seen	
between	COMMD10	 and	 other	 cis-Golgi	 localised	 proteins.	 COMMD10	 interacts	with	
protein	recycling,	and	thus	endosomal,	associated	proteins;	such	as	ccdc22	and	ccdc93	
(Starokadomskyy	 et	 al.,	 2013;	 Wan	 et	 al.,	 2015;	 Burstein	 &	 Starokadomskyy,	
unpublished	work)	providing	further	support	 for	the	hypothesis	that	COMMD10	and	
Arf1	could	be	interacting	in	endosomal	compartments	rather	than	the	cis-Golgi.	Recent	
studies	 have	 identified	 COMMD10’s	 family	 members,	 COMMD1	 and	 COMMD9,	 as	





To	 determine	 whether	 COMMD10	 localises	 to	 endosomal	 compartments	 co-
localisation	 studies	were	performed	between	COMMD10	and	 the	 endosomal	marker	
transferrin-546	 (Tf-546).	 As	 has	 been	 described	 earlier,	 transferrin	 is	 a	 plasma	
glycoprotein	 that	 is	 commonly	 used	 as	 a	 marker	 of	 the	 endocytosis	 and	 recycling	
pathways	 (Ponka	&	 Lok,	 1999).	 Co-localisation	 between	 Tf-546	 and	 COMMD10	was	
observed	intracellularly	but	was	not	seen	when	Tf-546	was	at	the	plasma	membrane	
(see	 section	 3.5.1,	 figure	 3.11	 suggesting	 that	 COMMD10	 is	 localised	 to	 endosomal	
compartments	 but	 is	 not	 found	 at	 the	 plasma	 membrane.	 It	 has	 previously	 been	
described	 that	 COMMD1	 co-localises	 with	 Tf-546	 (Chang	 et	 al.,	 2011)	 and	 recent	
studies	 have	 provided	 more	 evidence	 that	 COMMD1	 localises	 to	 endosomal	
compartments	(Phillips-Krawczak	et	al.,	2015;	Bartuzi	et	al.,	2016).	However,	whether	




To	 study	 further	 whether	 COMMD10	 localises	 to	 endosomal	 compartments,	 co-
localisation	 studies	 of	 COMMD10	 with	 Rab5a,	 Rab7	 and	 Rab11a	 were	 planned,	 as	
Rab5a/7/11a	have	all	been	shown	to	localise	to	various	endosomal	compartments	(Li	
&	 Stahl,	 1993;	 Press	 et	 al.,	 1998;	 Ren	 et	 al.,	 1998).	 Unfortunately	 co-localisation	
experiments	 were	 unsuccessful,	 however	 previous	 preliminary	 data	 suggests	 that	








(Biasio	et	al.,	 2004);	 in	particular	COMMD1	appears	 to	down	regulate	ENaC	 through	
increased	endocytosis	 (Ke	et	al.,	2010;	Chang	et	al.,	2011).	Further	studies	 identified	






numbers	 at	 the	 plasma	 membrane	 and	 secondly,	 COMMD10	 is	 also	 able	 to	 down	
regulate	 ENaC.	 Surprisingly	 the	 opposite	 effect	 was	 observed	 in	 stable	 C10	 KD	
epithelia.	 C10	 KD	 epithelia	 exhibited	 a	 significantly	 reduced	 Isc-amil	 compared	 to	
control	 KD	 epithelia	 (see	 section	 4.1.1,	 figure	 4.1)	 suggesting	 either	 a	 reduction	 in	
ENaC	numbers	at	 the	apical	plasma	membrane	or	 a	 reduction	 in	 the	Po	of	 the	ENaC	




A	 biotinylation	 assay	 suggested	 that	 there	 was	 a	 reduction	 in	 ENaC	 at	 the	 plasma	
membrane	 in	 C10	 KD	 cells,	 possibly	 explaining	 the	 reduction	 in	 Isc-amil,	 suggesting	
that	the	COMMD10	KD	either	decreases	forward	trafficking	of	ENaC	through	the	Golgi	
or	 increases	 ENaC	 endocytosis	 from	 the	 plasma	membrane.	 This	 could	 also	 suggest	
that	the	reduction	in	Isc-amil	is	not	due	to	a	change	in	the	Po			Unfortunately,	possibly	
due	to	low	ENaC	levels	at	the	plasma	membrane,	this	experiment	was	only	completed	
once	 and	 therefore	 further	 experiments	 are	 needed	 for	 any	 solid	 conclusion	 to	 be	
made.	One	possible	reason	for	low	ENaC	levels	at	the	plasma	membrane	could	be	due	
to	 the	high	passage	number	of	cells	used	 in	 this	study.	 It	has	been	described	 that	as	
passage	number	of	cells	increases	the	transfection	efficiency	decreases	(Madeira	et	al.,	
2010;	 Aydin	 et	 al.,	 2012;	 de	 Los	Milagros	 Bassani	Molinas	 et	 al.,	 2014).	 In	 terms	 of	
ENaC	it	has	previously	been	described	that	as	the	passage	number	of	 the	epithelium	
increases	 the	 Isc-amil	 reduces	 (Widdicombe	 et	 al.,	 2005)	 suggesting	 a	 reduction	 in	
ENaC	 numbers	 in	 the	 plasma	 membrane	 (although	Widdicombe	 et	 al.	 used	 human	
tracheal	epithelium),	but	in-house	studies	have	seen	a	similar	reduction	in	Isc-amil,	as	
passage	 number	 increase,	 and	 thus	 a	 reduction	 in	 ENaC	 numbers	 at	 the	 plasma	






disruption	 in	 the	 trafficking	 of	 ENaC	 through	 the	 Golgi	 to	 the	 plasma	membrane	 or	
because	 of	 an	 effect	 on	 the	 endocytosis/recycling	 of	 ENaC.	 Based	 on	
immunocytochemistry	results	suggesting	that	COMMD10	does	not	 localise	to	the	cis-
Golgi	 it	was	hypothesised	 that	COMMD10	does	not	 affect	ENaC’s	 trafficking	 through	
the	 Golgi	 (although	 further	 work	 needs	 to	 be	 done	 to	 confirm	 this,	 as	 described	
earlier).	 However,	 in-house	 studies	 have	 shown	 that	 COMMD10	 binds	 strongly	 to	









To	 investigate	 this	 further,	 protein	 trafficking	 through	 the	 Golgi	 was	 shutdown	 in	
Ussing	 chamber	 experiments	 using	 BFA	 (see	 section	 4.2.1,	 figure	 4.4).	 Any	 Isc-amil	
after	 BFA	 treatment	 would	 result	 from	 ENaC	 channels	 already	 present	 in	 the	
membrane	 and	 those	 able	 to	 recycle	 from	 endosomal	 compartments	 back	 to	 the	
membrane.	It	was	hypothesised	that	if	there	was	a	cumulative	effect	of	the	C10	KD	and	
the	BFA	treatment	then	the	knockdown	wasn’t	disrupting	ENaC’s	trafficking	through	
the	Golgi	whereas	 if	BFA	 treatment	did	not	have	an	additive	effect	on	 the	 Isc-amil	 in	
C10	KD	epithelia	then	the	knockdown	may	be	affecting	ENaC’s	trafficking	through	the	
Golgi.	 It	was	observed	 that	 in	C10	KD	epithelia	with	BFA	 treatment	 that	 the	 Isc-amil	
was	 almost	 abolished	 highlighting	 a	 cumulative	 effect	 of	 the	 C10	 KD	 and	 the	 BFA	












traffic	 directly	 from	 the	 ER	 to	 the	membrane	 (Hughey	 et	al.,	 2004b;	 Yu	 et	al.,	 2008;	
Frindt	et	al.,	2016a).	Hughey	et	al.	(2004)	identified	that	processing	of	ENaC	is	an	“all	
or	nothing	event”	 and	ENaC	can	be	present	 at	 the	 cell	 surface	as	mature	 (i.e.,	Golgi-
processed)	 or	 immature	 channels	 (which	 require	 processing	 in	 post-Golgi	
compartments)	(Hughey	et	al.,	2004b).	Yu	et	al.	(2008)	found	that	even	after	overnight	
exposure	 to	 BFA	 some	 ENaC	 activity	 at	 the	 plasma	membrane	 remained	 suggesting	
ENaC	may	be	able	to	bypass	the	Golgi	and	be	processed,	as	suggested	by	Hughey	et	al.	
(2004)	 in	 post-Golgi	 compartments	 (Yu	 et	 al.,	 2008).	 Frindt	 et	 al.	 (2016)	 provided	
evidence	 for	 this	 hypothesis	 by	 identifying	 that	 an	 immature	 form	 of	 the	 ENaC	 γ-
subunit	 localised	 to	 the	 endosome,	 and	 would	 become	 processed	 following	 sodium	
depletion	 (Frindt	et	al.,	 2016a),	 so	as	BFA	 inhibits	ER	 to	Golgi	but	not	ER	 to	plasma	
membrane	 trafficking,	 by	 bypassing	 the	 Golgi,	 a	 role	 for	 COMMD10	 in	 this	 process	
cannot	be	ruled	out	but	this	would	require	further	investigation.		
	
In	 fact,	 it	 has	 been	 shown	 that	 BFA	 treatment	 promotes	 ER	 to	 apical	 membrane	
trafficking	 (of	 secretory	 proteoglycans	 and	 glycoproteins)	 (Tveit	 et	al.,	 2009),	 but	 it	
has	 yet	 to	 be	 described	whether	 this	 is	 the	 case	 for	 ENaC.	A	 sub-apical	 vesicle	 pool	
containing	ENaC	channels	has	been	 identified	and	these	are	rapidly	mobilised	to	 the	
apical	 membrane	 under	 salt-depleted	 conditions	 (Loffing	 et	 al.,	 2001b).	 This	 sub-
apical	 vesicle	 pool	 is	 stimulated	 to	 traffic	 to	 the	 apical	 membrane	 by	 cAMP	
(Butterworth	 et	 al.,	 2005a;	 Rauh	 et	 al.,	 2016),	 induced	 by	 forskolin	 experimentally	
(Edinger	et	al.,	2012;	Rauh	et	al.,	2016),	and	these	experiments	cannot	rule	out	a	role	
for	COMMD10	in	this	process.	Further	studies	incubating	control	and	C10	KD	epithelia,	
with	 forskolin,	 would	 be	 required	 to	 analyse	 this.	 However,	 based	 on	 the	 results	
shown	it	was	decided	not	to	further	pursue	the	theory	that	COMMD10	regulates	ENaC	
trafficking	 through	 the	 Golgi	 and	 studies	 were	 conducted	 to	 investigate	 whether	
COMMD10	regulates	the	endocytosis	and	recycling	pathways	of	ENaC	trafficking.		
	
Endocytosis	 of	 ENaC	 is	 instigated	 by	 ubiquitination	 through	 the	 E3	 ubiquitin	 ligase	
Nedd4-2.	 COMMD1	 has	 been	 shown	 to	 down	 regulate	 ENaC	 by	 increasing	 ENaC	
ubiquitination	 through	Nedd4-2	 (Ke	 et	al.,	 2010;	 Chang	 et	al.,	 2011)	 and	 it	 has	 also	






may	 be	 able	 to	 regulate	 ENaC	 through	 Nedd4-2.	 As	 it	 was	 observed	 that	 when	
COMMD10	is	overexpressed	in	control	KD	epithelia	that	there	is	a	reduction	in	Isc-amil	
(see	 section	 4.1.2,	 figure	 4.2)	 it	 would	 be	 interesting	 to	 analyse	 whether	 there	 is	
similarly	 an	 increase	 in	 ENaC	 ubiquitination	 to	 add	 further	 evidence	 for	 COMMD10	
regulating	ENaC	through	Nedd4-2.		
	
SGK1,	 when	 phosphorylated,	 is	 able	 to	 prevent	 ENaC	 ubiquitination	 through	
phosphorylation,	and	thus	inhibition,	of	Nedd4-2	(Debonneville	et	al.,	2001;	Snyder	et	
al.,	2002).	Based	on	the	fact	that	Nedd4-2,	and	subsequent	ENaC	ubiquitination,	levels	
were	 increased	 in	 C10	KD	 cells	 it	was	 hypothesised	 that	 SGK1,	 and	 phosphorylated	





the	 long-term	 effects	 of	 the	 knockdown.	 When	 taking	 this	 pSGK1	 result	 with	 the	
earlier	described	different	effects	of	the	transient	and	stable	COMMD10	knockdowns	
on	Isc-amil	the	plausibility	of	a	possible	compensatory	mechanism	becomes	apparent.	
Although	 there	 appears	 to	 be	 no	 published	 data	 suggesting	 different	 effects	 of	
transient	and	stable	knockdowns	there	are	numerous	discussions	on	research	advice	





Due	 to	 an	 increase	 in	 ubiquitination	 of	 ENaC	 in	 C10	 KD	 cells	 it	 can	 be	 tentatively	
deduced	 that	 there	 is	 increased	ENaC	endocytosis	 in	 these	 cells,	 however	 this	 study	
analysed	the	ubiquitination	state	of	whole	cell	ENaC	and	not	surface	ENaC	populations	
and	thus	an	increase	in	ENaC	endocytosis	cannot	be	fully	concluded.	Using	transferrin-
546	 (Tf-546)	 as	 a	 marker	 of	 the	 endocytosis	 pathway	 it	 was	 investigated	 whether	
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there	was	 increased	 Tf-546	 uptake,	 i.e.	 endocytosis,	 in	 both	 FRT	 and	 U2OS	 C10	 KD	
cells	 (see	sections	3.5.3	and	4.3.4,	 figures	3.15	and	4.10).	 It	was	observed	 that	 there	
was	an	increased	rate	of	Tf-546	uptake	in	both	FRT	and	U2OS	C10	KD	cells	compared	
to	control	KD	cells	suggesting	an	increased	rate	of	endocytosis.	It	has	been	described	
that	a	COMMD1	knockdown	had	no	effect	on	Tf-546	uptake	 (Bartuzi	et	al.,	 2016)	 so	
the	 fact	 that	 a	 COMMD10	 KD	 increased	 the	 rate	 of	 Tf-546	 uptake	 suggests	 that	
members	 of	 the	 COMMD	 family	 play	 different	 roles.	 This	 also	 provides	 further	
evidence	that	the	reduction	in	Isc-amil	observed	in	C10	KD	epithelia	is	due	to	increased	
ENaC	endocytosis	 from	the	plasma	membrane	 to	 the	endosome.	To	confirm	this,	 co-
localisation	studies	between	Tf-546	and	ENaC	(as	has	previously	been	performed	in-
house	((Chang	et	al.,	2011))	should	be	performed	in	both	control	and	C10	KD	cells	to	
analyse	 whether	 there	 is	 an	 increased	 amount	 of	 ENaC	 found	 in	 endosomal	
compartments.	 Previous	 work	 from	 our	 laboratory	 has	 identified	 that	 COMMD1	
increases	 the	 localisation	of	ENaC	to	 the	endosome	(Chang	et	al.,	2011)	but	whether	
the	same	can	be	said	for	other	COMMD	family	members	is	unknown.		
	
To	 summarise	 these	 results,	 it	 can	 be	 concluded	 that	 a	 stable	 COMMD10	 KD	 down	
regulates	ENaC	activity,	most	likely	through	increased	ubiquitination	by	Nedd4-2.	The	
increased	rate	of	endocytosis	of	Tf-546	in	C10	KD	cells	suggests	that	ENaC	endocytosis	
may	 also	 be	 increased,	 as	 would	 be	 expected	 because	 of	 the	 increase	 in	 ENaC	
ubiquitination	in	C10	KD	cells,	however	co-localisation	studies	between	ENaC	and	Tf-
546	 should	 be	 performed	 in	 control	 and	 C10	 KD	 cells	 to	 definitively	 conclude	 this.	
These	 results	 also	 highlighted	 further	 the	 possibility	 of	 a	 compensatory	mechanism	
forming	 as	 a	 result	 of	 the	 stable	 COMMD10	 KD.	 The	 fact	 that	 pSGK1	 protein	 levels	
increased	 (the	 opposite	 to	 that	 predicted),	 as	 well	 as	 the	 previously	 described	
different	 effects	 of	 the	 transient	 and	 stable	 COMMD10	 knockdowns	 on	 the	 Isc-amil,	













hypothesised	 that	 if	 the	 Isc-amil	was	 completely	 rescued	 to	 levels	 of	 the	 control	 KD	






been	 identified	 as	 interacting	 partners	 of	 a	 recycling-associated	 complex,	 the	 CCC	
complex	(Starokadomskyy	et	al.,	2013),	and	COMMD1	has	been	shown	to	be	a	crucial	
regulator	of	protein	 recycling	 (Miyayama	et	al.,	 2010;	Phillips-Krawczak	et	al.,	 2015;	
Bartuzi	et	al.,	2016).	It	was	observed	in	both	experiments	that	the	Isc-amil	significantly	
increased	 in	 C10	 KD	 epithelia	 but	 did	 not	 reach	 the	 same	 levels	 as	 those	 seen	 in	
control	 KD	 epithelia	 treated	 identically.	 This	 suggests	 that	 inhibition	 of	 endocytosis	
only	 partially	 rescues	 the	 Isc-amil	 therefore	 highlighting	 the	 possibility	 that	 the	
COMMD10	KD	has	various	effects	on	ENaC	trafficking.	As	described	earlier,	COMMD10	
is	 localised	 to	 endosomal	 compartments	 (see	 section	 5.1.2)	 and,	 as	 mentioned,	
COMMD10	 has	 been	 shown	 to	 interact	with	 protein	 recycling,	 and	 thus	 endosomal,	
associated	proteins;	such	as	ccdc22	and	ccdc93	(Starokadomskyy	et	al.,	2013;	Wan	et	





The	 CCC	 (COMMD/ccdc22/ccdc93)	 complex	 has	 been	 identified	 as	 part	 of	 a	 larger	
protein	complex,	called	the	Retromer	complex.	The	Retromer	complex	 is	a	relatively	
newly	 described	 complex	 that	 has	 been	 implicated	 in	 the	 recycling	 of	 numerous	
membrane	proteins	from	endosomal	compartments	to	the	plasma	membrane	(Arighi	
et	 al.,	 2004;	 Temkin	 et	 al.,	 2011),	 including	 the	 aldosterone-regulated	 vasopressin	
receptor	 (Feinstein	 et	 al.,	 2013).	 Whether	 Retromer	 is	 involved	 in	 the	 recycling	 of	




ENaC	 (Geda,	 2015;	 Cheung	 &	 McDonald,	 unpublished	 work).	 Due	 to	 the	 fact	 that	
COMMD10	 has	 been	 implicated	 in	 the	 larger	 Retromer	 complex,	 protein	 levels	 of	
various	 Retromer	 proteins	 (COMMD1/ccdc22/Snx4/Vps35)	 were	 analysed	 to	
investigate	 the	 effect	 of	 the	 stable	 COMMD10	 KD	 on	 Retromer	 (see	 section	 3.5.2,	
figures	3.12	and	3.13).		
	
Interestingly,	 the	 COMMD10	 KD	 had	 varying	 effects	 on	 these	 Retromer	 proteins.	
Protein	levels	of	both	Vps35	and	COMMD1	were	diminished	in	C10	KD	cells	suggesting	
that	a	COMMD10	KD	disrupts	Retromer	protein	levels.	However,	levels	of	ccdc22	and	
Snx4	 remained	 unchanged	 perhaps	 highlighting	 that	 only	 certain	 complexes	 within	
Retromer	 are	 affected	 by	 the	 COMMD10	 knockdown	 but	 to	 confirm	 this	 analysis	 of	
other	 Retromer-associated	 proteins,	 such	 as	WASH1,	 Fam21	 and	 ccdc93	 should	 be	
performed.	The	fact	that	ccdc22	levels	are	unaltered	by	the	COMMD10	knockdown	is	
interesting	 as	 a	 previous	 study	 by	 Phillips-Krawczak	 et	 al.	 showed	 that	 COMMD1	
deficient	 fibroblasts	 had	 significantly	 reduced	 protein	 levels	 of	 ccdc22	 (Phillips-
Krawczak	et	al.,	2015),	and	Bartuzi	et	al.	showed	that	COMMD1	deficient	dogs	showed	





complexes	 that	 regulate	 specific	 cargoes	 (Li	 et	al.,	 2015)	 and	 it	was	 speculated	 that	
proteome-wide	 analyses,	 similar	 to	 those	 previously	 used	 to	 identify	 Retromer-
regulated	 cargoes	 (Steinberg	et	al.,	 2013),	 should	be	performed	 to	 identify	potential	





associated	 proteins	 and	 because	 a	 stable	 COMMD10	 KD	 appeared	 to	 disrupt	 some	
recycling-associated	 protein	 levels	 it	 was	 hypothesised	 that	 COMMD10	 may	 be	 a	




Tf-546	 recycling	 from	 endosomal	 compartments	 to	 the	 plasma	membrane	 has	 been	
suggested	to	be	recycled	through	Retromer	(Chen	et	al.,	2013)	making	this	a	suitable	
model	 to	examine	whether	COMMD10	regulates	protein	recycling	 through	Retromer	
and	 therefore	 whether	 COMMD10	 may	 regulate	 ENaC	 recycling.	 The	 COMMD10	
knockdown	appeared	 to	 increase	 localisation	of	Tf-546	 to	endosomal	 compartments	
suggesting	 that	 COMMD10	 is	 crucial	 for	 the	 trafficking	 of	 Tf-546	 from	 endosomal	
compartments	 back	 to	 the	 plasma	 membrane.	 Furthermore	 COMMD10	 KD	
significantly	 delayed	 the	 recycling	 of	 Tf-546	 back	 to	 the	 plasma	membrane	 (figures	
3.19	 and	 4.14),	 which	 can	 lead	 us	 to	 speculate	 that	 COMMD10	 is	 crucial	 for	 the	
recycling	of	Tf-546	back	to	the	plasma	membrane.	This	however,	 is	only	preliminary	
data	 and	 further	 work	 is	 required	 to	 confirm	 whether	 COMMD10	 plays	 a	 role	 in	





the	effect	of	 the	C10	KD	on	 the	 Isc-amil	 is	multi-factorial.	 Immunocytochemistry	and	
BFA	studies	(see	sections	5.1	and	5.2,	respectively)	provide	evidence	that	COMMD10	
does	not	regulate	trafficking	pathways	through	the	Golgi	and	recently	published	data	
suggests	a	role	 for	COMMD10	 in	 the	recycling-associated	Retromer	complex.	Protein	
levels	 of	 the	 Retromer	 complex	 proteins,	 COMMD1	 and	 Vps35	 were	 significantly	
reduced	in	C10	KD	cells	(see	figure	3.12)	suggesting	that	a	COMMD10	KD	disrupts	the	
Retromer	complex,	however,	protein	 levels	of	 two	more	Retromer	complex	proteins	
ccdc22	 and	 Snx4	 were	 unchanged	 (see	 figure	 3.13).	 Therefore,	 to	 confirm	whether	
COMMD10	 is	 able	 to	 disrupt	 Retromer,	 the	 effects	 of	 the	 knockdown	 on	 more	
Retromer	complex	proteins,	such	as	WASH1,	Fam21	and	ccdc93,	should	be	analysed.	
Analysis	 of	 the	 effect	 of	 the	 stable	 C10	 KD	 on	 recycling	 of	 Tf-546	 showed	 that	
COMMD10	increased	the	endosomal	location	of	Tf-546	and	significantly	increased	the	
time	 taken	 for	Tf-546	 to	 recycle	back	up	 to	 the	plasma	membrane	 (see	 figure	4.15).	
This	 suggested	 that	 COMMD10	 plays	 a	 crucial	 role	 in	 the	 recycling	 of	 Tf-546	 but	









pressure	 conditions	 to	 promote	 sodium	 reabsorption	 through	 ENaC	 and	 has	 both	
short	 and	 long-term	 effects	 on	 ENaC	 regulation.	 In	 the	 short-term	 (0-4	 hr),	
aldosterone	increases	cell	surface	ENaC	levels,	SGK1	levels	and	activity	(Loffing	et	al.,	
2001a;	 Loffing	 et	 al.,	 2001b)	 and	 increases	 membrane	 populations	 of	 the	 Na+/K+	
ATPase	(Summa	et	al.,	2001).	 In	the	 long-term	(4	hr	onwards)	aldosterone	increases	
mRNA	 and	 protein	 expression	 of	 the	Na+/K+	ATPase	 (Paccolat	 et	al.,	 1987;	 Beron	&	
Verrey,	1994)	as	well	as	mRNA	expression	of	all	three	ENaC	subunits	(May	et	al.,	1997;	
Spindler	et	al.,	1997).	The	fact	that	aldosterone	is	so	crucial	in	the	regulation	of	ENaC,	
and	 thus	 in	 the	 control	 of	 total	 body	 blood	 volume	 and	 blood	 pressure,	 makes	 it	
important	to	identify	possible	novel	aldosterone	effectors.		
	
Based	 on	Ussing	 chamber	 data	 presented,	 suggesting	 that	 the	 COMMD10	KD	down-
regulates	ENaC,	it	was	hypothesised	that,	if	COMMD10	was	regulated	by	aldosterone,	
then	aldosterone	would	 cause	an	up-regulation	of	COMMD10	protein	 levels.	Using	a	
kidney	 cortical	 collecting	 duct	 cell	 line	 (M1CCD)	 it	 was	 observed	 that	 COMMD10	
protein	 levels	were	 quickly	 diminished	 upon	 aldosterone	 stimulation	 of	 the	 cells	 (it	
was	then	shown	that	this	was	possibly	due	to	prevention	of	COMMD10	transcription	
rather	 than	 increased	 COMMD10	 degradation	 (figures	 4.17	 and	 4.19))	 although	
protein	levels	recovered	after	about	24	hr	(see	section	4.5.1,	figure	4.17).	Analysis	of	
the	5’	flanking	region	of	human	COMMD10	gene	identified	possible	steroid/hormone	





expected	 that	 COMMD10	 protein	 levels	 would	 increase,	 but	 instead	 they	 rapidly	
decreased	 and	 the	 reason	 is	 unknown.	 Although	 FRT	 cells	 were	 used	 for	 Ussing	
chamber	 experiments	 and	M1CCD	 cells	were	used	 for	 aldosterone	 experiments,	 this	
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again	raises	the	question,	however,	are	the	effects	seen	in	the	FRT	cells	with	the	stable	
COMMD10	 knockdown	 due	 to	 the	 long-term	 effects	 of	 the	 knockdown?	 To	 identify	
whether	 this	 is	 the	case	 further	studies	 involving	M1CCD	cells,	ENaC	and	 the	Ussing	
chamber	would	need	to	be	performed.	As	M1CCD	cells	endogenously	express	ENaC,	at	
low	passage	numbers,	studies	on	the	effect	of	stable	and/or	transient	knockdown	or	
overexpression	 of	 COMMD10	 on	 Isc-amil	 in	 M1CCD	 epithelia	 would	 provide	 more	




effect	 on	 other	 COMMD	 family	 members	 was	 subsequently	 analysed.	 Unfortunately	
COMMD3	 and	 COMMD9	 protein	 was	 unable	 to	 be	 detected	 in	 M1CCD	 cells	 by	 our	
antibodies.	However,	COMMD1	 levels	under	 aldosterone	 stimulation	were	examined	
(see	section	4.5.1,	figure	4.16).	It	was	observed	that	COMMD1	protein	levels	remained	
unchanged	with	aldosterone	 treatment	suggesting	 that	COMMD1	 is	not	 regulated	by	
aldosterone	(it	should	be	noted	here	that	not	all	regulators	of	ENaC	are	regulated	by	
aldosterone,	 such	 as	 Nedd4-2,	 and	 now	 COMMD1,	 and	 not	 all	 aldosterone	 effectors	






Prior	 to	 this	 study,	 the	 idea	 that	 different	 COMMD	 family	 members	 are	 differently	
regulated	 and	 have	 different	 functions	 had	 not	 been	 explored,	 although	 the	 initial	
study	into	the	COMMD	proteins	by	Burstein	et	al.	suggested	that	the	family	probably	
serve	 unique	 and	 non-redundant	 functions,	 due	 to	 their	 ability	 to	 differentially	
regulate	 NF-κB-mediated	 transcription	 (nuclear	 factor-κB)	 (Burstein	 et	 al.,	 2005).	 A	
number	 of	 studies	 have	 identified	 that	 mice	 deficient	 (i.e.,	 COMMDX-null	 mice)	 in	
COMMD1	(van	de	Sluis	et	al.,	2007)/	COMMD9	(Li	et	al.,	2015)	or	COMMD10	(Burstein	
&	 Starokadomskyy,	 unpublished	 work)	 result	 in	 embryonic	 lethality,	 however	 the	
lethality	 occurs	 at	 different	 timepoints	 through	 embryogenesis	 suggesting	 different	
roles	 for	 the	 family	members.	Li	et	al.,	 2015	suggested	 that	different	COMMD	 family	
members	may	be	able	 to	 form	distinct	CCC	complexes	 that	regulate	specific	cargoes.	
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They	 identified	 that	 COMMD9	 and	 COMMD5,	 when	 knocked	 down,	 both	 regulated	
Notch	trafficking	but	other	family	members	were	not	involved	in	this	process	(Li	et	al.,	
2015),	 however	 it	was	 still	 concluded	 that	 different	 COMMD	 family	members	 likely	
play	similar	roles	in	the	Retromer	complex,	but	it	could	be	hypothesised	that	different	






stable	 COMMD10	 knockdown	 appeared	 to	 down-regulate	 ENaC	 activity,	 a	 transient	
COMMD1	 knockdown	 significantly	 increased	 it	 (Ke	 et	al.,	 2010).	 In	 correlation	with	
this,	investigations	into	the	ubiquitination	of	ENaC	in	experiments	highlight	again	that	
COMMD1	and	COMMD10	have	differing	effects.	COMMD1	has	been	shown	to	increase	
ENaC	 ubiquitination	 (Ke	 et	 al.,	 2010)	 whereas	 this	 study	 has	 shown	 that	 when	
COMMD10	 is	 knocked	 down	 ENaC	 ubiquitination	 increases.	 Because	 there	 is	 the	
difference	 in	 short	 and	 long-term	knockdown	 it	 is	 possible	 that	 the	different	 effects	
are	 because	 of	 the	 ability	 of	 the	 cells	 to	 compensate	 for	 the	 loss	 of	 COMMD1	 in	 the	
short-term	but	 in	 the	 long-term	a	 secondary	 compensatory	mechanism	 is	 formed	 to	
cope	with	the	loss	of	COMMD10.		
	
Secondly,	 it	was	 identified	that	COMMD1	was	not	able	 to	rescue	the	reduction	 in	 Isc-
amil	observed	in	C10	KD	epithelia	whereas	COMMD10	was	able	to	fully	rescue	the	Isc-
amil	 in	 C10	 KD	 epithelia	 highlighting	 the	 effect	 of	 the	 stable	 COMMD10	 KD	 was	
reversible.	COMMD1,	however,	 further	decreased	 the	 Isc-amil.	 It	has	been	previously	
observed	 that	 COMMD1	down-regulates	ENaC	 (Ke	et	al.,	 2010),	which	was	 similarly	
observed	 in	 this	 study	 (see	 figure	4.3),	 so	 it	was	unexpected	 that	 the	 Isc-amil	would	
reduce,	however	it	was	a	surprise	that	COMMD10	and	COMMD1	had	opposing	effects	
in	 C10	 KD	 epithelia.	 Unlike	 the	 observed	 different	 effects	 of	 the	 COMMD1	 and	
COMMD10	knockdowns,	which	could	possibly	be	explained	by	the	difference	in	short	
and	 long-term	 knockdown	 effects,	 this	 result	 provides	 more	 concrete	 evidence	 of	
different	 roles	 for	 COMMD1	 and	 COMMD10.	 This	 result	 suggests	 that	 COMMD1	 is	
unable	to	compensate	for	the	loss	of	COMMD10	and	therefore	suggests	that	the	family	
members	 do	 not	 play	 redundant	 roles	 and	 that	 the	 effect	 seen	 in	 C10	 KD	 cells	 is	
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COMMD10	 dependent.	 Conversely,	 in	 a	 previous	 study	 from	 our	 laboratory	 both	
COMMD3	and	COMMD9	have	also	been	shown,	similarly	to	COMMD1,	to	reduce	the	Isc-
amil	 in	 FRT	 epithelia	 and	 interestingly	 both	were	 able	 to	 rescue	 the	 current	 in	 FRT	
epithelia	with	a	transient	COMMD1	knockdown	(Liu	et	al.,	2013).	It	would	therefore	be	
interesting	 to	 investigate	 whether	 COMMD3	 or	 COMMD9,	 as	 well	 as	 other	 family	
members,	 are	 able	 to	 rescue	 the	 Isc-amil	 in	 C10	 KD	 epithelia	 to	 provide	 further	
evidence	of	whether	different	family	members	have	different	roles.	
			
Finally,	 and	 perhaps	 most	 conclusively,	 it	 appears	 as	 though	 COMMD	 proteins	 are	
differently	 regulated	 by	 aldosterone,	 which	 would	 provide	 the	 first	 evidence	 that	
COMMD	 proteins	 are	 differentially	 regulated	 at	 the	 transcriptional	 level.	 COMMD10	
protein	levels	appeared	to	rapidly	diminish	upon	aldosterone	stimulation,	before	later	
recovering,	 whereas	 COMMD1	 protein	 levels	 remained	 unchanged	 throughout	 the	
timecourse.	 Analysis	 of	 5’	 flanking	 regions	 of	 COMMD2/3/4/7/8/9	 and	 COMMD10	
highlighted	 potential	 SREs	 located	 anywhere	 up	 to	 ~2000	 bp	 upstream	 of	 their	
respective	 transcription	 start	 sites	 (see	appendix	 IV),	 suggesting	 they	are	 capable	of	
being	 regulated	 by	 aldosterone.	 For	 COMMD10,	 interestingly,	 the	 location	 and	
sequence	 of	 one	 potential	 SRE	 was	 very	 similar	 to	 that	 of	 another	 aldosterone-
regulated	 gene,	 SGK1	 and	 this	 sequence	 was	 highly	 conserved	 throughout	 species	
suggesting	a	crucial	role	 for	 this	HRE	in	regulation	of	COMMD10.	For	COMMD1/5/6,	
however,	 no	 potential	 SRE	 consensus	 sequences	 were	 identified	 anywhere	 up	 to	
~2000	 bases	 upstream	of	 the	 transcription	 start	 site	 (see	 appendix	 IV)	 highlighting	
perhaps	 that	 COMMD1	 is	 not	 regulated	 by	 aldosterone.	 This	 is	 possibly	 the	 most	
conclusive	 evidence,	 presented	 here,	 that	 members	 of	 the	 COMMD	 family	 are	
differently	 regulated	 but	 further	 studies	 are	 required	 to	 investigate	 this	 further	 as	
there	 have	 been	 no	 studies	 analysing	 whether	 COMMD	 proteins	 are	 differently	
regulated	at	the	transcriptional	level.	For	example,	the	effect	of	aldosterone	on	protein	
levels	on	other	COMMD	members	protein	 levels	should	be	analysed,	however	 this	 is	
dependent	on	reliable	antibodies.	Studies	should	also	be	conducted	into	the	effects	of	
overexpression	or	knockdown	of	the	other	COMMD	members	on	the	Isc-amil	in	ENaC-






This	 study	 has	 shown	 that	 a	 stable	 COMMD10	 KD	 down	 regulates	 ENaC.	 It	 was	
observed	that	COMMD10	does	not	appear	to	localise	to	the	ER	or	the	cis-Golgi	and	the	
COMMD10	KD	wasn’t	affecting	ENaC’s	trafficking	through	the	Golgi	cisternae	towards	
the	 plasma	membrane.	 It	 was	 identified	 that	 the	 stable	 knockdown	 was	 increasing	
ENaC	 ubiquitination	 and	 thus	 reducing	 ENaC	 surface	 populations.	 However,	
ubiquitination	wasn’t	the	only	effect	of	the	knockdown	and	preliminary	data	suggests	
that	COMMD10	is	involved	in	the	recycling	of	membrane	proteins,	and	possibly	ENaC,	




C10	KD	cells.	A	 stable	COMMD10	knockdown,	 created	using	 shRNA,	decreases	ENaC	
abundance	 at	 the	 plasma	 membrane,	 by	 increasing	 endocytosis	 through	 Nedd4-2,	
suggesting	 that	 in	 control	 cells	 COMMD10	 is	 able	 to	 prevent	 ENaC	 ubiquitination.	
Inhibition	of	ENaC	ubiquitination,	by	Nedd4-2	siRNA	or	βY620A,	only	partially	rescued	
this	 phenomenon	 suggesting	 that	 there	was	more	 than	 one	 effect	 of	 the	 COMMD10	
knockdown.	Studies	with	Tf-546	suggested	that	COMMD10	is	required	for	successful	
recycling	 of	 membrane	 proteins	 from	 endosomal	 compartments	 to	 the	 plasma	
membrane,	 however,	 whether	 this	 is	 the	 case	 requires	 further	 investigation.	 The	
recycling	pathways	of	ENaC	have	not	been	well	described	and	the	mechanisms	behind	
















A	 -	 COMMD10	 knockdown	 down-regulates	 ENaC	 surface	 expression	 by	 promoting	
ubiquitination	 through	 the	 ubiquitin	 ligase	 Nedd4-2	 prompting	 an	 increase	 in	 ENaC	
endocytosis	however	it	appeared	as	though	ENaC	recycling	was	also	hampered.	B	-	In	control	






Throughout	 this	 project,	 a	 number	 of	 studies	 began	 to	 identify	 members	 of	 the	
COMMD	 family	 in	 the	 recycling-associated	 CCC	 complex	 and	 thus	 part	 of	 the	 larger	
Retromer	complex	(Starokadomskyy	et	al.,	2013;	Li	et	al.,	2015;	Phillips-Krawczak	et	
al.,	 2015;	Bartuzi	et	al.,	 2016)	 suggesting	 they	are	 required	 for	 recycling	of	proteins	




COMMD	 proteins	 may	 even	 work	 together	 for	 correct	 Retromer	 function	 (Li	 et	 al.,	

















A	 –	 Commonly	 hypothesised	 model	 for	 the	 Retromer	 complex	 with	 a	 COMMD	 protein	
(COMMD1	here)	as	part	of	the	CCC	complex	with	ccdc22	and	ccdc93.	B	–	Proposed	Retromer	















required	 throughout	 the	 human	 body	 in	 regulating	 the	 cell	 surface	 population	 of	
multiple	 proteins	 and	 thus	 any	 changes	 in	 COMMD10	 would	 lead	 to	 a	 number	 of	
human	 pathophysiologies.	 If	 these	 results	 are	 taken	 just	 in	 the	 context	 of	 ENaC	
recycling	 it	 could	 be	 suggested	 that	 COMMD10	may	 play	 a	 role	 in	 the	 regulation	 of	
blood	pressure	and	blood	volume.	If	these	results	are	taken	in	the	context	of	a	role	for	
COMMD10	 in	 the	 Retromer	 complex	 there	 are	 a	 large	 number	 of	 pathophysiologies	
COMMD10	could	be	involved	in,	for	example	Cystic	Fibrosis,	Alzheimer’s	disease	and	






To	 provide	more	 evidence	 for	 the	working	models	 provided	 in	 figures	 5.1	 and	 5.2,	
several	avenues	should	be	investigated.	For	example,	further	biotinylation	assays	need	
to	 be	 performed	 to	 confirm	 that	 a	 stable	 COMMD10	 KD	 reduces	 ENaC	 plasma	
membrane	 population.	 It	 would	 also	 be	 interesting	 to	 determine	 any	 difference	 in	
ENaC	cell	surface	populations	in	transient	and	stable	COMMD10	KD	cells.		
	
To	 investigate	whether	 COMMD10	 interacts	with	Nedd4-2	 and/or	 SGK1,	 to	 regulate	
ENaC	ubiquitination,	co-immunoprecipitation	(Co-IP)	assays	may	be	performed.	Co-IP	
is	one	of	the	most	commonly	used	methods	to	determine	protein-protein	interactions	
and	 can	 isolate	 multi-protein	 complexes	 so	 that	 even	 indirect	 protein-protein	
interactions	 can	 be	 detected.	 COMMD1	 interacts	with	 both	 SGK1	 and	 ENaC,	 but	 not	
with	Nedd4-2	(Ke	et	al.,	2010)	and	thus	whether	this	is	the	case	for	COMMD10	would	
provide	 evidence	 as	 to	 whether	 the	 COMMD10	 KD	 effect	 occurs	 directly	 through	
Nedd4-2	or	SGK1.	Co-IP	studies	between	COMMD10	and	Retromer	proteins,	 such	as	
ccdc93	 or	 Snx1,	 could	 also	 be	 performed	 to	 provide	 further	 evidence	 for	 a	 role	 for	
COMMD10	 in	 protein	 recycling.	 In	 addition	 to	 this,	 further	 ubiquitination	 assays	
assessing	the	ubiquitination	state	of	the	α-	and	γ-ENaC	subunits	in	C10	KD	cells	could	
be	 performed	 to	 assess	whether	 COMMD10	 regulates	 the	 ubiquitination	 of	 all	 three	
ENaC	subunits.	A	number	of	these	experiments	should	also	be	repeated	in	another	cell	
line,	 endogenously	 expressing	 ENaC,	 such	 as	 the	 kidney	 epithelial	 cell	 line	mpkCCD	
(Butterworth	 et	 al.,	 2012)	 or	 the	 lung	 epithelial	 cell	 line	 H441	 (Itani	 et	 al.,	 2002a;	




in	vivo	 studies	 could	be	 employed.	 Firstly:	 analysis	of	COMMD10	protein	 and	mRNA	
expression,	and	COMMD1	as	this	study	has	identified	that	COMMD1	is	not	regulated	by	
aldosterone	 whereas	 COMMD10	 is,	 in	 salt-starved	 or	 dexamethasone-treated	 (thus	
aldosterone	secreting)	mice.	It	would	also	be	interesting	to	perform	these	studies	with	
other	 COMMD	 proteins	 to	 provide	 further	 evidence	 that	 the	 family	 members	 are	









in	 regulating	ENaC	 then	pharmacologically	 targeting	COMMD10	 for	 the	 treatment	of	
hypertension	 may	 be	 a	 possibility.	 Hypertension	 affects	 1/5	 New	 Zealanders	
(www.heartgroup.co.nz)	 and	 is	 the	 leading	 cause	of	heart	disease,	 of	which	172,000	





treatment	 of	 hypertension	 is	 not	 currently	 employed	 or	 at	 least	 commonly	 used.	
Recently	a	compound	that	increases	the	stability	of	the	Retromer	complex	(R55),	and	
thus	hypothetically	would	increase	ENaC	recycling	back	to	the	plasma	membrane,	was	
identified	 through	 in	 silico	 screening	 (Mecozzi	 et	 al.,	 2014).	 For	 the	 treatment	 of	
hypertension	 however,	 it	 may	 be	 possible	 to	 employ	 a	 similar	 tactic	 to	 identify	
compounds	 that	 could	 down-regulate	 Retromer,	 possibly	 through	 COMMD10,	 to	
reduce	sodium	reabsorption	through	ENaC.	However,	Retromer	has	been	linked	to	the	




membrane	proteins	 is	also	a	 tempting	avenue	of	 investigation	(i.e.	 is	 this	COMMD10	
effect	ENaC-specific	or	specific	to	plasma	membrane	proteins).	There	are	a	number	of	
different	channels/proteins	that	could	be	investigated,	including	comparing	the	effects	
of	 a	 COMMD10	 KD,	 as	 well	 as	 other	 COMMD	 proteins,	 on	 basolaterally-localised	
proteins,	such	as	the	potassium	channel	KCa3.1.	As	COMMD10	has	been	identified	as	
part	of	the	CCC	complex,	and	thus	presumably	the	larger	Retromer	complex,	it	would	
be	 interesting	 to	 investigate	 whether	 this	 COMMD10	 KD	 affects	 the	 polarity	 of	
epithelial	 cells.	Retromer	regulates	epithelial	polarity	 through	recycling	of	 the	apical	




assay	 to	 analyse	whether	 a	 COMMD10	KD	 changes	 the	 localisation	 of	 apical	 and/or	
basolateral	proteins	from	their	correct	membranes.	
	
In	 conclusion,	 this	 study	 has	 shown	 that	 a	 stable	 knockdown	 of	 COMMD10	 down	
regulates	 ENaC	 by	 increasing	 ENaC	 ubiquitination	 through	 Nedd4-2.	 This	 causes	 a	
reduction	 in	 surface	 expression	 of	 ENaC	 and	 a	 predicted	 increase	 in	 endosomal	
localisation	 of	 ENaC.	 Prevention	 of	 ENaC	 ubiquitination	 did	 not	 completely	 rescue	
ENaC	 down	 regulation,	which	when	 taken	with	 recent	 studies	 into	 COMMD	 protein	
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much	 improved	MCS.	Transcription	of	 the	DNA	 insert	 is	driven	by	SV40	and	AdMLP	



































In	 this	 study	 control	 sh/siRNA	was	 used	 for	 the	 stable	 knockdown	 of	 COMMD10	 in	














Primers	 were	 annealed	 and	 cloned	 into	 AgeI	 and	 EcoRI	 digested	 pLKOtrc.	 DNA	
sequencing	confirmed	the	insertions	were	correct.	The	pLKOtrc	plasmid	coding	for	the	






Nedd4-2	 siRNA	was	 used	 in	 this	 study	 to	 analyse	 the	 effect	 of	 a	 transient	 Nedd4-2	
knockdown	on	Isc-amil	in	ENaC-expressing	control	and	C10	KD	epithelia.	The	sequence	


























































































































































































































all	 those	 in	orange	are	potential	HRE/SRE	sequences	(HRE	similar	 to	 those	 found	 in	
the	5’	flanking	region	of	the	human	COMMD10	gene)	and	the	sequence	in	bold	is	the	
translation	start	site.		
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COMMD1	(no	HRE	sequences	found):	
 
CCAGCCTGGACAACATGGCGAAACCCTGCCTCTACTAATACAAAAATGAGCCGGGTGTGGCGGTGCGCATCTGTAGTCCCAGCTAGCTACTCGGGAGG
CTGAGGCAGGAGAACCGCTTGAACCCAGGAGGCAGAAGTTGCAATGAGCAGAGATCACACCACTGCACTCCAGCCTGGGGGACAGAGCAAGACAGACT
CCATCTCAACAAACAAACCAAACCTAACAAACCAAACAAAAACCAAAACTCTCAAATCATAGCTTTTGGTCATCATCAGTATGTTATAAAACATCTCT
GGGGCCGGGTGCGGTGGCTCACGCCTGTAATCCCAGCGCTTTGCGAAGCCAAGGCAGGCCGTCACTTGAGGCCAGGAGTTTAAGACATAACGGGTCAT
CTTCACAGATAACTTAGGTGGCCTTTCCTTCCCACATGCACACCCTCCTCTGTTGTTTCAGTTCTTTGTCTGCTTTTGTTTCAAAGGTTGCTAATTTC
CCACTTATTTTGTTTGTTGAATATCAACCATATTATAAACTCTCTTGGCCCCCAAATTTATCTTTTTTTTTTTTTGAGACGGAGTTTCGCTCGTCACC
CTGGCTGGAGTGCAATGGCGCGACGTCAGTTCACGGCAACCTCCGCCTCCCAGGTTCAAGCTATTCCCCTGCCTCAGCCTCCCGAGTAGCTGGGACTA
CAGGCCTACGCCAACACACCCACCTAATTTTGTATTTTTAGTAGAGACGGGGTTTCTCCATGTTGGTCAGGCTGGTCTTGAACTCCTGACCTCATGTG
ATCCGCCAGCCTCAGCCTCCCAAATTGCTGGGATTACAGACGTGAGCCACCCTGCCCGACCCAAAATTTATCTTTCAACATTCTGTTCCTAATCTAAT
AAATGTAAGCTTCAACTATGGTCCCTAGACAATTATCCTACAAACCTTCGTTTCCAGGTGTATTATCTCCTAAACTTACAAATGACTCCTAATCTGGC
CATTCTGACCTTTCCAACTCATTAGGACAAGTTAGAAACTATTACTTTTTCTTACATCCAGCGTTACCTATCTTAGCGCCATCACATTCCCAGTTACT
TGGGCTGATGACTGCAAACACATGTAAGGTGTACTTTATATACGTGGGTCTTTATATGCTTTCTCACTGAATCCTCACAGCAAGCCTACACGATGGCT
AAAAAGAAATGATCCCATAGCTGGGGGAGATTAAGCCAAATACTTTCCAGGACACCAGGCCTTTAACATCTGCCCCAACCTAGCTTTCTAATCTCACC
TCTTCTGTAAACATACTACTATTCTCCAACCCAAAAGAACTACTATACTCAATATACACTCGGGCAAGATCTCTAAACCTCTGTCCTGACTTTTCCTT
CCAGATTTTTCTATTTCAACTCGATTTCTCTTAATCTTAACTCTAAAAAGCAAACATTTTCCTCCAATTTTATAAGTGAATCTTTGGCACAGAGGTTA
CAGGTCACTAAGACATGAAGTAACGGAAGCAGAGAATGAAACTCTGGTCTTCCTGATTTCCAACGTGTGCCACACACTTCCACAAAAAAAACAAATAA
TTGTTTCTTGATTTGCCTATGTTTCACTGCACATGCGGAGACGACATCAACGTAACTTTTCCGCAACTATTTCAAACACGACACGTAAGTCGGTTCCC
ACATCCATCCCAGTACAATGGGCCCCGCCCCAATTTAGACTCGGAGAGTTCACCCAATTCGTCTCAACAGTTGTGCCAAGTGAAGTTTATTTAATAGT
TCTTTAAATAAGAATAACAAAGCTGAAAGATACTGTGCATTCTACCAGTTCCAATAAGCAATAAGCGACAGCCCTCAAGCGTCAGATCCCTAGTGAAG
ACTGCATGCAATCCTCGGCATTTTGAACTGCTTTCGGCTCCAATATGAATGATGCACAGTGCAGGATGAAAAACTAAGGGAGATTAAGATGCAAAATG
ATGAGAGCGCAGAGCACAACCCCGCGGCGCCGCGGGTCAGGCCATGAGAGTGATACCTTTGGCGGCGGAAATGTTGCTGAAGCGGATCTGGGCTGGT 
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COMMD2	(1	HRE	sequence,	3	potential	HRE	sequences):	
	
	
 
CAACAGCCATGAGTCCAAAAGTTTTGACATACCATAATGGGCGAATATAGAAAAAGTAATTTCATATCCTTAGTGGGTTAAAAGGCAGTATCAATAAT
ACAAATATCTATGTTAATGTGCTCTAAAACTGGGCTTTTACTTGAGTTGTTGCCATTCTAAACCCAAGCAACTTTTGAATAAGATGAACTTTTTATAA
TTATAATGTAAATTATGTTTGTTATCATTAGAAATATTACCAATTATATGACCACCAGAGTGAGAGACTGTGTTTTTTTATTGTGCTTGAGCCTAAGT
TGACATTTTTTAGTTGCAAAGACTACACTTTTCATTTTCTTCTCTTGCAGTTATCATATCCTCTGTTGCAGAAGAGTCTGCCCAGCAGCCAAAAAGGG
AAATAACACAAAAAAGATTTGTGCCTTATCTCACCAACCATATGAGGCCTTTTAACTTTTAAAATTTTTTTTACTCTGCTCTGTTACACTAAGCTATA
AACTACCCACTTATGCATGGCATTATATTGATAACAAAGCACATTTTGAAATCTTTTCTGGCTTTTTTACATGGTACAGATTCAGTTTTGTTAATAGT
AGGTACTTAGAGTGACCCATATTGTGTGTTGAACAAAGGATAAAGTTCTAGTCTCAGAATTTAGAATGCTCTTAGGCTGTTCCATCCTCTAAAATAGT
TTAATCCATAAGCTCATTAGGCTGCAGAAAGGAATCTCCTGAGGGAGTTATTCTGAAGAAGGGAAGTTCCTCTGGTCTGGTGTCTACTAGAATTGCTT
TTCCTTGAAACTCTGCCTTCTTCTGGAAGGCAGAAATCTAACATGATTCAATGGCTACAGCTGTGGAAGTGTGCAGAGGAAAGGTGAAATCATTATAG
AATACTGAGGAATACTTTGACAGAAATTATCCTTACTCTTTTTCCATTGAAGTGGGGTCCCCTGAGGTAACCAGAGGTGTGATGGGAAAAGCAAATCA
AGTTATTTTTTACCTGTGTGCCAATGTTGTGATTGTCATAAGTCCAATGAGAAGTGGATGCCTGTGGTTTTGAAGGAATGTGCTTAGTTCACAGAACG
AAAAGGCTTCTCAGTTAACTCGAAGACTAAAAGCACACAGATTAAAATTCAGAGAATGAGGAAAAGAAAATCCAGGGAAGTCTGAGTTTCATTGGAGC
AAGTATAGATGGTTAGGATATGATTTCCTGGCATGGTCTGAAAACCATATTCTTTCATTCCAAATAAATAAAAAATTCTTACAAAGCTCAAGTGAGTT
TAAGTGCTGCACCATAATAAAATGGCTTGATTTGCAGCTGAGACTTGGCACAATTCATAGACTAAAAGAAGAGCTTAAGAAAAGCTACAGGCATTTTT
TTTTTTTTTTAGTATTTGGGGGGAAAAATGAGCAAGTCCCCATGTACTTTTCAAAAAGGCAAAAATTATTTATCTCTTGGTATGAGCAATGTAATTAA
AACCTTTTTTTTATGTTTAGGCTTTCAAGAATATAATTATTGGGTATTCTTTTCTATGCTTGTTTCATCTACTCTTTGTTTTTACCAAGGGATAAATA
CTAAATTCCATGCCTTTCTTGGGCCCTTAAAACAATTTATTTTCATGCCAAACCTCTCATTAAGCCTCCTCCCTTTCTTTTTAAAATTTATTTTTTAT
TGAGATAAAATTCACATAAAATTTACCCTTTCAAAATGTACAATTCAGTGGCTTTAGGATGTTCACAAAATTGTGCAACCATTACCACTATCTGATTA
CAGAACATTTTTATCATACCCAAAAGAAACCTGTAATTATTAGCAATCACTCTTCATTTTCCCTTCTTCTAGCAACCACTAATCTACTTTCTGTAGAT
TTGCCTATTCTGGATATTTCATATAAGTGGAATTATATAATATGTGGCCTTTTGTGTCTGGCTTCTTTCACTTAACATAATGTTTTCAAGGTTCATCC
ATGTTCTAGCATGTATCAGTATTTCATGCACTTTATGACTGAATAATATTCCATTCTATGGATACTCCTTTTCACAGTATTTTAACAAGCCTTATTT 
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COMMD3	(2	HRE	sequences,	2	potential	HRE	sequences):	
	
	
 
ATTAGAACACATTATGGTGAAAATTTTTGTGAGCTTAAAATGTGCCCATCACTTAGGCCTAACACATGAATATACTTAGGCCTAAGAGGAGGAAACAT
TCTAAGAGAAAGTACTTATACATGGGCAACAAAGTAATATGACAGCTATTATGGAAACAATCCTTCTGAATTTCCTAACTTTCATGCCCACAAATTGA
CAACCACTTGTGTTTATTTTTCTTTTAAAATAATATTTTAAAATCTATGTCCATGATTAATACTCTCTTTTTTGACACTAAATTGAGTATTAGAGTTA
TCAACTCAAATTCTATTAGAGTATTAATAATCAACGTTACACTAGGTCATAAAATACATGTGTAATAAACATAATAAGCTTGGGTGTTGTTAATATTG
TTGAACATTTACACAACTCTGTCCTGACTATTCTCTATGTAATCAGGTATCATGAAGTTTTTCAACTGACATTTTACTACTAATGAGAAACAAATTAG
GAAGATGAGTGATGGGAAGAAAAGATGAACATGATTAATAGGTGCTTGTTTCATAAAGACTCTAGGGAGACTTTTAAATCCTTCACTGCTACTATATT
CTCACCGAGTGAGGAGCCACTGCACGTGCCTTTTAAAGCTTTCAAAGGAGGGCTGAGTAGTTACTCAATCTGTTACTGATGCTTACTCCATTTGCATC
CTGTTGTGAAATGAGGTACACTTTATGTATTGGTGCCAAGGTAAATGTCAACTGTATCCATCAAAAATTTTTAAAACAGACATCTAAGTTAGAAAAAG
AAAATAATGTTTCACTTTGGGTCTAATGTTGCAAATAATCGCTCCTGAAGACTAAAACATCTTTGTTGTTCCGCATCCCTTCCCTCCACCCTTCAAGA
ACTTGCATTTTTTAACTTTTCAAGTGCTTTTGATTAAAAATACCTAATCTACTTTGCTTCACGGGTTTTTTAAAGAATCATTCTTGTTCTCTAAACCA
ACTTCGTAGAAATAGAGAGGAAGTTAAACTTTATACAGTATTTGAATCTTTAAAGGTATGAGCATCCTAAACAGTAACTCACTTCTAATAAAGATCTT
GCCATTCCTAACTGTACTTTACTAAGGTAGCTGTTTAATAAAAACGTATTTATGCAGATTCTATAGAGCAACTAAAACGGGACCCATAGATGTGGTGA
GTAGCACAAAATGTGTATGGCAGTTGGCTTTATTTGCAGCGGCATATAAAATTGTTAATAATCCTGTCAAATCTGTTCATGAATAATTTATTAATCCG
ATTGCTGGAGTGCAGTGCATACAGGAACTCTATGTATGCGTGCATGTGTACACACCCCCCATGCAGGAAGGACACTACTGCCGTATTCCAGAAATGAC
AAAAAAAAAAAAGTAAAAATAAGCAAGAATCACATAATTAGATGTCTTACAGTCTCATAAAAGGGCAGTGCTGCGAGGTTAAGCTGGTGAGCTAAAAA
ACAAACAAAACAAACAAAAAACCACAAAAGCAAAATCCAGTTGCCTGAGATCGGAGCTTCCCGCAGGATTCGCGCAGAGCGAGGAGCGGGGAGGACGC
CGTTTGCGGGAGGCGGGGGCCGGGATCCCGACACCGTCCGCAGTCTCCCCGGGGTCTCTCAGGGAACCGAGCTGGTGGCCGTCCGAGGTAAGCGCCGA
ACCAAGGAGAAAGCGCCGAGCGCGTCCACAAAACGCCCGAGGCCGCCCTTCTCGCCAAGGCTCGGCAGCTCCCGCGGCCTGCGCTGGACAAGCGAGAG
CTGGACGGAAACGGTGGGAGGCCGTAGGCGGCGGCTGGGGGCGCGGGACCCGCGCGCGGGCGCGGAGGCGGGCGGGGAGGCCCCGCAGCCCGCGCCGC
CGCCAGCCGCCCCGAGCCGCGTGCGCGCGCGGCCGCATCAGCTGAGCGCGCGGCGCGTGTCACGTGGTGTGCGTGTCGAAGGTCACGGCGCGCTCACA
ATGGAGCTCTCGGAGTCTGTGCAGAAAGGCTTCCAGATGCTGGCGGATCCCCGCTCCTTCGACTCCAACGCCTTCACGCTTCTCCTCCGGGCGGCAT 
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COMMD4	(1	HRE	sequence,	2	potential	HRE	sequences):	
	
	
 
GGCATGAGCCACCGTGCCCAGCCTTTATTTATTTATTTATTTATTTATTTATTTATTTTTATTTTATTTTATTTTTCTGAGATGGTCTCCTTCTGTTG
CTCAGGATGGATGGAGTACAGTGGTGCCATCATGGTTCACTGCAGCCTCCACCTCCCAGGCTCAAGAGATCCTCTGACCTCAGCCTCTTAGGTAGCTG
GGACAACACGTGTGCACCAGGACAAGCGGGTAATTTTTTGTAGAGACTGGGGTCTCCCTATGTTGCACAAGCTGGTCTAGAACTCCTGGGCTCAAGCG
ATCCACCGGCCTTGGCCTACCAAAGTGCTATGATTAAAGGTCTTAACATTCTTAAAAAATTTTTTTGACATGGTTTAGGATAGTCTAGTAACTTAACG
TACTGTTGTTTTCAACAGGCTAGTGGTTATGATTTGTAAAAGAACTCTTCAGAAATGAGCTCAATTTTACCATGAATTGGGGACACTTTACATTTCTA
TTTTATAGTGCAGTTTAATTGTCATGGGCTCTGTCTTTTAAAAACCTGAAAGCCTGCAACAATAAAACCAGCTGCACCTGTTGCATGGGATAGGCATG
GAATTGAGGAGAGAGCTCAAACTACAGTCAGCCCTCTGTATCCTGAGGTTCTGGATCCTTGGATTTAACCAACTGTGCATCGAAAATATTTGGAAAAA
GTAAAACAATAAAAAAACACAGGTCGGGTGCAGTGGCGGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATGGCGTGAACCCGGGTG
GCAGAGCTGGCAGCGAGTGGAGATCGCGCCACTGCACTCCAGCCTGGGCAACAGAGCAAGACTCCGTCTCAAAAAAAAAAATTAAAAAACTTTATAAC
AGCTATTTACAAAGCATTTACGTTGTATTAGGTATTATAGTAATCTAGAGATGATTTAAAGTATACGGAAGGATGTGCACAGGTTATTTGCAAATACT
ATGCCATATTATATCAGGGACTTGAGTATCTGTGAATTTTGGTATCTCTGGGGTCCTGGAACCAACATCCTGAGGTTACCAAAGGACGACTGTATTCA
ATTTTGTCTCTGGTTATTAGTCTATTCTCAAATGTATTTTTCTTGTTGTTTTGTCTTTTTGTTTTTGCCTCTTCAAGTCAATGTCGGAAACTTAGTTG
TTCTAGACTACCCATTAGCTCAGAGCTACCAGTAATCAGACTACCACTGCAACCTAAGCAACCGATTTTTCTTCCCCATCAGACTGGCAAAAATTAAG
ATAAGCATCTATTGATGTTGAAGCTGTAGGGAGTTTTCCTGAGCAAGTAATTATGACAGCCCTTTTTGCTAGGCACCTAGATGATTCATCAAAATGAA
ATAAAATACCCATGCACTTGAAGAAGTTATCTGGTTTATTTCCTTACCTGGGTGCTGGTTATGTGAGGTGTACAGTTGATGAAAACTTATTAAGCTTT
ATAATAGGTACAATTTTCTGTATGTGTAGTAGACGTCAATAGTTTTTAAAATGTCTTTTGCCACAGCCCGCAGCTGTGAATAATGCTATTCGCTTAAC
AGTGGAAAACGTGTCAATGACCTGAAACACCCTGGCTCCCGGGATCCTACCCCCTTAAGTTAAACAAATGAAATAACTTCCACTGTCTTTCCTAATGT
CTTAATTCGGTCCTCAGTTAAACTGGCGGTTGGCGCCAGTTTTTTCCAGGGAAGGATTCTGGGAGACGGAGGAGGAGACGCCAGCATTTCGCCCCCTG
CACCTCCAGCGGGCTGCGGTCCGCTCCCGGCCTCACTCGAGCAGGCCCCGCCCTCCCAGAGGCAGTTAGTCCAAGTCACGTGATCGTCGACTCAGCTG
ACCCTGCGGGACCGGAAAAAGAAATTCCCGGGCCCTGGCTTCTTGGCGCGATGGTGAGGCACTAGGGGCGAAGCGAGGCTTGGGCTGCTGGAGCGGGA
ATGAGGGGGCGCCAAGTGGCTCCGGAAACTGGGGGAGGTTGTACTGGCCTCTCCGCAAACACAGTGTGTGCGGGCGTGAGGGCTGTGAGTCTGGTAG 
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			COMMD5	(No	HRE	sequences	found):				
 
TGAGGAACCCAAGGACTGCCAGAAAACCACCAGCTGCCCGGAGAGGCAGGACAGGATCCTTCCCTAAAGCCTTCACAGGGGGGCACGGCCCTGCTTGC
TGACCCCCCGGTTTCAGATTTCCGGCCTCCACAGCTGTGAGACAATAAATTTCTGTTGTTTTAAGCTTCCTAGTCTGTGGTTCATTGTTATGGCAGCC
ACAGGAAAGTAATGCACTCCTGGAGCCTGAGAGGGTCTGAAGGGAGCTGCCTCAGGGAATATGCTTACCCGAGGAGAGGTTACTGAATGCCAAACCTA
ACCCTTCACTTGGATCCATAGGTTTGTATCTTTGCTTAACGAAAGTATGAGTAAAATTAAAAATAGAACAAAATGTGACATGATTCAAAAACAAGCTC
CGTTTTTGTGGAAATGCATGGGTTTTTGTGTCTTGGCTCTTCTGCAGTTTGGCCTCTCCCAAGGCAGCCCCACAACGGGTCTATGCTCCCTTCTAGGT
GCTGGATGCTGCTTCCCCAGTAGCATTCCCAGGCATCCCAGTGTAGCCCCCGCGACTCACCCACAGCTACCCACAGTTGTGAGGCCCCTCCTGCAGTT
TCTCCTCACCCCAGGGCTTCTCTGCGATGGGATCTAAGCCTCACCTGTCTTGGAGTCCTTGGTGCCTCGTCCCCTCTGCTCCCTGCAGGTCGAGGACC
CATGGCTCTTCTCCCTGCTCCAGCCGAGAGATCAGCTCAGGCTTGAAAACCAGGAATCCTGCTGTGTGTGCGGCAGAGAAGACAACAGTGTCAGCATG
ACGGGAAGTGTGCAGCACAGGGCTAAGTCTTCCCCAGTTTCCAAATGGAAAGGGGCAGGGGGGCTACAAGGCACAGGCCAAGCTCCTGCAGGGAGAGT
GGGTGGAGGGTGGGGAGAATCTGGGGACACAGCAGCCCTTTCTGTCCAGATCTGTCCACCTCCTGTGGCTGGACAGCAAGGGATACCTGACTCCCACA
ATCTCCAGGCGACCCTGTCACCAAACAGTCTGCAAAGGACAGTCCGCCTCTACCCCTGGAACTCGGGAAAGAGAAGGAGAAGCCCAAGCTTCACTTAG
CAGAACCGGGCCTGTCCCTCAGTTCAGAGAGCAGAGATGCTCCAAGAGGCAGGGGTGGTTACAAAATAAGGTAACAAACAACGATGAATAGACACAAA
CGAAGCACATTTTGCATCAGAAAGCTCCAAGGTCCAGTCCTCAGCCAGTGTCCTTCCAGCCTCAAGTCCCTGCACAAAGGATGCCTCAGGGCCTGCCT
CCCTCGCTGCAGACTGGGTGGCAGAGACCTGTGGGGGCCCACCTGGCACCCTGCCTTCTTGGGGCCACCTGCCCCCATACCCTCTTTGTGCCGGTCAG
TACAGAGATGAGCAGTTGATCCATGGGCCAGCCAAGGCCTCTGTTTAGAAGCTTCCTTCAGGGTTCCCCCAACTGGAAGGAAAGAGGCAGGCAGAGAT
TCCAAAGGCCTATAGCCAATAAGCTGAAACCCCCAGATGCAGGCAGGACTCCACATTCAACAGAAAATGCATATCCTCTCCAAGTACATGTGGAACAA
AGAAACAGCCTTGGGTCAAGCCACAAACTGAGTCACAGACATGCCAAAGAAATACCACAGAACACGCGCCCAGGCAAATGCAACTCAGTGTGAAACTC
ACCACAAAATGGTGCTTAGATGCCATTAGCTACTTGGAAACTACATAATAAATGACTAAGTGGCAACTGTATTTATTATGAGTCAGAATTTATAGGAT
GCAGCCCAAGCAGTATGTAAAGATAAAATGTTATTTATTTAGAGATACGGTCTTGCTCTAGCACTCAGGCCGGAGTGCAGTGGCACCATCACAGCTCA
CTATAGCCTAGGCCAATCCTCCCGCCTCAACCTACTGAGTAGCTAGGACTACAGGTGCGTGACACCACACCCAGCTAATTTTTAAATTCTTTGCAGAC
ATGTGGTCTCGCTATGTTGCCCAGGCTGGCCTCAAACTCCTGGGCTCAAACAATCCTCCTGCCTCAGCCTCCTAAGTAACTGAGATTATAGGCATATG 
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COMMD6	(No	HRE	sequences	found):	
 
 
 
GATAACTGTGCATGAGGTTCCTCTGTCTCCCACTTACTTCGGATTAACACCTTCCTCTTTCCCCTTCCCTGTTTGCAGGGTAGCATTTCTAGGTTTAA
GGCAATATGCAAAAAGACCCAAAGTTAGGCCCTGGCTCAAACACTGTGGGTAGCAGATTTGAAATAAATTTAAATTGCATGTTTGTCTTTTGAATTTA
AAAAGCAAGTTTTAACCTTGCACAGTGGCTCCCTTCTGTAATCCCAGCATTTTGGGAGGCTGAGGTGGGCAGATCACTTGAGGCCAGGAATTCAAGAC
CAGCTTGGCCAACATGGCAAAACCCCATCTTTACAAAAAATACAAAAATTAGCCAGGTATGATGGCACATACCTATAATCCCAGCTACTCGGGAGGCT
GAGGCAAGAGAATTGTTTGAACCCGGGAGGCAGAGGTCACAGTAAGCCAAGATCGCATCATTGCACTCCAGCCTGGGTGACAGAGTGACACTCTCCCC
CCCCAAAAAAAAATAAAAATAAAAAGCAAGATTTTTTCATACTGTAGTTTTACACGATTTTTATTACAAATGTCTAGTTTTGCTTTATTAAGCACTTA
ATCAGCTTTACTGGGCTGGCCTGGGAATTAACCATTGTTAACATTTCTGTGGAAAAGGGTGTTTCAAGTTTCAAACAGTTGACTTAAATGTAAACTTT
TAGAAAACAACTCATTCTCAAATTGGAAACTATTAATACGCTTTTAAGTTTTCAAAAGGAAATAGATTGCCCCCACCCTGAATTCATCAAGCAAAACC
CAAGTCTTTTCATGTATTCCACTACCAAGACATGTTGACATAAGTATCAGTTTTATATAGAAAGAAGGCAAAATTCACAAGGTACTTAAGCAGAATTG
TCTTTTCAAACAATTTCTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGAGACGGAGTCTCCCTCTGTCTCCCGGTCTGGAGTGCAGTG
GTGTGATCTCAGCTCACTGCAACCTCTGCCTCCCGGGTTCAAGCTATGCTCCAGCCTCAGCCTCCGGAGTAGCTGGGATTACAGTGTGCGCCACTGCG
TTTGGCTAATTTTTGTATTTTTAGTAGAGACAGGGTTTCACCATATTGGCCAGGCTGATCTCAAACTCCTGACCTCAGGTGATCCGCCCATCTTGGCC
TCCCAAAGTGCTGGGATTACAGGCATGAGCCACTGCACCGGGCCTTTCCAAACAAATTTTTAAAAATCTTTTGTACCTTATGTTTTTTACAACTTCAT
AAAAGTTTTAAATTTATAGAAAAATTGTGGAAATAGTAGAGCTCCCATATTCTCCATGTCCAGTTTCCCCTATTAACATATTAGTATGGTCATTTGTT
ATAATTAACAAGCCAATATTGATATATTAGGTTTCTTTAGTTTTTGCCTAATGTCCTTTTTCTGATCTAGGATCCCATCCAGGATACCTCATTACATT
TAGTTGTTATGTCTCCTTAAGCTCATCTGGTTATGACAGTTTCTCAGACTTTCCTTGTTTTTGATGACCTCGAGAGTTTTGAGGAGTACTAGTCAGGT
ATAATTTAGGGTGCTCCTCAATTGGGTATTGTCTGATGTGTTTCTGGAATTGAATTGTGGGTTTTTGGGAGGAAGATCACAGAGGTAAAATGCCATTT
TCTACATGTCATACCAAGAGTACATATAGCAAAGTGATTTATAGTGGTTTATGTTGACCTTGATAATTGACTGAAGTAGTGTTTGTCAAGTTACTCTT
TTTCCCCCTTCTTTCCATACTTTACTCTTTGAAAGGAAGGCACTATCTGCTGCCCATACTGAAGGAGTGGGAAGTTATACCCCTCTCTTTTACGGTGG
AGCACCTACGTATTTTATTTGAAATTCTTCTGTGAGCAAGGTTTGTCTCTTCTCCCCCATTTATTAATTTATTCAATCATTGATATCAGTATGTACCC
ATGGATATTTATTTTATACTTGGGGTTATAACTGAATTTTTTTGTTGCTCAAATTATTCCACCTTTTCCATTGGTAGCTCTTTGGGTTGGCTCCTGG 
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COMMD7	(2	HRE	sequences,	2	potential	HRE	sequences):	
	
 
GGAGGGGATGCAGACTCTTTATAAAATGATATGGAAAGATCTCCTAGATGTATTAACAAAAGTATGTAGAGTGTGCAATTATCTGTGTAAACAAAAAA
GGGTGTAAAAATAAAAATTCACGTTGTTTATTTTTTCATTTTTTGAGACAGGGTCTCACTCTGTCGCCCAGGCTGCAGTGCAGTGGTATGACTGATCA
CAGCTCACTGCAGCCTCTAACTCCTAGGATCAACTAATCCTTCTGCCCCAGCCTCTCAAGTGGCTGGGACAACAGACATACACCATCAAGTTCAGCAA
TTATTTTTTTTTTTCCCGATATGGAGTTTTGCCTGTTGCCCAGGCTGGAGTGCAGTGGTACGATATCGGCTCACTGCAACTTCTGCCTCCCAGGTTCA
AGCAATTCTCCTACCTCAGACTCCTGAGTAGGTGGGATTACAGGTGCCTGCCACTACAACTGGCTAATTTTTGTATTTTTAGTAGAGATGCAGTTTCG
CCATGTTGGCCAGACTGGTCTTGAACTCCTGACCTCGTGATCCACCTGCCTCAGCCTGCCAAAGTGCTGGGATTACAGGTGTGAGCCACTGTGCCCAG
CCACGTTCAGCAAACTTTTAAATTTTTTGTAGAGACAGGGTCTCCCCATGTTGCCCAGGCTGGTTTCAAACTCCTGGCCTCAAGCAATCCTCCTGCCT
CGGCCTCCAAAAATGCTGGGATTACAGGTGTGAGCCACCATGACTGACCCTATTGTTTCTATGTGGGGAAAAATAAAAACCTGTGGAAGGGTACCTAA
GAAACTAACAACAGAGGTTATCTATTGGAACAGGCCAGTGGGAGAATTAAGTAAATGGGAGACAAGGGAGAAGAAACCTTTTGTTTTACTCTTTTTTA
TACTCTTTGATAAATGTACATATTCTATCACCCAGCAGTTCCATACCCATGTAATTACCTTATAAACATACTTCCATATGTGCAAAACGACATATATA
CAAGGATATTCTGTTGTGGCATTATTTGTAAGAGAAAAAGAATGGGAACAACCTAGACACCCATCAGCAAGAAACTGATTAAATAAATCATCCATTTG
AAGTAAAACGGTGCATTTGTTACCAAGAATGACGCAGTTCTCTGTGTTCTGATATGGAACGATTTCCAAGTTGAATGGAAAAAAGAAAGGTGCAGGAC
GGTGGGTACATAATGCTACCATTTGTGTGGGAAGAAAAGTGAAACTATATGCATATCCGTTTGCAAATGCAGTTAATGTCTTCAGAACACAGAATAAA
CTAATAACAGTGGCTACCTCTGGGGAAGAGAACTGGGTAACTGGGAAACGGTGGTGGGGAGGGGTTATTACCTTACACTGTACCTTTTAATCATGGGC
ATCTTTTAGCTATTCAAAACTTTATAAAATTTCTGAGGAGGTATTTGCCAGGCGCGGTGGCTCACGCCTGTGATCCCAGCACTTTGGGAGGCCAAGGC
GGGCAGATCACGAGGTCAAGAAATCGAGATCATCCTGGCTAACATGGTGAAACCCCCTTTCTACTAAAAATACAAAAAATTAGCTGGGCGTGGTGGCG
GGTGCCTGTAGTCCCAACTACTCAGGAGGCTGAGGCAGGAGAATGGCGTGAACCCGGGAGGCGGAGCCTGCAGGGAGCCGAGATGCCGCCATTGCACT
CCAGCCTGGGTGACAGAGTGAGACTCCGTCTCAAAAAAAAAAAAAAAAAATTCTGAGGAGGAGGGTAGTGGAGGAGGAGGAGCAGGAAAAGTCATCTG
TACACAAAGCATTTCACATGTTATGCTTTTTCCTGTGGCTTTTAACCTGAGTTTCCCCGGAATTGCTCTTACAAATTCCAACTTTGGAACAGACCCAA
TTTCACTGGAGACCCAGGATCGTCACAAAACCAGGAAGATAATTTTTAAAGACAAGAGCAAGCACTAGCTCTCTGCAAGGTACACGACTCTTTAATCC
ATGCAGAAAGACAACTGGATCCAGACCTTTTCTTCAGAACCTTTTTATTCATCATCTAACCAACAGAGGTGGTTGGCTCGAACTCAAACTAAAATGC 
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CAAATATGAGATAAGACTATGTACACATCCACTTTTGTTAATAAACTCAATATTGAATACTTTGGGATGTTAAATTCATTGGAAAAACAAACCATTTG
TAACCTCAGTTAACTTTAACAACAAGCATTCTGAGCAAATGAAAAGTGTCTTGTTTTATTTTTATATATTGCTTTATTTTAAATGACTCCAAATAACT
CAGTAGTTATACGTAATTATACGTAACTCAATAATACATAATTAATAGGTGCTTGCTATTTGCAAGCCATATGGCTTATTAGAGCATCAGACTATTCT
TTGAGGCATCCGGAGCAATTATTACTATTCTCATCATACAGATGAGGATAGGCTTAGAGTGTTTTCTGAGTGTGATCTAAACAGTGCTACTCAAAATG
TGTCTGCAGAGAAGTGCTTGTCTGTGAACTGTTTGTTACAGGTCAGTGATTCAATAAGGAGCTTGGGCCAGAAAGTGTATCAGTATACTGCTGTCTTC
ATCGAGAAATTTTGGTTTTAAAAAAATTATCAGCTGAAGGAAATAGTGTGCTTAGTGTGGTAGTTAATTTATCTTCTTGTGCAAGTTATTTGTTATGA
TGGGCCAGTGATGGTTTGTAGAACAGCACTTCGAGTAGCACTCATTGTGAAGTCTCTTCTAAATTTCAGCTTTCCATGCAGTATCTCCTTTACAAGAA
AAACGTCTTGCTATAGTTAGTCTCTCTCTCACCACTTGGTAACACTCCATTAGCACATTCAGCAGCTTTATCGAAATTGAATCAGTATACTAAATACT
GTGCATACTAAAGTGTGCAATGTGATATTTTGACATATACATATTTACATCCATGAAAGCATCACCACAAATTAGGATAATGAACATTTGATCACTCC
TGAAGCTTTCCTCTTGGTCCTCTATAGTCCCTGTCCCTTCCATTTCCCACAAGTAACCACTGATCTGCTTCCTGTCACTATAGATGGTTGCATTTTTG
GAAGTTTAGTATAAAGGAATCATATAGTGTGTAATTTTTTTTTAATCTGGCTTCTTTCAGCATTATTTTGCGTTTCATCCATGTTGCATGTATCCGTA
GTTCATTTCTTTTTATTGTTCAGAAGTATTATGTTGTAGAGTTCTGCCACAATTTATTCACCTATTGATGGATATTTTGGTTGGTTCAAGTTTTAGGC
ATTAGAATACACAGAATGCTGCGAACTTTCTTGCATACATCTTTGAACGAACATATGCTTTTTTTTGAGCAAGTACTTTAGAATGAAATGGCTGGATG
ATATGGTAGGTTTATTTTTTCAAGATACTACCGAAATTAAAAAAAAATTTTATTTGAATAATTTTTGAGGGTACAGGTGGTTTTTGGTTGCACGGAGA
AGTTATTTAGCGGTGATTTCTGAGATTTTAGTGCACCCATCACCCGAGCAGTATACTGTACCCTAAATGTAATCTTTTATCCTTCATGCCCCTCCCAG
CCTTCCTCCCCAAGTCCACCATGTCCATTATATTACTCTTACGCCTTTGTATCCTCATAGCTTAGGTTTTCCATTCCCGAGTTACTTCGCTTAGAATA
ATGACTGTCAAGCTTTTTCAAAGTGATTTTAACATTTTGCATTTCCATTGCAGTCTATGAGAGTTCCAGCTCCATCTTGCCAACACTTGGCATTGCCA
GTCTTTTTAATTTCAGTTATTTTAATATGTATTGTCTCACAGTGGTTTTAGCAATATTTAACAAATTTCCCTAATGACCAATGATGTTAAGCATCTTT
TCATGTGCATATTTGCCATGTATACATCTTCAGTGAAGTGTCTGCTCAGATCTGTTGCCCATTTTTCAATTGGATTTTTTGTTTTCCTAGTATTGAGG
TTTGAGAGCTCTTTTGACTTATTCTGAATACAAATCCTTTATTAGATAGATACTTTGCAGATACTTTCTTCTAATCTGTGGCTTATCTTTTTTCCCCC
ATGTAAATTGACCCTATATTGTTTTAGAACAGTTTTAGATAAACCAAACTTTAAGAGATAGTACAGAGTTTCTATATTATTAACATTTTACATTAGA 
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COMMD9	(1	HRE	sequence,	3	potential	HRE	sequences):	
	
	
 
AGCCCAGTATAGGTGTCTGGGCAGTTGGACATTTCCTCTAGCCAGATCTGTCCGAATAGAGCCATCTGGGTACATGACGCAGAGGGCATTTGATAAAT
AACTGGAAAAGTCAATAAATCTTTGCTACCCTTCACCTCGTGATCATTTAAGGCATTTGTTTTCCTCTGTTAGTGATGATGGATTGTTTGTAGATACC
GTATTTCTGGTTGGCCTGGCCCTATCTCAGAAGGGCCTCCTGGCTCTTATCTGTTGATCTCAAAGGAAGTTGGCTCATTCACTGCTTGTCTGGTTTCC
CAGTAGTACTTTGTGTGATGAAGCAGCTGTATACAAACTGTCCTTCCTCAGGGTGTGGCAAGGTTTGGATGTCCAAACTCCATCCACAGAAGGACAAT
GATCCATCTCACTGGTGCCTGTGCTGGCTGCCCAACACATCCCACCCAGCCACCCACCAACAGGGGTCAGCATCTGCCTCAATCCTGATCAAATGCAT
GTGCCACAGCGATTGTCTCATGAATGTTCATGATTCCAATCAGCCAATCTGAGTCTGTCCCTGGGGCTTTCTCTGCTGTAATTTCTGAGACCACCTCC
TGCCTCTAGGCTCTGACAGCCAGGCCAGTGATGATGAGGTCCATCTTCCTGCCACACCGAAAGCTCATCTGCAGTCGGAGAGGCCATCTAGACCCCAG
AGGTTGGGAAGAAGATGAGAAAATCTTGGTACCTGATGCCATTCCCACTCTTCCTCCTTATGTATTCATCAGGACGGACCAGGCTTGTGTTAAGGTGT
ACCCGGGATTTGTTTTAATCAGGAATGGCAAGACTCACAGGCACAGAGGTGATTGTCATGAGGAAGAAGTCTGTGCTCACAGAACCCTAGAAACAGGA
GGCATGGCATGCCACGTAGGGCCACATGGGGAAGGACCATCTCTCTGGGGCTTTTGGGGAAGTTGGAAACAGGTGCTCTTTTTCCTTCCCGTTGATCA
TTAAACATTGAGTCCCTCGTCTCTAGGGAGGGGACTTCTTATTTACCCCTGGGTTGGGAAATAAATCATGACAGCAGCAATCAGACAACAGCAGAGAA
GTGTGTGATCTGAACATCTGTGGGATGCCGTGATCCCTGGAGGAGCCCTTCACACTGATCCCATGAATGGCCCTCAACACATGCACGAGCAAGGAGCA
AGCGTTCCGACAAGTGCTCTCGCAGTACTCCAAGGAAGAGGCTGAAATTTGACTCAGCAAAGCCCAGAGGGAAAAGGGAAAGTGGTTTATGAGTGTCC
TCAGGAGCTATCACATCCTAGACACTAGGCACTTTCATCTAAATGACTCTGATGACCCCAGTGTTGTCAGTGCTCCTCAGTCAGTGGATCAGACTTGC
CCTTGGCATGAGGAGGATAGTCAGTCACTCCTGGTCCCCTTCAGAGGGACCTTTTGAGAAAAAAATATAGCCAATTACTTATGTAACCCCAGGCACTC
TGTCCTGAATCCTGGGCATTCCACCACCGTGGAGAAATAGGTTAGTCCCAGACACATGACACCAGCCTATGAGGCAGCTCCGGGACTCAGCTGCTCGA
ACGAGCGTCGCAATTTCAAGTTGGGAATTAACGGCAACACCTGACAACACAACACAATGCAGTAGCCATCAAGCAGGAAGCCCGAGCACTCCACTCTC
AGCTGTACCTTGCCAAGCAGTGGCTGCTGTCTGTCGGGAGCAGGTAGCAAGTCAAGATCAGTCTAAGGACATTCCATGTCCATCTGGCATCAAACCAC
CCTGCTACCTATGCCAGTTGTTCTCAGGATTTGTTTTAATCAGGAATGGTAAGACATAAGGCACACAGACGTGGAAATGATTATCATGAAGGAAGAAG
TTTGTGCTCATAGAGCTCTAGAAGCAGGAGGTGTGGCACACGGGGCCACATGGTTCGGAAGGATAAGTGTTGGTCAGGAGGCAGGGAGAGGGGAGAGC
ATGGCCCCAAGCCTTTATTGGGGTTTTCATAGGAAGGAATGGTTAAGACAAGGTACATATGCTGGCTAAGTTTAGGGTTGGATAGTTTGAATAATTG 
	 248	
	
